<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pharmacology Test  Ii - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / NEET PG Test Series Subject Wise / Year 2019 - 20
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x248e04=_0x772b;(function(_0x533fe4,_0x69818b){const _0x3d8cd0=_0x772b,_0x31ba4e=_0x533fe4();while(!![]){try{const _0x418602=-parseInt(_0x3d8cd0(0x3cb))/0x1+-parseInt(_0x3d8cd0(0x2fd))/0x2*(parseInt(_0x3d8cd0(0x363))/0x3)+-parseInt(_0x3d8cd0(0x156))/0x4*(-parseInt(_0x3d8cd0(0x194))/0x5)+parseInt(_0x3d8cd0(0x234))/0x6*(-parseInt(_0x3d8cd0(0x2b2))/0x7)+parseInt(_0x3d8cd0(0x419))/0x8*(parseInt(_0x3d8cd0(0x2ab))/0x9)+-parseInt(_0x3d8cd0(0xb4))/0xa*(parseInt(_0x3d8cd0(0x256))/0xb)+parseInt(_0x3d8cd0(0x1d6))/0xc;if(_0x418602===_0x69818b)break;else _0x31ba4e['push'](_0x31ba4e['shift']());}catch(_0x4de572){_0x31ba4e['push'](_0x31ba4e['shift']());}}}(_0x4c07,0xc6c64));const _0x1ebf60=(function(){const _0x5c3a72=_0x772b,_0x19249b={'YhjSx':function(_0x353fda,_0x685af7,_0x110e81){return _0x353fda(_0x685af7,_0x110e81);},'jbWOK':function(_0x2e9ac4,_0x531f87){return _0x2e9ac4===_0x531f87;},'xSDiG':_0x5c3a72(0x33d)};let _0x91ab76=!![];return function(_0x42d363,_0x51565d){const _0x1b6180=_0x5c3a72;if(_0x19249b[_0x1b6180(0x1c4)](_0x19249b[_0x1b6180(0x157)],_0x1b6180(0x33d))){const _0x541c61=_0x91ab76?function(){const _0x1c5fad=_0x1b6180;if(_0x51565d){const _0x42a24f=_0x51565d[_0x1c5fad(0x1b8)](_0x42d363,arguments);return _0x51565d=null,_0x42a24f;}}:function(){};return _0x91ab76=![],_0x541c61;}else _0x19249b['YhjSx'](_0x3abce0,_0x245c11,_0x513175);};}()),_0x5ef201=_0x1ebf60(this,function(){const _0x49449b=_0x772b;return _0x5ef201[_0x49449b(0x282)]()['search']('(((.+)+)+)+$')[_0x49449b(0x282)]()[_0x49449b(0x1cf)](_0x5ef201)[_0x49449b(0x123)]('(((.+)+)+)+$');});_0x5ef201();const _0x5796a6=(function(){let _0x13d45d=!![];return function(_0x1b4ff3,_0x7f5fab){const _0x55ba33=_0x13d45d?function(){const _0x2d6fa6=_0x772b;if(_0x7f5fab){const _0x1b232a=_0x7f5fab[_0x2d6fa6(0x1b8)](_0x1b4ff3,arguments);return _0x7f5fab=null,_0x1b232a;}}:function(){};return _0x13d45d=![],_0x55ba33;};}()),_0x59db03=_0x5796a6(this,function(){const _0x3276f7=_0x772b,_0x193dc9={'wnPmw':function(_0x1df4f2,_0x173a1f){return _0x1df4f2(_0x173a1f);},'Amwpx':function(_0x1696bf,_0x5ce4b0){return _0x1696bf+_0x5ce4b0;},'NjkqF':_0x3276f7(0x3be),'TYDhV':'{}.constructor(\x22return\x20this\x22)(\x20)','iPbnf':'warn','OICXc':'info','yYoxj':_0x3276f7(0x168),'MhnJl':_0x3276f7(0x1c2),'jFzWM':_0x3276f7(0x383),'UqEbt':function(_0x3540ea,_0x3ed433){return _0x3540ea<_0x3ed433;}};let _0x4669bd;try{const _0x3ff5a3=_0x193dc9[_0x3276f7(0x254)](Function,_0x193dc9['Amwpx'](_0x193dc9[_0x3276f7(0x1e4)](_0x193dc9[_0x3276f7(0x97)],_0x193dc9['TYDhV']),');'));_0x4669bd=_0x3ff5a3();}catch(_0x4e6117){_0x4669bd=window;}const _0x5202be=_0x4669bd[_0x3276f7(0x402)]=_0x4669bd['console']||{},_0x56c25a=[_0x3276f7(0x27f),_0x193dc9[_0x3276f7(0xb1)],_0x193dc9[_0x3276f7(0x1a6)],_0x193dc9[_0x3276f7(0x1ae)],_0x3276f7(0x2be),_0x193dc9[_0x3276f7(0x40b)],_0x193dc9[_0x3276f7(0x371)]];for(let _0x24b463=0x0;_0x193dc9[_0x3276f7(0x2ed)](_0x24b463,_0x56c25a[_0x3276f7(0x125)]);_0x24b463++){const _0x2e5f5a=_0x5796a6[_0x3276f7(0x1cf)][_0x3276f7(0x14e)][_0x3276f7(0x193)](_0x5796a6),_0x411a23=_0x56c25a[_0x24b463],_0xee6059=_0x5202be[_0x411a23]||_0x2e5f5a;_0x2e5f5a[_0x3276f7(0x158)]=_0x5796a6['bind'](_0x5796a6),_0x2e5f5a[_0x3276f7(0x282)]=_0xee6059['toString']['bind'](_0xee6059),_0x5202be[_0x411a23]=_0x2e5f5a;}});_0x59db03();let questionsData=[{'text':_0x248e04(0x20c),'choices':[{'id':0x1,'text':_0x248e04(0x3ff)},{'id':0x2,'text':_0x248e04(0x25e)},{'id':0x3,'text':_0x248e04(0x175)},{'id':0x4,'text':_0x248e04(0x20a)}],'correct_choice_id':0x1,'solution':'<p><strong>Primaquine</strong>\x20is\x20<strong>gametocidal</strong>\x20<strong>to\x20all\x20species</strong>\x20causing\x20malaria.\x20It\x20inhibits\x20transmission\x20of\x20malaria.</p>\x0a<p>The\x20drugs\x20with\x20clinically\x20important\x20gametocidal\x20activity\x20(against\x20all\x20species)\x20are:</p>\x0a<ul>\x0a<li>High\x20activity:\x0a<ul>\x0a<li>Artemisinins</li>\x0a<li>Primaquine</li>\x0a</ul>\x0a</li>\x0a<li>Low\x20to\x20moderate\x20activity:\x0a<ul>\x0a<li>Chloroquine</li>\x0a<li>Quinine</li>\x0a<li>Atovaquone/proguanil</li>\x0a</ul>\x0a</li>\x0a<li>No\x20activity:\x0a<ul>\x0a<li>Mefloquine</li>\x0a<li>Pyrimethamine</li>\x0a<li>Sulfadoxine</li>\x0a<li>Tetracycline</li>\x0a</ul>\x0a</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[_0x248e04(0x41f)]},{'text':_0x248e04(0x8c),'choices':[{'id':0x1,'text':_0x248e04(0x30e)},{'id':0x2,'text':'Erlotinib\x20–\x20Human\x20EGFR1\x20monoclonal\x20Ab'},{'id':0x3,'text':_0x248e04(0x395)},{'id':0x4,'text':_0x248e04(0x34a)}],'correct_choice_id':0x3,'solution':_0x248e04(0xad),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'The\x20drug\x20efavirenz\x20inhibits','choices':[{'id':0x1,'text':_0x248e04(0x3d5)},{'id':0x2,'text':_0x248e04(0x224)},{'id':0x3,'text':_0x248e04(0x435)},{'id':0x4,'text':_0x248e04(0x191)}],'correct_choice_id':0x3,'solution':_0x248e04(0x405),'explanation_video':'','question_images':[],'explanation_images':[_0x248e04(0x388)]},{'text':'Which\x20among\x20the\x20following\x20is\x20a\x20motilide?','choices':[{'id':0x1,'text':_0x248e04(0x3e8)},{'id':0x2,'text':_0x248e04(0x1f3)},{'id':0x3,'text':'Tetracycline'},{'id':0x4,'text':_0x248e04(0x162)}],'correct_choice_id':0x1,'solution':_0x248e04(0x1cc),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x253),'choices':[{'id':0x1,'text':_0x248e04(0x1ab)},{'id':0x2,'text':'Tinidazole'},{'id':0x3,'text':'Ofloxacin'},{'id':0x4,'text':_0x248e04(0x32a)}],'correct_choice_id':0x3,'solution':'<p>The\x20given\x20clinical\x20scenario\x20of\x20a\x20patient\x20developing\x20symptoms\x20like\x20<strong>restlessness</strong>\x20and\x20<strong>flushing</strong>\x20<strong>after\x20taking\x20alcohol\x20after\x20medication</strong>\x20is\x20suggestive\x20of\x20a\x20<strong>disulfiram-like\x20reaction</strong>.\x20Among\x20the\x20given\x20drugs,\x20<strong>ofloxacin</strong>\x20is\x20<strong>not\x20associated</strong>\x20with\x20a\x20<strong>disulfiram-like\x20reaction</strong>.</p>\x0a<p>Some\x20important\x20drugs\x20which\x20cause\x20a\x20disulfiram-like\x20reaction\x20are:</p>\x0a<ul>\x0a<li><strong>Metronidazole,\x20Tinidazole</strong></li>\x0a<li>Some\x20cephalosporins<strong>&nbsp;</strong>like\x20<strong>cefoperazone</strong></li>\x0a<li>1st\x20generation\x20sulfonylureas\x20like\x20tolbutamide</li>\x0a<li>Procarbazine</li>\x0a</ul>\x0a<p>These\x20drugs\x20<strong>inhibit\x20aldehyde\x20dehydrogenase</strong>,\x20similar\x20to\x20disulfiram.\x20When\x20alcohol\x20is\x20combined\x20with\x20these\x20drugs,\x20acetaldehyde\x20accumulates\x20and\x20causes\x20unpleasant\x20symptoms\x20like\x20flushing,\x20sweating,\x20tachycardia,\x20hypotension,\x20nausea,\x20vomiting,\x20dizziness,\x20and\x20headache.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20drug\x20can\x20be\x20used\x20for\x20pain\x20relief\x20in\x20a\x20patient\x20with\x20the\x20following\x20barium\x20swallow?','choices':[{'id':0x1,'text':_0x248e04(0x16e)},{'id':0x2,'text':'Tramadol'},{'id':0x3,'text':_0x248e04(0x1ea)},{'id':0x4,'text':_0x248e04(0x418)}],'correct_choice_id':0x4,'solution':'<p><strong>Sildenafil\x20citrate</strong>\x20-\x20PDE\x205\x20inhibitor\x20can\x20be\x20used\x20for\x20pain\x20relief\x20in\x20<strong>diffuse\x20esophageal\x20spasm</strong>.</p>\x0a<p>The\x20image\x20<strong>depicts\x20Corkscrew\x20/\x20Rosary\x20bead\x20appearance</strong>\x20of\x20the\x20esophagus,\x20characteristically\x20seen\x20in\x20<strong>Diffuse\x20Esophageal\x20Spasm.</strong></p>\x0a<p>The\x20pathophysiology\x20of\x20the\x20disease,\x20at\x20least\x20in\x20part,\x20involves\x20inadequate\x20Nitric\x20Oxide(NO)\x20synthesis\x20or\x20impaired\x20Degradation\x20of\x20NO.</p>\x0a<p><strong>Treatment</strong>:</p>\x0a<p>Initial\x20Therapy:\x20Calcium\x20Channel\x20Blocker\x20-\x20<strong>CCB</strong>\x20(Diltiazem)</p>\x0a<p>Tri-Cyclic\x20Antidepressants\x20-\x20<strong>TCA</strong>\x20(Imipramine)</p>\x0a<p>For\x20resistant\x20Cases:NO\x20Donors\x20(<strong>Sildenafil/Nitrates)</strong></p>\x0a<p><strong>Botulinum\x20Toxin.</strong></p>','explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/df616c8d96b94adca2542967a691f8a6.JPEG'],'explanation_images':[]},{'text':_0x248e04(0x1a8),'choices':[{'id':0x1,'text':_0x248e04(0x24d)},{'id':0x2,'text':_0x248e04(0x298)},{'id':0x3,'text':_0x248e04(0x35a)},{'id':0x4,'text':'Calcium\x20Supplements'}],'correct_choice_id':0x3,'solution':'<p>The\x20image\x20shows\x20an\x20X-Ray\x20that\x20is\x20suggestive\x20of<strong>\x20Rickets.\x20</strong>There\x20is\x20<strong>thickening\x20and\x20widening\x20of\x20the\x20growth\x20plate.</strong></p>\x0a<p><strong>Stoss\x20therapy</strong>\x20is\x20used\x20to\x20treat\x20<strong>nutritional\x20rickets.</strong><br\x20/><br\x20/></p>\x0a<p>Treatment\x20of\x20<strong>nutritional\x20rickets</strong>\x20is\x20by\x20:</p>\x0a<p><strong>Stoss\x20therapy</strong>\x20-\x203\x20-\x206\x20lakh\x20international\x20units\x20of\x20Vit\x20D\x20IM\x20or\x20Oral.\x20Alternatively,\x20Daily\x20high\x20dose\x20Vit.\x20D\x20orally\x20-\x202000-5000\x20IU\x20Day,\x20over\x204-6\x20weeks\x20-&gt;\x20followed\x20by\x20400\x20IU\x20per\x20day\x20with\x20calcium\x20supplements\x20for\x202-4\x20months.</p>\x0a<p><strong>Hypophosphatemic\x20Rickets</strong>\x20is\x20treated\x20with\x20Joule&rsquo;s\x20Solution\x20(\x20Dibasic\x20Sodium\x20Phosphate\x20&amp;\x20Phosphoric\x20Acid).</p>\x0a<p><strong>Renal\x20Tubular\x20Acidosis</strong>\x20<strong>associated\x20Rickets</strong>\x20is\x20treated\x20with\x20<strong>Shohl&rsquo;s\x20Solution</strong>\x20(\x20Citric\x20Acid\x20&amp;\x20Sodium\x20Citrate),\x20Bicarbonate\x20and\x20Phosphate\x20supplementation.</p>','explanation_video':'','question_images':[_0x248e04(0xc6)],'explanation_images':[]},{'text':_0x248e04(0x3ef),'choices':[{'id':0x1,'text':_0x248e04(0x174)},{'id':0x2,'text':_0x248e04(0xd3)},{'id':0x3,'text':_0x248e04(0x3ed)},{'id':0x4,'text':'Ceftizoxime'}],'correct_choice_id':0x1,'solution':_0x248e04(0x2ee),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x96),'choices':[{'id':0x1,'text':'50\x20ng/min'},{'id':0x2,'text':_0x248e04(0x430)},{'id':0x3,'text':_0x248e04(0x2b6)},{'id':0x4,'text':_0x248e04(0x271)}],'correct_choice_id':0x2,'solution':_0x248e04(0x3fa),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x411),'choices':[{'id':0x1,'text':'Maximum\x20recommended\x20daily\x20dose\x20is\x20400\x20mg'},{'id':0x2,'text':'Tramadol-induced\x20respiratory\x20depression\x20is\x20reversed\x20by\x20naloxone'},{'id':0x3,'text':_0x248e04(0x35b)},{'id':0x4,'text':_0x248e04(0x40c)}],'correct_choice_id':0x3,'solution':'<p>For\x20the\x20treatment\x20of\x20<strong>mild-to-moderate\x20pain</strong>,\x20<strong>tramadol</strong>\x20is\x20as<strong>\x20effective\x20</strong>as<strong>\x20morphine</strong>\x20or\x20meperidine.\x20However,\x20for\x20the\x20treatment\x20of\x20severe\x20or\x20chronic\x20pain,\x20tramadol\x20is<strong>\x20less\x20effective.</strong></p>\x0a<p><strong>Tramadol&nbsp;</strong>is\x20a\x20synthetic\x20codeine\x20analog&nbsp;that\x20acts\x20as\x20a\x20<strong>mu-opioid\x20receptor&nbsp;agonist</strong>.\x20It\x20also\x20acts\x20by\x20inhibiting\x20the\x20uptake\x20of\x20norepinephrine\x20and\x20serotonin.&nbsp;The\x20<strong>action\x20peaks</strong>\x20within<strong>\x202&ndash;3\x20hours</strong>\x20of\x20oral\x20dosing.\x20The\x20<strong>duration</strong>\x20of\x20<strong>analgesia</strong>\x20is\x20about\x20<strong>6\x20hours</strong>.</p>\x0a<p>The\x20<strong>maximum\x20recommended\x20daily\x20dose</strong>\x20is:</p>\x0a<ul>\x0a<li><strong>400\x20mg</strong>\x20for\x20<strong>adults</strong></li>\x0a<li>300\x20mg\x20in\x20patients\x20&gt;75\x20years\x20old</li>\x0a<li>200\x20mg\x20for\x20patients\x20with\x20low\x20creatinine\x20clearance</li>\x0a</ul>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20386\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Adverse\x20effects\x20include\x20nausea,\x20vomiting,\x20dizziness,\x20dry\x20mouth,\x20sedation,\x20headache\x20and\x20respiratory\x20depression.\x20Tramadol-induced\x20<strong>respiratory</strong>\x20<strong>depression</strong>\x20is\x20<strong>reversed</strong>\x20by<strong>\x20naloxone</strong>.\x20Tramadol\x20can\x20<strong>exacerbate\x20seizures</strong>\x20in\x20patients\x20with\x20predisposing\x20factors.\x20Tramadol\x20should\x20be\x20avoided\x20in\x20patients\x20taking\x20MAO\x20inhibitors,\x20SSRIs,\x20or\x20other\x20drugs\x20that\x20lower\x20the\x20seizure\x20threshold.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p><strong>Clinical\x20relevance</strong>:\x20Precipitation\x20of\x20withdrawal\x20necessitates\x20that\x20tramadol\x20is\x20tapered\x20prior\x20to\x20discontinuation.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0xb8),'choices':[{'id':0x1,'text':'Ezetimibe'},{'id':0x2,'text':_0x248e04(0x16a)},{'id':0x3,'text':_0x248e04(0x3ab)},{'id':0x4,'text':'Niacin'}],'correct_choice_id':0x4,'solution':_0x248e04(0x88),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x2f4),'choices':[{'id':0x1,'text':_0x248e04(0x438)},{'id':0x2,'text':_0x248e04(0x225)},{'id':0x3,'text':'Prilocaine'},{'id':0x4,'text':_0x248e04(0x10b)}],'correct_choice_id':0x3,'solution':_0x248e04(0x93),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x3d3),'choices':[{'id':0x1,'text':_0x248e04(0xc7)},{'id':0x2,'text':_0x248e04(0x1df)},{'id':0x3,'text':_0x248e04(0x291)},{'id':0x4,'text':_0x248e04(0x339)}],'correct_choice_id':0x3,'solution':'<p>Methacholine\x20has\x20a\x20<strong>predominantly\x20muscarinic\x20effect</strong>\x20with\x20only\x20<strong>minor\x20nicotinic</strong>\x20actions,\x20the\x20former\x20manifest\x20most\x20clearly\x20in\x20the\x20cardiovascular\x20system.</p>\x0a<p>Methacholine\x20is\x20administered\x20by\x20inhalation\x20for\x20the\x20<strong>diagnosis\x20of\x20bronchial\x20airway\x20hyperreactivity</strong>\x20in\x20patients\x20who\x20do\x20not\x20have\x20clinically\x20apparent\x20asthma.</p>\x0a<p>It\x20is\x20a\x20synthetic\x20choline\x20ester\x20that\x20differs\x20from\x20ACh\x20chiefly\x20in\x20its\x20<strong>greater\x20duration</strong>\x20and\x20selectivity\x20of\x20action.\x20Its\x20action\x20is\x20more\x20prolonged\x20because\x20the\x20added\x20<strong>methyl\x20group\x20increases\x20its\x20resistance</strong>\x20to\x20hydrolysis\x20by\x20cholinesterases.</p>\x0a<p>&nbsp;</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Coadministration\x20of\x20lenalidomide\x20with\x20which\x20other\x20drug\x20increases\x20the\x20risk\x20for\x20thrombosis?','choices':[{'id':0x1,'text':_0x248e04(0x2b3)},{'id':0x2,'text':_0x248e04(0x307)},{'id':0x3,'text':'Glucocorticoids'},{'id':0x4,'text':_0x248e04(0x167)}],'correct_choice_id':0x3,'solution':_0x248e04(0x278),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x3b5),'choices':[{'id':0x1,'text':_0x248e04(0x333)},{'id':0x2,'text':_0x248e04(0x308)},{'id':0x3,'text':_0x248e04(0x2fc)},{'id':0x4,'text':_0x248e04(0x17b)}],'correct_choice_id':0x3,'solution':_0x248e04(0x400),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'The\x20inhibition\x20of\x20hydrochloric\x20acid\x20secretion\x20by\x20omeprazole\x20occurs\x20within\x20an\x20hour,\x20reaches\x20a\x20peak\x20at\x202\x20hours,\x20and\x20plateaus\x20by\x20the\x204th\x20day.\x20After\x20how\x20many\x20days\x20will\x20the\x20secretion\x20gradually\x20normalize\x20after\x20stopping\x20the\x20drug?','choices':[{'id':0x1,'text':_0x248e04(0x2af)},{'id':0x2,'text':'1-2\x20days'},{'id':0x3,'text':_0x248e04(0xab)},{'id':0x4,'text':'6-10\x20days'}],'correct_choice_id':0x3,'solution':_0x248e04(0x3e0),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x301),'choices':[{'id':0x1,'text':_0x248e04(0x2eb)},{'id':0x2,'text':'Hypokalemia'},{'id':0x3,'text':'Hyperkalemia'},{'id':0x4,'text':_0x248e04(0x361)}],'correct_choice_id':0x2,'solution':_0x248e04(0x159),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0xf8),'choices':[{'id':0x1,'text':_0x248e04(0x243)},{'id':0x2,'text':_0x248e04(0x40d)},{'id':0x3,'text':_0x248e04(0x36e)},{'id':0x4,'text':_0x248e04(0x436)}],'correct_choice_id':0x2,'solution':_0x248e04(0x169),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0xd9),'choices':[{'id':0x1,'text':'Metronidazole'},{'id':0x2,'text':_0x248e04(0x3fb)},{'id':0x3,'text':_0x248e04(0x396)},{'id':0x4,'text':_0x248e04(0x31a)}],'correct_choice_id':0x1,'solution':_0x248e04(0x263),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/2863a47642994f5f876865075adb5f88.JPEG'],'explanation_images':[]},{'text':_0x248e04(0x137),'choices':[{'id':0x1,'text':_0x248e04(0x3d8)},{'id':0x2,'text':_0x248e04(0x209)},{'id':0x3,'text':'Lomefloxacin'},{'id':0x4,'text':_0x248e04(0x1f8)}],'correct_choice_id':0x2,'solution':_0x248e04(0x349),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Tolerance\x20occurs\x20to\x20all\x20actions\x20of\x20morphine\x20except:','choices':[{'id':0x1,'text':_0x248e04(0x2bc)},{'id':0x2,'text':'Analgesic'},{'id':0x3,'text':'Euphoric'},{'id':0x4,'text':'All\x20of\x20the\x20above'}],'correct_choice_id':0x1,'solution':_0x248e04(0x145),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x434),'choices':[{'id':0x1,'text':_0x248e04(0x3a8)},{'id':0x2,'text':'Insulin'},{'id':0x3,'text':_0x248e04(0x317)},{'id':0x4,'text':_0x248e04(0x398)}],'correct_choice_id':0x1,'solution':_0x248e04(0x32b),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x38f),'choices':[{'id':0x1,'text':'Phenytoin'},{'id':0x2,'text':_0x248e04(0x1d0)},{'id':0x3,'text':'Vigabatrin'},{'id':0x4,'text':_0x248e04(0x2e3)}],'correct_choice_id':0x3,'solution':_0x248e04(0x2d3),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x15e),'choices':[{'id':0x1,'text':_0x248e04(0x229)},{'id':0x2,'text':_0x248e04(0x185)},{'id':0x3,'text':_0x248e04(0x221)},{'id':0x4,'text':_0x248e04(0xb6)}],'correct_choice_id':0x3,'solution':_0x248e04(0x201),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20antitubercular\x20drug\x20is\x20bacteriostatic:','choices':[{'id':0x1,'text':_0x248e04(0x342)},{'id':0x2,'text':'Rifampicin'},{'id':0x3,'text':'Pyrazinamide'},{'id':0x4,'text':_0x248e04(0x153)}],'correct_choice_id':0x4,'solution':_0x248e04(0x166),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x34d),'choices':[{'id':0x1,'text':_0x248e04(0x394)},{'id':0x2,'text':_0x248e04(0x34e)},{'id':0x3,'text':_0x248e04(0x325)},{'id':0x4,'text':'Dorzolamide'}],'correct_choice_id':0x2,'solution':'<p>The\x20use\x20of\x20<strong>brimonidine\x20</strong>is<strong>\x20unsafe\x20</strong>in\x20infants<strong>.\x20</strong>It\x20is\x20an<strong>\x20alpha-2\x20agonist</strong>&nbsp;that&nbsp;can\x20cross\x20the\x20blood-brain\x20barrier.\x20This&nbsp;may\x20result\x20in\x20<strong>CNS\x20depression</strong>\x20and<strong>\x20apnoea</strong>\x20in\x20neonates.\x20Therefore\x20it\x20is\x20contraindicated&nbsp;in\x20children\x20less\x20than\x202\x20years.</p>\x0a<p>&alpha;<sub>2</sub>&nbsp;agonists,\x20through\x20the\x20activation\x20of\x20G-protein\x20coupled\x20receptor\x20activation,\x20inhibit\x20the\x20activity\x20of\x20adenylate\x20cyclase.\x20This\x20reduces\x20cAMP\x20and\x20hence\x20reduces\x20aqueous\x20humor\x20production\x20by\x20ciliary\x20action.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x26d),'choices':[{'id':0x1,'text':_0x248e04(0x1fe)},{'id':0x2,'text':_0x248e04(0x237)},{'id':0x3,'text':_0x248e04(0x259)},{'id':0x4,'text':_0x248e04(0x11e)}],'correct_choice_id':0x4,'solution':_0x248e04(0x18b),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x381),'choices':[{'id':0x1,'text':'Insulin\x20aspart'},{'id':0x2,'text':'Insulin\x20glargine'},{'id':0x3,'text':_0x248e04(0x1dd)},{'id':0x4,'text':_0x248e04(0x2f3)}],'correct_choice_id':0x1,'solution':_0x248e04(0x30f),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Initial\x20dose\x20of\x20edrophonium\x20for\x20diagnoisis\x20of\x20myasthenia\x20gravis\x20is_____________','choices':[{'id':0x1,'text':_0x248e04(0x14d)},{'id':0x2,'text':_0x248e04(0x247)},{'id':0x3,'text':_0x248e04(0x87)},{'id':0x4,'text':_0x248e04(0x1f0)}],'correct_choice_id':0x3,'solution':'<p><strong>Edrophonium</strong>\x20is\x20used\x20in\x20<strong>Ameliorative\x20test</strong>\x20for\x20diagnosing\x20myasthenia\x20gravis.\x20An\x20initial\x20dose\x20of\x20<strong>2mg</strong>\x20is\x20given\x20as\x20IV\x20push\x20over\x2015-30sec..</p>\x0a<ul>\x0a<li\x20style=\x22text-align:\x20left;\x22>Initially,&nbsp;<strong>2\x20mg</strong>\x20is\x20administered.\x20If\x20improvements\x20of\x20symptoms\x20do\x20not\x20occur\x20within\x2045\x20seconds,\x20an\x20additional\x208\x20mg\x20can\x20be\x20administered.</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Improvement\x20of\x20strength\x20unaccompanied\x20by\x20lingual\x20fasciculations\x20is\x20a\x20positive\x20test.</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Edrophonium\x20is\x20short-acting\x20because\x0a<ul>\x0a<li\x20style=\x22text-align:\x20left;\x22>The\x20binding\x20site\x20of\x20edrophonium\x20to\x20acetylcholine\x20esterase:\x20choline\x20subsite\x20of\x20the\x20active\x20center</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>No\x20reaction\x20with\x20the\x20enzyme:\x20reversible\x20binding\x20only</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Quaternary\x20structure:\x20rapid\x20elimination</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p>Edrophonium\x20in\x20Reversal\x20of\x20Nondepolarizing\x20Neuromuscular\x20Blockers:</p>\x0a<ul>\x0a<li>10\x20mg\x20IV\x20over\x2030-45\x20secs</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20presents\x20with\x20seizures,\x20severe\x20abdominal\x20pain,\x20and\x20dark-colored\x20urine.\x20She\x20has\x20a\x20previous\x20history\x20of\x20repeated\x20hospital\x20admission\x20for\x20similar\x20complaints.\x20A\x20diagnosis\x20of\x20acute\x20intermittent\x20porphyria\x20was\x20made\x20after\x20a\x20detailed\x20workup.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20contraindicated\x20in\x20this\x20patient?','choices':[{'id':0x1,'text':_0x248e04(0x2b1)},{'id':0x2,'text':'Barbiturate'},{'id':0x3,'text':_0x248e04(0x2c9)},{'id':0x4,'text':_0x248e04(0x40e)}],'correct_choice_id':0x2,'solution':_0x248e04(0x393),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'The\x20replacement\x20dose\x20of\x20hydrocortisone\x20for\x20chronic\x20adrenal\x20insufficiency\x20is\x20(in\x20mg/day):','choices':[{'id':0x1,'text':'10'},{'id':0x2,'text':'12'},{'id':0x3,'text':'20'},{'id':0x4,'text':'5'}],'correct_choice_id':0x3,'solution':'<p>The\x20<strong>replacement\x20dose</strong>\x20of\x20hydrocortisone\x20for\x20<strong>chronic\x20adrenal\x20insufficiency</strong>\x20is\x20<strong>2</strong><strong>0\x20mg/day.</strong></p>\x0a<p>The\x20treatment\x20of\x20chronic\x20adrenal\x20insufficiency\x20(<strong>not\x20in\x20crisis</strong>)\x20requires\x20glucocorticoid\x20replacement\x20at\x20a\x20dose\x20that\x20replaces\x20the\x20physiologic\x20daily\x20cortisol\x20production.\x20This\x20is\x20achieved\x20by\x20administering\x20an\x20oral\x20replacement\x20dose\x20of\x2015-25mg\x20Hydrocortisone.\u00a0<br\x20/>A\x20<strong>midpoint\x20dose\x20of\x2020mg</strong>\x20is\x20given\x20in\x202-3\x20divided\x20doses:\x20<strong>10mg\x20+\x205mg\x20+\x205mg</strong>.\u00a0<br\x20/>Half\x20the\x20daily\x20dose\x20should\x20be\x20administered\x20to\x20all\x20patients\x20in\x20the\x20morning.\x20This\x20is\x20to\x20follow\x20the\x20normal\x20circadian\x20rhythm.\u00a0</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x126),'choices':[{'id':0x1,'text':_0x248e04(0x221)},{'id':0x2,'text':_0x248e04(0x246)},{'id':0x3,'text':_0x248e04(0xb6)},{'id':0x4,'text':_0x248e04(0x3d6)}],'correct_choice_id':0x1,'solution':_0x248e04(0x373),'explanation_video':'','question_images':[],'explanation_images':['https://dhmbxeygs57ff.cloudfront.net/uploads/378bdd93332c47f1ac9b787f8fc79dccx512x140.PNG']},{'text':_0x248e04(0x21d),'choices':[{'id':0x1,'text':'Chlorpheniramine'},{'id':0x2,'text':'Dichlorphenamide'},{'id':0x3,'text':'Diethylcarbamazine'},{'id':0x4,'text':_0x248e04(0x438)}],'correct_choice_id':0x2,'solution':_0x248e04(0x2aa),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2040-year-old\x20male\x20comes\x20to\x20the\x20OPD\x20requesting\x20medications\x20to\x20quit\x20smoking.\x20He\x20complains\x20about\x20feeling\x20helpless\x20and\x20hopeless\x20most\x20of\x20the\x20time\x20since\x20years\x20and\x20also\x20reports\x20having\x20suicidal\x20ideations.\x20Which\x20of\x20the\x20following\x20is\x20the\x20drug\x20of\x20choice\x20in\x20this\x20patient?','choices':[{'id':0x1,'text':'Nortriptyline'},{'id':0x2,'text':_0x248e04(0x1b9)},{'id':0x3,'text':'Bupropion'},{'id':0x4,'text':_0x248e04(0x2d4)}],'correct_choice_id':0x3,'solution':'<p>The\x20patient\x20in\x20this\x20case\x20is\x20<strong>well\x20motivated\x20to\x20quit\x20smoking</strong>\x20however\x20the\x20patient\x20is\x20suffering\x20from\x20<strong>depression</strong>\x20and\x20hence\x20the\x20<strong>drug\x20of\x20choice\x20is\x20Bupropion\x20(depressed\x20patient\x20wishing\x20to\x20quit\x20smoking</strong>).</p>\x0a<ul>\x0a<li>A\x20sustained-release\x20preparation\x20of\x20the\x20<strong>antidepressant\x20bupropion</strong>\x20improves\x20abstinence\x20rates\x20among\x20smokers\x20and\x20remains\x20a\x20useful\x20option.\x20However,\x20Bupropion\x20decreases\x20the\x20seizure\x20threshold\x20and\x20should\x20be\x20<strong>avoided\x20in\x20patients\x20with\x20a\x20history\x20of\x20seizures.</strong></li>\x0a<li><strong>Varenicline,\x20a\x20partial\x20agonist\x20at\x20the\x20α4β2\x20subtype</strong>\x20of\x20the\x20nicotinic\x20acetylcholine\x20receptor,\x20reduces\x20cigarette\x20craving\x20and\x20improves\x20long-term\x20abstinence\x20rates.\x20It\x20has\x20high\x20receptor\x20affinity,\x20thus\x20blocking\x20access\x20to\x20nicotine,\x20so\x20if\x20the\x20treated\x20smoker\x20relapses,\x20there\x20is\x20hardly\x20any\x20reward,\x20and\x20abstinence\x20is\x20more\x20likely\x20to\x20be\x20maintained.</li>\x0a<li>The\x20nicotine\x20withdrawal\x20syndrome\x20can\x20be\x20alleviated\x20by<strong>\x20nicotine\x20replacement\x20therapy\x20(e.g.,\x20nicotine\x20inhaler\x20and\x20nasal\x20spray,\x20nicotine\x20gum\x20or\x20lozenge,\x20or\x20nicotine\x20transdermal\x20patch)</strong>.\x20These\x20methods\x20suppress\x20the\x20symptoms\x20of\x20nicotine\x20withdrawal.\x20However,\x20most\x20resume\x20smoking\x20over\x20the\x20ensuing\x20weeks\x20or\x20months.</li>\x0a<li>The\x20<strong>cannabinoid\x20CB1\x20receptor\x20inverse\x20agonist\x20rimonabant\x20</strong>improves\x20abstinence\x20rates\x20and\x20reduces\x20the\x20weight\x20gain\x20seen\x20frequently\x20in\x20ex-smokers.\x20It\x20was\x20found\x20to\x20be\x20linked\x20to<strong>\x20depressive\x20and\x20neurologic\x20symptoms\x20</strong>and\x20is\x20not\x20approved\x20by\x20the\x20FDA.</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20atypical\x20antipsychotics\x20has\x20the\x20highest\x20risk\x20of\x20galactorrhea?','choices':[{'id':0x1,'text':_0x248e04(0x368)},{'id':0x2,'text':_0x248e04(0x17e)},{'id':0x3,'text':'Clozapine'},{'id':0x4,'text':_0x248e04(0x147)}],'correct_choice_id':0x2,'solution':_0x248e04(0x141),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Longest\x20acting\x20SSRI\x20is','choices':[{'id':0x1,'text':'Fluoxetine'},{'id':0x2,'text':_0x248e04(0x2da)},{'id':0x3,'text':_0x248e04(0x82)},{'id':0x4,'text':_0x248e04(0x2d9)}],'correct_choice_id':0x1,'solution':_0x248e04(0x1ec),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x1fb),'choices':[{'id':0x1,'text':_0x248e04(0x216)},{'id':0x2,'text':_0x248e04(0x31f)},{'id':0x3,'text':_0x248e04(0x240)},{'id':0x4,'text':_0x248e04(0x31d)}],'correct_choice_id':0x1,'solution':_0x248e04(0x15c),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x42a),'choices':[{'id':0x1,'text':_0x248e04(0x1a4)},{'id':0x2,'text':_0x248e04(0x272)},{'id':0x3,'text':_0x248e04(0x1c6)},{'id':0x4,'text':_0x248e04(0x300)}],'correct_choice_id':0x1,'solution':_0x248e04(0x1c5),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x391),'choices':[{'id':0x1,'text':'Tacrine'},{'id':0x2,'text':_0x248e04(0x1e2)},{'id':0x3,'text':'Rivastigmine'},{'id':0x4,'text':_0x248e04(0x359)}],'correct_choice_id':0x3,'solution':_0x248e04(0x1ad),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x288),'choices':[{'id':0x1,'text':'Zanamivir'},{'id':0x2,'text':'Oseltamivir'},{'id':0x3,'text':'Peramivir'},{'id':0x4,'text':_0x248e04(0x90)}],'correct_choice_id':0x3,'solution':'<p><strong>Peramivir</strong>\x20is\x20available\x20for<strong>\x20intravenous\x20administration</strong>\x20in\x20<strong>uncomplicated\x20influenza\x20B\x20infections.</strong></p>\x0a<p>Route\x20of\x20administration\x20of\x20<strong>neuraminidase\x20inhibitors</strong>\x20in\x20influenza</p>\x0a<p>Zanamivir:\x20Inhalational</p>\x0a<p>Oseltamivir:\x20Oral</p>\x0a<p>Peramivir:\x20Intravenous</p>\x0a<p>Note:</p>\x0a<p>Oseltamavir\x20and\x20Zanamavir\x20IV\x20formulations\x20are\x20only\x20investigational\x20at\x20present</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x12f),'choices':[{'id':0x1,'text':_0x248e04(0x177)},{'id':0x2,'text':_0x248e04(0x399)},{'id':0x3,'text':_0x248e04(0x29f)},{'id':0x4,'text':_0x248e04(0x1b6)}],'correct_choice_id':0x3,'solution':'<p><strong>Gastric\x20bezoar</strong>\x20can\x20be\x20seen\x20in\x20a\x20patient\x20taking\x20sucralfate.\x20Sucralfate\x20produces\x20a\x20<strong>viscous\x20gel\x20that\x20has\x20a\x20‘sticky\x20nature’</strong>.\x20The\x20sticky\x20nature\x20may\x20be\x20responsible\x20for\x20gastric\x20bezoars,\x20particularly\x20in\x20those\x20with\x20gastroparesis.</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20919\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Sucralfate\x20is\x20composed\x20of\x20a\x20sulfate\x20of\x20sucrose\x20with\x20Al(OH)<sub>3.\u00a0</sub>It\u00a0undergoes\x20cross-linking\x20to\x20produce\x20a\x20viscous\x20polymer\x20that\x20sticks\x20to\x20epithelial\x20cells\x20and\x20ulcers\x20in\x20acidic\x20environments.\x20It\x20inhibits\x20hydrolysis\x20of\x20the\x20mucosal\x20proteins\x20by\x20pepsin.</p>\x0a<p>It\x20is\x20used\x20in\x20the\x20prophylaxis\x20of\x20stress\x20ulcers,\x20and\x20in\x20conditions\x20where\x20mucosal\x20ulceration\x20is\x20not\x20responding\x20to\x20acid\x20suppression.</p>\x0a<p>Adverse\x20effects\x20of\x20sucralfate\x20include\x20constipation\x20and\x20bezoar\x20formation.\x20It\x20may\x20inhibit\x20absorption\x20of\x20other\x20drugs\x20like\x20digoxin,\x20cimetidine,\x20ketoconazole,\x20and\x20fluoroquinolone\x20antibiotics\x20due\x20to\x20the\x20viscous\x20layer\x20formed\x20in\x20the\x20stomach.\x20Hence\x20it\x20should\x20be\x20taken\x20at\x20least\x202\x20hours\x20after\x20administration\x20if\x20these\x20drugs.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p>The\x20other\x20options:</p>\x0a<p><strong>Vitamin\x20B12\x20deficiency\x20</strong>and<strong>\x20increased\x20risk\x20of\x20bone\x20fractures\x20</strong>are\x20side\x20effects\x20of<strong>\u00a0proton\x20pump\x20inhibitors\x20</strong>(PPIs).\x20However,\x20their\x20clinical\x20significance\x20has\x20not\x20been\x20proven\x20yet.\u00a0<strong>Hypergastrinemia</strong>\x20is\x20more\x20commonly\x20seen\x20with<strong>\x20PPIs\x20</strong>than\x20H2\x20receptor\x20antagonists.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0xa0),'choices':[{'id':0x1,'text':_0x248e04(0x210)},{'id':0x2,'text':_0x248e04(0x1fa)},{'id':0x3,'text':_0x248e04(0x38e)},{'id':0x4,'text':_0x248e04(0x13c)}],'correct_choice_id':0x3,'solution':_0x248e04(0x269),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x32d),'choices':[{'id':0x1,'text':_0x248e04(0x341)},{'id':0x2,'text':'Perphenazine'},{'id':0x3,'text':_0x248e04(0x1aa)},{'id':0x4,'text':_0x248e04(0xf4)}],'correct_choice_id':0x3,'solution':_0x248e04(0x32e),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20statements\x20accurately\x20depicts\x20the\x20effect\x20of\x20ethyl\x20alcohol\x20on\x20CYP2E1?','choices':[{'id':0x1,'text':_0x248e04(0x42b)},{'id':0x2,'text':'Chronic\x20consumption\x20results\x20in\x20induction'},{'id':0x3,'text':_0x248e04(0x2a0)},{'id':0x4,'text':_0x248e04(0x23e)}],'correct_choice_id':0x2,'solution':_0x248e04(0x3f0),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x179),'choices':[{'id':0x1,'text':'Vigabatrin'},{'id':0x2,'text':_0x248e04(0x91)},{'id':0x3,'text':_0x248e04(0xbd)},{'id':0x4,'text':'Gabapentin'}],'correct_choice_id':0x2,'solution':'<p><strong>Tiagabine</strong>\x20acts\x20by\x20<strong>depressing\x20GABA\x20transporter\x20GAT-1</strong>\x20that\x20is\x20involved\x20in\x20the\x20removal\x20of\x20synaptically\x20released\x20GABA.</p>\x0a<p>Vigabatrin\x20is\x20an\x20inhibitor\x20of\x20GABA\x20transaminase\x20(option\x20a).</p>\x0a<p>Pregabalin\x20and\x20gabapentin\x20are\x20structurally\x20similar\x20to\x20GABA\x20but\x20do\x20not\x20have\x20any\x20effect\x20on\x20GABA\x20transporter\x20or\x20metabolism\x20(options\x20c\x20and\x20d).</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0xdb),'choices':[{'id':0x1,'text':_0x248e04(0x29c)},{'id':0x2,'text':_0x248e04(0x268)},{'id':0x3,'text':_0x248e04(0x274)},{'id':0x4,'text':_0x248e04(0x2ac)}],'correct_choice_id':0x3,'solution':_0x248e04(0xac),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x1ca),'choices':[{'id':0x1,'text':_0x248e04(0xe8)},{'id':0x2,'text':_0x248e04(0x26c)},{'id':0x3,'text':_0x248e04(0x324)},{'id':0x4,'text':_0x248e04(0x21e)}],'correct_choice_id':0x2,'solution':'<p>Angiotensin\x20II\x20through\x20central\x20action\x20increases\x20ADH\x20secretion\x20and\x20<strong>induces\x20thirst</strong>\x20(option\x20b).</p>\x0a<p>Angiotensin\x20II\x20causes\x20the\x20release\x20of\x20aldosterone\x20from\x20the\x20adrenal\x20cortex\x20(option\x20d).</p>\x0a<p>Angiotensin\x20II\x20is\x20recently\x20approved\x20(2017-USFDA)\x20for\x20clinical\x20use\x20to\x20increase\x20blood\x20pressure\x20in\x20patients\x20with\x20septic\x20or\x20other\x20distributive\x20shocks\x20(option\x20a).</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x21b),'choices':[{'id':0x1,'text':'Sodium'},{'id':0x2,'text':_0x248e04(0x344)},{'id':0x3,'text':_0x248e04(0x36c)},{'id':0x4,'text':'Calcium'}],'correct_choice_id':0x3,'solution':_0x248e04(0x116),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Choose\x20the\x20correct\x20pair\x20matching\x20with\x20the\x20diagram','choices':[{'id':0x1,'text':'A:\x20Thiazides\x20B:\x20Carbonic\x20anhydrase\x20inhibitors'},{'id':0x2,'text':'A:\x20Loop\x20diuretics\x20B:\x20Thiazides'},{'id':0x3,'text':_0x248e04(0x36b)},{'id':0x4,'text':_0x248e04(0xbf)}],'correct_choice_id':0x4,'solution':'<p><strong>A\x20is\x20the\x20loop\x20of\x20Henle;\x20loop\x20diuretics</strong>\x20act\x20on\x20the\x20thick\x20ascending\x20limb\x20of\x20the\x20loop\x20of\x20Henle.\x20<strong>B\x20is\x20proximal\x20convoluted\x20tubule;\x20carbonic\x20anhydrase\x20inhibitors</strong>\x20act\x20on\x20this\x20part.</p>\x0a<p>\u00a0</p>\x0a<p>\u00a0</p>','explanation_video':'','question_images':[_0x248e04(0x89)],'explanation_images':[]},{'text':_0x248e04(0x144),'choices':[{'id':0x1,'text':_0x248e04(0x379)},{'id':0x2,'text':_0x248e04(0x31f)},{'id':0x3,'text':'Anakinra'},{'id':0x4,'text':_0x248e04(0x3f5)}],'correct_choice_id':0x3,'solution':_0x248e04(0x180),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following,\x20acts\x20by\x20inhibiting\x20the\x20action\x20of\x20a\x20transporter?','choices':[{'id':0x1,'text':_0x248e04(0x28c)},{'id':0x2,'text':_0x248e04(0x163)},{'id':0x3,'text':'Acetazolamide'},{'id':0x4,'text':_0x248e04(0xfc)}],'correct_choice_id':0x2,'solution':_0x248e04(0xbc),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0xc9),'choices':[{'id':0x1,'text':_0x248e04(0x385)},{'id':0x2,'text':_0x248e04(0x41b)},{'id':0x3,'text':'Thiazide\x20like\x20diuretics'},{'id':0x4,'text':'Carbonic\x20anhydrase\x20inhibitors'}],'correct_choice_id':0x3,'solution':_0x248e04(0x3d7),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0xe3),'choices':[{'id':0x1,'text':_0x248e04(0x2a9)},{'id':0x2,'text':_0x248e04(0x280)},{'id':0x3,'text':_0x248e04(0x26b)},{'id':0x4,'text':_0x248e04(0x3a3)}],'correct_choice_id':0x3,'solution':_0x248e04(0x2c3),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x2bf),'choices':[{'id':0x1,'text':_0x248e04(0x196)},{'id':0x2,'text':_0x248e04(0x1d1)},{'id':0x3,'text':_0x248e04(0x213)},{'id':0x4,'text':_0x248e04(0x3ac)}],'correct_choice_id':0x4,'solution':'<p><strong>Tilisolol</strong>\x20is\x20a\x20third-generation\x20non-selective\x20beta-blocker\x20having\x20an\x20additional\x20action\x20of\x20opening\x20the\x20potassium\x20channels.</p>\x0a<p>Additional\x20activities\x20of\x203<sup>rd</sup>\x20generation\x20beta-blockers:</p>\x0a<ul>\x0a<li>α1\x20adrenergic\x20receptor\x20blockade:\x20labetalol,\x20carvedilol,\x20bucindolol,\x20bevantolol,\x20nipradilol</li>\x0a<li>Increased\x20production\x20of\x20NO:\x20celiprolol,\x20nebivolol,\x20carteolol,\x20bopindolol,\x20nipradolol</li>\x0a<li>β2\x20agonist\x20properties:\x20celiprolol,\x20carteolol,\x20bopindolol</li>\x0a<li>Ca2+\x20entry\x20blockade:\x20carvedilol,\x20betaxolol,\x20bevantolol</li>\x0a<li><strong>Opening\x20of\x20K+\x20channels:\x20tilisolol</strong></li>\x0a<li><strong>Antioxidant\x20action:\x20carvedilol</strong></li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x21a),'choices':[{'id':0x1,'text':_0x248e04(0x18d)},{'id':0x2,'text':_0x248e04(0x39f)},{'id':0x3,'text':_0x248e04(0x293)},{'id':0x4,'text':'HLA-B\x202406'}],'correct_choice_id':0x2,'solution':_0x248e04(0x15b),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'The\x20most\x20effective\x20drug\x20in\x20the\x20treatment\x20of\x20loa-loa\x20is?','choices':[{'id':0x1,'text':_0x248e04(0xbb)},{'id':0x2,'text':_0x248e04(0x25e)},{'id':0x3,'text':_0x248e04(0x33c)},{'id':0x4,'text':_0x248e04(0x178)}],'correct_choice_id':0x3,'solution':_0x248e04(0x2e1),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x14b),'choices':[{'id':0x1,'text':_0x248e04(0x30a)},{'id':0x2,'text':_0x248e04(0x16f)},{'id':0x3,'text':_0x248e04(0x2c5)},{'id':0x4,'text':'Janus\x20associated\x20kinase(Jak1)\x20inhibitor'}],'correct_choice_id':0x1,'solution':'<p><strong>Ibrutinib</strong>\x20is\x20a\x20<strong>Bruton</strong>\x20<strong>Tyrosine\x20kinase</strong>\x20<strong>inhibitor</strong>.\x20It\x20inhibits\x20malignant\x20B\x20cell\x20proliferation\x20-\x20used\x20in\x20CLL,\x20SLL,\x20Waldenstrom\x27s\x20Macroglobulinemia.</p>\x0a<p>Imatininib\x20is\x20a\x20BCR-\x20ABL\x20kinase\x20inhibitor.</p>\x0a<p>Palbociclib\x20is\x20a\x20CDK\x20inhibitor\x20approved\x20for\x20use\x20in\x20metastatic\x20breast\x20carcinoma.</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x201216\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Ruxolitinib\x20is\x20Jak1/2\x20inhibitor\x20indicated\x20for\x20the\x20treatment\x20of\x20patients\x20with\x20polycythemia\x20vera\x20who\x20have\x20had\x20an\x20inadequate\x20response\x20to\x20hydroxyurea\x20and\x20for\x20the\x20treatment\x20of\x20myelofibrosis.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x318),'choices':[{'id':0x1,'text':_0x248e04(0x245)},{'id':0x2,'text':'Increases\x20calcium\x20reabsorption\x20from\x20kidney'},{'id':0x3,'text':_0x248e04(0x3cc)},{'id':0x4,'text':_0x248e04(0x3f8)}],'correct_choice_id':0x4,'solution':'<p><strong>Alendronate</strong>,\x20a\x20bisphosphonate\x20acts\x20by\x20<strong>direct\x20inhibition\x20of\x20bone\x20resorption.</strong>\x20Bisphosphonates\x20concentrate\x20at\x20sites\x20of\x20active\x20remodeling,\x20remain\x20in\x20the\x20matrix\x20until\x20the\x20bone\x20is\x20remodeled,\x20and\x20then\x20are\x20released\x20in\x20the\x20acid\x20environment\x20of\x20the\x20resorption\x20lacunae\x20and\x20<strong>induce\x20apoptosis\x20in\x20osteoclasts.</strong></p>\x0a<p>Although\x20bisphosphonates\x20prevent\x20hydroxyapatite\x20dissolution,\x20their\x20<strong>antiresorptive\x20action\x20is\x20due\x20to\x20direct\x20inhibitory\x20effects\x20on\x20osteoclasts.</strong></p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x3a1),'choices':[{'id':0x1,'text':'I'},{'id':0x2,'text':'II'},{'id':0x3,'text':'III'},{'id':0x4,'text':'IV'}],'correct_choice_id':0x2,'solution':_0x248e04(0x331),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x39c),'choices':[{'id':0x1,'text':'Aprepitant'},{'id':0x2,'text':_0x248e04(0x294)},{'id':0x3,'text':_0x248e04(0x252)},{'id':0x4,'text':_0x248e04(0x37d)}],'correct_choice_id':0x3,'solution':_0x248e04(0x43c),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0xa8),'choices':[{'id':0x1,'text':_0x248e04(0x164)},{'id':0x2,'text':_0x248e04(0x94)},{'id':0x3,'text':_0x248e04(0xed)},{'id':0x4,'text':_0x248e04(0x250)}],'correct_choice_id':0x3,'solution':'<p>Racecadotril\x20is\x20a\x20<strong>peripheral\x20enkephalinase\x20inhibitor.</strong></p>\x0a<p>Enkephalins\x20are\x20delta-opioid\x20receptor\x20agonists\x20that\x20decrease\x20secretions.\x20Racecadotril\x20acts\x20as\x20an\x20antisecretory\x20agent\x20by\x20<strong>increasing\x20enkephalin\x20levels.</strong>\x20It\x20has\x20minimal/no\x20effect\x20on\x20motility.</p>\x0a<p>Racecadotril\x20is\x20indicated\x20for\x20<strong>symptomatic\x20treatment\x20of\x20diarrhea\x20in\x20infants\x20and\x20children</strong>.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x25a),'choices':[{'id':0x1,'text':_0x248e04(0x320)},{'id':0x2,'text':'Avibactam'},{'id':0x3,'text':_0x248e04(0x1dc)},{'id':0x4,'text':_0x248e04(0x251)}],'correct_choice_id':0x2,'solution':'<p><strong>Avibactam</strong>\x20is\x20a\x20<strong>newer\x20non-beta\x20lactam\x20beta-lactamase\x20inhibitor</strong>.\x20It\x20is\x20a\x20non-suicidal\x20inhibitor.\x20Causes\x20<strong>reversible\x20acylation\x20of\x20beta-lactamase\x20targets</strong>.\x20Has\x20a\x20<strong>broader\x20spectrum</strong>\x20of\x20action\x20than\x20suicidal\x20inhibitors.\x20<strong>Vaborbactam</strong>\x20is\x20another\x20non-suicidal\x20inhibitor.</p>\x0a<p>Suicidal\x20inhibitors</p>\x0a<ul>\x0a<li>Clavulanic\x20acid</li>\x0a<li>Tazobactam</li>\x0a<li>Sulbactam</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x15f),'choices':[{'id':0x1,'text':_0x248e04(0x323)},{'id':0x2,'text':_0x248e04(0x17c)},{'id':0x3,'text':_0x248e04(0x207)},{'id':0x4,'text':_0x248e04(0x258)}],'correct_choice_id':0x4,'solution':_0x248e04(0x3b3),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'True\x20regarding\x20liraglutide\x20is\x20_____','choices':[{'id':0x1,'text':_0x248e04(0x3f3)},{'id':0x2,'text':_0x248e04(0x1d8)},{'id':0x3,'text':_0x248e04(0x3e4)},{'id':0x4,'text':_0x248e04(0x305)}],'correct_choice_id':0x2,'solution':'<p><strong>Liraglutide</strong>\x20is\x20a&nbsp;<strong>GLP-\x201\x20receptor\x20agonist.</strong></p>\x0a<p>Liraglutide\x20is\x20a\x20soluble\x20fatty\x20acid-acylated\x20GLP-1\x20analog.\x20The\x20half-life\x20is\x20approximately\x2012\x20hours,\x20permitting\x20once-daily\x20dosing.\x20It\x20is\x20approved\x20in\x20patients\x20with\x20type\x202\x20diabetes\x20who\x20achieve\x20inadequate\x20control\x20with\x20diet\x20and\x20exercise\x20and\x20are\x20receiving\x20concurrent\x20treatment\x20with\x20metformin,\x20sulfonylureas,\x20or\x20thiazolidinediones.</p>\x0a<p>It\x20reduces\x20post-meal\x20hyperglycemia\x20by</p>\x0a<ul>\x0a<li>Increasing\x20glucose\x20mediated\x20insulin\x20release</li>\x0a<li>Lowering\x20glucagon\x20levels</li>\x0a<li>Slowing\x20gastric\x20emptying</li>\x0a<li>Decreasing\x20appetite</li>\x0a</ul>\x0a<p>It\x20is\x20used\x20in\x20type\x202\x20DM\x20and\x20is\x20the<strong>\x20only\x20GLP-1\x20receptor\x20agonist\x20used\x20in\x20obesity.</strong></p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x222),'choices':[{'id':0x1,'text':_0x248e04(0x2fa)},{'id':0x2,'text':_0x248e04(0x1f3)},{'id':0x3,'text':_0x248e04(0x3d2)},{'id':0x4,'text':_0x248e04(0x212)}],'correct_choice_id':0x1,'solution':_0x248e04(0x223),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x286),'choices':[{'id':0x1,'text':_0x248e04(0x2fe)},{'id':0x2,'text':_0x248e04(0x2ec)},{'id':0x3,'text':'Pegfilgrastim'},{'id':0x4,'text':'Granulocyte-macrophage\x20colony-stimulating\x20factor'}],'correct_choice_id':0x4,'solution':_0x248e04(0x2a5),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'The\x20recent\x20drug\x20approved\x20for\x20the\x20treatment\x20of\x20dry\x20mouth\x20associated\x20with\x20Sjogren’s\x20syndrome\x20is\x20_____','choices':[{'id':0x1,'text':_0x248e04(0xa2)},{'id':0x2,'text':_0x248e04(0x408)},{'id':0x3,'text':_0x248e04(0x1e2)},{'id':0x4,'text':_0x248e04(0x277)}],'correct_choice_id':0x1,'solution':_0x248e04(0x265),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0xc5),'choices':[{'id':0x1,'text':_0x248e04(0x1f1)},{'id':0x2,'text':_0x248e04(0x27c)},{'id':0x3,'text':_0x248e04(0x267)},{'id':0x4,'text':_0x248e04(0x152)}],'correct_choice_id':0x4,'solution':_0x248e04(0x2e4),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x1bf),'choices':[{'id':0x1,'text':_0x248e04(0x36d)},{'id':0x2,'text':_0x248e04(0x3b8)},{'id':0x3,'text':'Tell\x20the\x20mother\x20to\x20feed\x20when\x20it\x20is\x20least\x20efficacious'},{'id':0x4,'text':_0x248e04(0x114)}],'correct_choice_id':0x4,'solution':'<p>Ideally,\x20the\x20mother\x20should\x20feed\x20just\x20before\x20the\x20next\x20dose,\x20when\x20the\x20plasma\x20concentration\x20of\x20the\x20drug\x20would\x20be\x20the\x20least.</p>\x0a<ul>\x0a<li>The\x20drugs\x20are\x20present\x20in\x20breast\x20milk\x20in\x20variable\x20amount\x20but\x20<strong>lesser\x20than\x20in\x20plasma</strong>\x20of\x20mother.</li>\x0a<li>Breastfeeding\x20is\x20advised\x20at\x20least&nbsp;<strong>3-4\x20hours\x20after\x20drug\x20intake</strong>\x20so\x20that\x20plasma\x20concentration\x20is\x20lesser\x20and\x20hence\x20the\x20concentration\x20in\x20the\x20breast\x20milk\x20is\x20also\x20less.</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x3ad),'choices':[{'id':0x1,'text':'1'},{'id':0x2,'text':'2'},{'id':0x3,'text':'4'},{'id':0x4,'text':'8'}],'correct_choice_id':0x3,'solution':_0x248e04(0x173),'explanation_video':'','question_images':[_0x248e04(0x1cb)],'explanation_images':[]},{'text':_0x248e04(0x264),'choices':[{'id':0x1,'text':_0x248e04(0x39e)},{'id':0x2,'text':_0x248e04(0x2de)},{'id':0x3,'text':_0x248e04(0x365)},{'id':0x4,'text':'Counterfeit\x20drugs'}],'correct_choice_id':0x1,'solution':_0x248e04(0xec),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'The\x20loading\x20dose\x20of\x20a\x20drug\x20is\x20governed\x20primarily\x20by:','choices':[{'id':0x1,'text':_0x248e04(0x9b)},{'id':0x2,'text':_0x248e04(0x322)},{'id':0x3,'text':_0x248e04(0x3da)},{'id':0x4,'text':_0x248e04(0x142)}],'correct_choice_id':0x2,'solution':_0x248e04(0xe1),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0x2dc),'choices':[{'id':0x1,'text':_0x248e04(0x19e)},{'id':0x2,'text':'Doxycycline,\x20doxycycline'},{'id':0x3,'text':_0x248e04(0xaf)},{'id':0x4,'text':_0x248e04(0x109)}],'correct_choice_id':0x4,'solution':_0x248e04(0x11c),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20drugs\x20should\x20be\x20sold\x20only\x20on\x20prescription\x20from\x20a\x20registered\x20medical\x20practitioner?','choices':[{'id':0x1,'text':_0x248e04(0x2d1)},{'id':0x2,'text':_0x248e04(0x426)},{'id':0x3,'text':_0x248e04(0x414)},{'id':0x4,'text':'Schedule\x20X\x20drugs'}],'correct_choice_id':0x2,'solution':'<p><strong>Schedule\x20H\x20drugs</strong>\x20should\x20be\x20sold\x20only\x20if\x20the\x20prescription\x20is\x20from\x20a\x20registered\x20medical\x20practitioner\x20(RMP).&nbsp;</p>\x0a<p>Important\x20schedules\x20under\x20the\x20&ldquo;drugs\x20and\x20cosmetics\x20act&rdquo;:<strong>&nbsp;</strong></p>\x0a<ul>\x0a<li>C\x20and\x20C1:\x20Biological&nbsp;and\x20special\x20products</li>\x0a<li>F\x20and\x20F1:\x20Bacterial\x20vaccines</li>\x0a<li>G:\x20Drugs\x20that\x20must\x20be\x20labelled\x20with\x20the\x20word\x20&ldquo;caution&rdquo;\x20should\x20not\x20be\x20taken\x20without\x20medical\x20supervision</li>\x0a<li>J:\x20List\x20of\x20diseases\x20and\x20ailments\x20which\x20a\x20drug\x20may\x20not\x20claim\x20to\x20prevent\x20or\x20cure</li>\x0a<li>M:\x20Good\x20Manufacturing\x20Practices\x20(GMP)</li>\x0a<li>P:\x20Expiry\x20period\x20of\x20drug\x20formulations</li>\x0a<li>W:\x20Drugs\x20marketed\x20under\x20generic\x20name\x20only</li>\x0a<li>X:\x20Psychotropic\x20drugs\x20requiring\x20a\x20special\x20license\x20for\x20manufacture\x20and\x20sale</li>\x0a<li>Y:\x20Requirements\x20and\x20guidelines\x20on\x20clinical\x20trials,\x20import,\x20and\x20manufacture\x20of\x20new\x20drugs.</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x248e04(0xb7),'choices':[{'id':0x1,'text':_0x248e04(0x387)},{'id':0x2,'text':_0x248e04(0xd0)},{'id':0x3,'text':_0x248e04(0xf3)},{'id':0x4,'text':_0x248e04(0xcd)}],'correct_choice_id':0x1,'solution':_0x248e04(0x31c),'explanation_video':'','question_images':[],'explanation_images':[_0x248e04(0x1e6),_0x248e04(0xdf),_0x248e04(0x27b)]}],quizName=_0x248e04(0x3ba);const quizFilename=_0x248e04(0xe6);let hierarchy=[_0x248e04(0x20f),_0x248e04(0x38b),_0x248e04(0x2ae)];if(window['location'][_0x248e04(0x1b2)][_0x248e04(0x374)](_0x248e04(0x29a))){const customData=JSON['parse'](localStorage[_0x248e04(0x22c)]('customQuizData'));customData&&(questionsData=customData[_0x248e04(0x2a2)],quizName=customData[_0x248e04(0x227)],hierarchy=customData['hierarchy'],document[_0x248e04(0x3f9)]=quizName+_0x248e04(0x375),document['getElementById']('totalQuestions')[_0x248e04(0x3d4)]=questionsData[_0x248e04(0x125)],document['getElementById']('quizHierarchy')[_0x248e04(0x3d4)]=hierarchy[_0x248e04(0x327)](_0x248e04(0x9e)));}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x248e04(0x124),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x248e04(0x292)](),quizStartTime=Date[_0x248e04(0x292)](),isQuizCompleted=![],questionStates=new Array(questionsData['length'])['fill'](null)[_0x248e04(0x127)](()=>({'status':_0x248e04(0x10e),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x248e04(0x125)]};function saveProgress(){const _0x146157=_0x248e04,_0x1c5c76={'ORxsm':'userHistory','GdAyU':'incomplete'};if(isQuizCompleted)return;const _0x5a3afa=JSON[_0x146157(0x19c)](localStorage[_0x146157(0x22c)](_0x1c5c76[_0x146157(0x2d7)]))||{};_0x5a3afa[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x1c5c76[_0x146157(0x297)],'lastSeen':new Date()[_0x146157(0x192)]()},localStorage[_0x146157(0x2fb)](_0x146157(0x3d9),JSON[_0x146157(0xc1)](_0x5a3afa));}function loadProgress(){const _0x43bb3e=_0x248e04,_0x427e6c={'JpwGs':_0x43bb3e(0x41d),'UrYbE':_0x43bb3e(0x424),'shDpw':_0x43bb3e(0x3d9),'CIqrA':function(_0x5bdc40,_0x11fcca){return _0x5bdc40!==_0x11fcca;},'oHxGk':'vigsC','FTiny':_0x43bb3e(0x161),'QPorn':_0x43bb3e(0x37f)},_0x595bbc=JSON['parse'](localStorage['getItem'](_0x427e6c[_0x43bb3e(0x345)]))||{},_0x258784=_0x595bbc[quizFilename];if(_0x258784){if(_0x427e6c[_0x43bb3e(0x2b9)](_0x427e6c['oHxGk'],_0x43bb3e(0x21f)))_0x3053eb()?(_0x5ea5d6[_0x43bb3e(0x303)](_0x427e6c['JpwGs'])[_0x43bb3e(0x1a5)]['display']=_0x427e6c[_0x43bb3e(0x1f4)],_0xf0602e()):(_0x18e906(),_0x593ced[_0x43bb3e(0x303)](_0x427e6c['JpwGs'])['style'][_0x43bb3e(0x1bd)]=_0x43bb3e(0x22a));else{const _0x3286a0=_0x427e6c['FTiny'][_0x43bb3e(0x105)]('|');let _0xf6e7b9=0x0;while(!![]){switch(_0x3286a0[_0xf6e7b9++]){case'0':currentQuestionIndex=_0x258784[_0x43bb3e(0x406)];continue;case'1':console[_0x43bb3e(0x27f)](_0x427e6c[_0x43bb3e(0x14c)]);continue;case'2':return!![];case'3':currentMode=_0x258784[_0x43bb3e(0x3c3)];continue;case'4':questionStates=_0x258784['questionStates'];continue;case'5':stats=_0x258784[_0x43bb3e(0x3af)];continue;}break;}}}return![];}function clearProgress(){const _0x11883a=_0x248e04,_0x102bca={'Jvnci':'userHistory','qKFdo':_0x11883a(0x3c0)},_0x552a66=JSON[_0x11883a(0x19c)](localStorage['getItem'](_0x102bca['Jvnci']))||{};_0x552a66[quizFilename]&&(delete _0x552a66[quizFilename],localStorage[_0x11883a(0x2fb)](_0x102bca[_0x11883a(0xcc)],JSON[_0x11883a(0xc1)](_0x552a66)),console[_0x11883a(0x27f)](_0x102bca[_0x11883a(0xba)]));}function markQuizAsCompleted(){const _0x66d85a=_0x248e04,_0x3f1c84={'gwWXZ':_0x66d85a(0x3d9),'vUltU':_0x66d85a(0x439)},_0x548415=JSON[_0x66d85a(0x19c)](localStorage[_0x66d85a(0x22c)](_0x3f1c84[_0x66d85a(0x183)]))||{},_0x505d22=questionsData[_0x66d85a(0x125)],_0x9cb554=stats[_0x66d85a(0x3fe)]||0x0;_0x548415[quizFilename]={'score':_0x9cb554,'total':_0x505d22,'status':_0x3f1c84[_0x66d85a(0x23d)],'completedOn':new Date()[_0x66d85a(0x192)]()},localStorage[_0x66d85a(0x2fb)](_0x3f1c84[_0x66d85a(0x183)],JSON['stringify'](_0x548415));}const urlParams=new URLSearchParams(window[_0x248e04(0x176)]['search']),startAt=parseInt(urlParams[_0x248e04(0x9a)](_0x248e04(0x24e))),resume=urlParams[_0x248e04(0x9a)](_0x248e04(0x43b))===_0x248e04(0x27d);function goBack(){const _0x3d186a=_0x248e04,_0x3cab0f={'VSfLX':function(_0x4970b1){return _0x4970b1();}};if(!isQuizCompleted)_0x3cab0f[_0x3d186a(0x428)](saveProgress);window[_0x3d186a(0x176)]['href']=document[_0x3d186a(0x404)]||'index.html';}function selectMode(_0x37aa1c){const _0x62470b=_0x248e04,_0x13b180={'MxhQc':_0x62470b(0x41d),'XrMGB':_0x62470b(0x424),'KUUnb':function(_0x365f76){return _0x365f76();}};currentMode=_0x37aa1c,document[_0x62470b(0x303)](_0x13b180[_0x62470b(0x3a4)])['style'][_0x62470b(0x1bd)]=_0x13b180[_0x62470b(0x401)],_0x13b180['KUUnb'](initializeQuiz);}function initializeQuiz(){const _0x60996=_0x248e04,_0x5c1e3e={'KmJeJ':'markReviewBtn','JqUBa':_0x60996(0x149),'UrDXU':function(_0x53724d,_0x48ebc8){return _0x53724d===_0x48ebc8;},'giUml':_0x60996(0x1f5),'erGxw':function(_0x72e22f,_0x170859){return _0x72e22f===_0x170859;},'UgtTP':_0x60996(0x129),'baYMn':_0x60996(0x100),'MmpTL':'block','RUTNy':_0x60996(0x2d5),'oZNcM':'none','XyFqi':_0x60996(0x22a),'pfZmv':'timerContainer','duRAu':'hidden','wMurJ':function(_0xecdca,_0x5542b4){return _0xecdca(_0x5542b4);},'Qthgp':function(_0x5b7187,_0x4e441c){return _0x5b7187>=_0x4e441c;},'AnGxV':function(_0x5e6731){return _0x5e6731();},'dvcrK':function(_0x1bfd9){return _0x1bfd9();}};quizStartTime=Date[_0x60996(0x292)]();const _0x3d9beb=document[_0x60996(0x303)](_0x60996(0x2cc)),_0x3ad07d=document[_0x60996(0x303)](_0x5c1e3e[_0x60996(0x417)]),_0x29297b=document['getElementById'](_0x5c1e3e[_0x60996(0x99)]),_0x3568eb=_0x5c1e3e[_0x60996(0x350)](currentMode,_0x5c1e3e[_0x60996(0x407)])||_0x5c1e3e[_0x60996(0xd4)](currentMode,_0x5c1e3e['UgtTP']);document[_0x60996(0x303)](_0x60996(0x2c1))['style'][_0x60996(0x1bd)]=_0x3568eb?_0x60996(0x424):_0x60996(0x432),document[_0x60996(0x303)](_0x5c1e3e['baYMn'])[_0x60996(0x1a5)][_0x60996(0x1bd)]=_0x3568eb?_0x60996(0x424):_0x5c1e3e[_0x60996(0x3dc)],document['getElementById'](_0x5c1e3e['RUTNy'])[_0x60996(0x1a5)]['display']=_0x3568eb?_0x5c1e3e[_0x60996(0x3dc)]:_0x5c1e3e[_0x60996(0x12a)],document[_0x60996(0x303)](_0x60996(0x1c7))[_0x60996(0x1a5)][_0x60996(0x1bd)]=_0x3568eb?_0x5c1e3e[_0x60996(0x3dc)]:_0x5c1e3e[_0x60996(0x12a)],_0x3d9beb[_0x60996(0x1a5)][_0x60996(0x1bd)]=_0x3568eb?_0x5c1e3e[_0x60996(0x12a)]:_0x60996(0x22a),_0x3ad07d['style'][_0x60996(0x1bd)]=_0x3568eb?_0x5c1e3e[_0x60996(0x352)]:_0x5c1e3e[_0x60996(0x12a)],_0x29297b['style'][_0x60996(0x1bd)]=_0x3568eb?_0x5c1e3e[_0x60996(0x352)]:_0x5c1e3e[_0x60996(0x12a)],(_0x5c1e3e['UrDXU'](currentMode,'timed_study')||_0x5c1e3e[_0x60996(0xd4)](currentMode,'timed_exam'))&&document[_0x60996(0x303)](_0x5c1e3e[_0x60996(0x3c5)])['classList'][_0x60996(0x3a2)](_0x5c1e3e[_0x60996(0xf7)]),!_0x5c1e3e[_0x60996(0x343)](isNaN,startAt)&&_0x5c1e3e[_0x60996(0x338)](startAt,0x0)&&startAt<questionsData['length']&&(currentQuestionIndex=startAt),_0x5c1e3e[_0x60996(0xf0)](loadBookmarkedQuestions),_0x5c1e3e[_0x60996(0x2f7)](generateQuestionNav),_0x5c1e3e[_0x60996(0x2f7)](updateStats),displayQuestion();}function generateQuestionNav(){const _0x5ed3d2=_0x248e04,_0x174eb0={'NiFqa':_0x5ed3d2(0x2d6),'oktSP':function(_0x2bdc38,_0x19adbf){return _0x2bdc38<_0x19adbf;},'bOBNa':_0x5ed3d2(0x1a7),'dvPSO':function(_0x5a69ce,_0x595c31){return _0x5a69ce+_0x595c31;},'FwLqU':_0x5ed3d2(0x37c),'KTWzX':function(_0x4e9dab){return _0x4e9dab();}},_0x5c0398=document[_0x5ed3d2(0x303)](_0x174eb0[_0x5ed3d2(0x33f)]);_0x5c0398[_0x5ed3d2(0x1ed)]='';for(let _0x100adf=0x0;_0x174eb0[_0x5ed3d2(0xb2)](_0x100adf,questionsData['length']);_0x100adf++){const _0x4f50e7=document['createElement'](_0x174eb0[_0x5ed3d2(0x13a)]);_0x4f50e7[_0x5ed3d2(0x3d4)]=_0x174eb0[_0x5ed3d2(0x139)](_0x100adf,0x1),_0x4f50e7[_0x5ed3d2(0x1d7)]=_0x174eb0[_0x5ed3d2(0x2cd)],_0x4f50e7[_0x5ed3d2(0x133)]=()=>jumpToQuestion(_0x100adf),_0x4f50e7['id']=_0x5ed3d2(0x2f8)+_0x100adf,_0x5c0398['appendChild'](_0x4f50e7);}_0x174eb0[_0x5ed3d2(0xf2)](updateQuestionNav);}function updateQuestionNav(){const _0x10775d=_0x248e04,_0x48f9a9={'MrDoy':'application/vnd.apple.mpegurl','xLedL':function(_0x41adf3,_0x466cb0){return _0x41adf3<_0x466cb0;},'PuhJC':function(_0xeeb7af,_0x3a9f80){return _0xeeb7af===_0x3a9f80;},'ofTXy':'jhKhY','qpjvh':'aERol','UWMkm':function(_0x39580b,_0x35ce50){return _0x39580b!==_0x35ce50;},'oePcV':'cHESr','VUjQf':'nav-btn-current','mNSTo':_0x10775d(0x36f),'QyrUD':_0x10775d(0xfd),'uulhw':_0x10775d(0x124),'WsjAv':function(_0x17cd1a,_0x3d38ae){return _0x17cd1a===_0x3d38ae;},'UgiUE':_0x10775d(0x28f),'WaeKd':function(_0x53a2e9,_0x245524){return _0x53a2e9===_0x245524;},'dkdwq':_0x10775d(0xd2),'MxbrJ':_0x10775d(0xc2),'AXzqh':function(_0x3888c3,_0x2df0b5){return _0x3888c3===_0x2df0b5;},'DxGfg':'correct','uXBay':_0x10775d(0x17a),'YIDhC':_0x10775d(0x16c),'Sufew':_0x10775d(0xa3),'mwRlR':_0x10775d(0x128),'YxPXI':_0x10775d(0x1b3)};for(let _0x1eef8c=0x0;_0x48f9a9[_0x10775d(0x22f)](_0x1eef8c,questionsData[_0x10775d(0x125)]);_0x1eef8c++){if(_0x48f9a9[_0x10775d(0x18a)](_0x48f9a9[_0x10775d(0x121)],_0x48f9a9['qpjvh']))_0x1dd4eb();else{const _0x38855a=document['getElementById'](_0x10775d(0x2f8)+_0x1eef8c),_0x55c250=questionStates[_0x1eef8c];let _0x250fc3='';if(_0x48f9a9[_0x10775d(0x18a)](_0x1eef8c,currentQuestionIndex)){if(_0x48f9a9[_0x10775d(0x306)](_0x10775d(0x416),_0x48f9a9[_0x10775d(0x135)])){const _0x1c3766=new _0x598ee8();_0x1c3766['loadSource'](_0x58d1df),_0x1c3766[_0x10775d(0x160)](_0x29ce9e);}else _0x250fc3=_0x48f9a9[_0x10775d(0x3e1)];}else{if(_0x55c250[_0x10775d(0x24b)])_0x10775d(0x1a3)===_0x10775d(0x1a3)?_0x250fc3=_0x48f9a9[_0x10775d(0x2c2)]:_0xf981bc=_0x422b92;else{if(_0x55c250[_0x10775d(0x12d)])_0x250fc3=_0x48f9a9['QyrUD'];else{if(currentMode===_0x48f9a9[_0x10775d(0x262)]||_0x48f9a9['WsjAv'](currentMode,_0x48f9a9[_0x10775d(0x332)])){if(_0x48f9a9[_0x10775d(0x8d)](_0x48f9a9[_0x10775d(0x231)],_0x48f9a9[_0x10775d(0x255)])){if(_0xcc40ff['isSupported']()){const _0x235ff7=new _0x4d75e8();_0x235ff7[_0x10775d(0x43a)](_0x1eb6fd),_0x235ff7[_0x10775d(0x160)](_0x567597);}else _0xf6c28[_0x10775d(0x3e3)](_0x48f9a9[_0x10775d(0x2b0)])&&(_0x93f0a1['src']=_0x4b4a6a);}else{if(_0x48f9a9[_0x10775d(0x134)](_0x55c250[_0x10775d(0x1e8)],_0x48f9a9[_0x10775d(0xca)]))_0x250fc3=_0x48f9a9['uXBay'];else{if(_0x48f9a9[_0x10775d(0x8d)](_0x55c250[_0x10775d(0x1e8)],_0x48f9a9[_0x10775d(0x11b)]))_0x250fc3=_0x48f9a9[_0x10775d(0x1f6)];else _0x250fc3=_0x48f9a9[_0x10775d(0x20b)];}}}else{if(_0x48f9a9[_0x10775d(0x306)](_0x55c250[_0x10775d(0x24f)],null))_0x250fc3=_0x48f9a9[_0x10775d(0x270)];else _0x250fc3=_0x48f9a9[_0x10775d(0x20b)];}}}}_0x38855a['className']=_0x10775d(0x18c)+_0x250fc3;}}}function jumpToQuestion(_0x18846a){const _0x537534=_0x248e04,_0x139109={'ZnKTy':function(_0x130c4d,_0x27d05c){return _0x130c4d>=_0x27d05c;},'aJDxu':function(_0x51e30f,_0x23fb2b){return _0x51e30f<_0x23fb2b;},'gtWDW':function(_0x5c2e5e,_0xd78567){return _0x5c2e5e-_0xd78567;},'KVdTj':function(_0x3831f3){return _0x3831f3();},'UQBMO':function(_0x46e1e6){return _0x46e1e6();}};_0x139109['ZnKTy'](_0x18846a,0x0)&&_0x139109['aJDxu'](_0x18846a,questionsData[_0x537534(0x125)])&&(questionStartTime&&(questionStates[currentQuestionIndex][_0x537534(0x24a)]+=_0x139109[_0x537534(0x370)](Date[_0x537534(0x292)](),questionStartTime)),currentQuestionIndex=_0x18846a,_0x139109[_0x537534(0x1b0)](displayQuestion),_0x139109[_0x537534(0x3eb)](saveProgress));}function updateStats(){const _0x5ee919=_0x248e04,_0x3f23f4={'FVMkj':function(_0x251d3d,_0x3d0453){return _0x251d3d===_0x3d0453;},'PFtpD':'study','MHofz':_0x5ee919(0x28f),'JFhDv':_0x5ee919(0x3f7),'VVJeu':_0x5ee919(0x422),'bnFQY':'totalAttempted','tIQgy':_0x5ee919(0x1a1),'iEdqg':function(_0x531082,_0x62ef5b){return _0x531082+_0x62ef5b;},'PiqfK':function(_0x2815ef,_0x5d8697){return _0x2815ef/_0x5d8697;},'qoill':function(_0x766fff,_0xc2588b){return _0x766fff%_0xc2588b;},'EHZAg':_0x5ee919(0x24a)};if(_0x3f23f4[_0x5ee919(0x19d)](currentMode,_0x3f23f4[_0x5ee919(0x199)])||currentMode===_0x3f23f4[_0x5ee919(0x409)]){document[_0x5ee919(0x303)](_0x3f23f4[_0x5ee919(0xd8)])[_0x5ee919(0x3d4)]=stats['correctAnswers'],document['getElementById'](_0x3f23f4[_0x5ee919(0x22e)])[_0x5ee919(0x3d4)]=stats[_0x5ee919(0x380)],document[_0x5ee919(0x303)](_0x3f23f4[_0x5ee919(0x366)])['textContent']=stats[_0x5ee919(0x257)];const _0x183531=stats['totalAttempted']>0x0?Math['round'](stats[_0x5ee919(0x3fe)]/stats[_0x5ee919(0x257)]*0x64):0x0;document[_0x5ee919(0x303)](_0x3f23f4['tIQgy'])['textContent']=_0x3f23f4[_0x5ee919(0x2a8)](_0x183531,'%'),stats[_0x5ee919(0x3c8)]=questionStates[_0x5ee919(0x115)]((_0x20c186,_0x4bdc6e)=>_0x20c186+_0x4bdc6e[_0x5ee919(0x24a)],0x0);const _0x41f418=Math[_0x5ee919(0x1c8)](stats[_0x5ee919(0x3c8)]/0x3e8),_0x33b14b=Math['floor'](_0x3f23f4[_0x5ee919(0x15d)](_0x41f418,0x3c)),_0x476ac3=_0x3f23f4[_0x5ee919(0xd1)](_0x41f418,0x3c);document[_0x5ee919(0x303)](_0x3f23f4['EHZAg'])['textContent']=_0x3f23f4[_0x5ee919(0x2a8)](_0x33b14b,':')+_0x476ac3[_0x5ee919(0x282)]()[_0x5ee919(0x29d)](0x2,'0');}}function setupVideo(_0x145b89,_0x597603){const _0x25f4a0=_0x248e04,_0x3bf1c5={'EUtHS':_0x25f4a0(0x336)};if(Hls[_0x25f4a0(0x233)]()){const _0x145e62=new Hls();_0x145e62['loadSource'](_0x597603),_0x145e62['attachMedia'](_0x145b89);}else _0x145b89[_0x25f4a0(0x3e3)](_0x3bf1c5[_0x25f4a0(0x362)])&&(_0x145b89['src']=_0x597603);}function displayQuestion(){const _0x153977=_0x248e04,_0x1ad23f={'SJjCq':function(_0x512200){return _0x512200();},'AVcKK':function(_0x2edb69,_0x54f8e9){return _0x2edb69!==_0x54f8e9;},'gqiUt':_0x153977(0x10f),'eRfdP':_0x153977(0x3d9),'zOOMp':_0x153977(0x3c0),'bMCsV':function(_0x2100c1,_0xdec16a){return _0x2100c1===_0xdec16a;},'sFtgj':_0x153977(0x423),'nYLWn':_0x153977(0x1eb),'MMvkR':function(_0x37c66a,_0x434ece){return _0x37c66a+_0x434ece;},'CjsjC':function(_0xa327d9,_0x21d581){return _0xa327d9-_0x21d581;},'HbLTY':function(_0x492511,_0x1ef291){return _0x492511===_0x1ef291;},'JKAFT':_0x153977(0x226),'IUqWP':function(_0x2ee8aa,_0x53e475){return _0x2ee8aa(_0x53e475);},'tmXzY':_0x153977(0x25b),'wilME':_0x153977(0x304),'tDyIJ':'No\x20questions\x20available\x20for\x20this\x20quiz.','bJPhH':function(_0x3d2697,_0x4a1f6b){return _0x3d2697*_0x4a1f6b;},'aplOM':_0x153977(0xde),'poDct':_0x153977(0x241),'gVytN':function(_0x4a93a0,_0x12775f){return _0x4a93a0+_0x12775f;},'hRrUr':_0x153977(0x1e1),'utHKM':_0x153977(0x353),'oCkGv':_0x153977(0x427),'PWmhI':'No\x20question\x20text\x20available','LkjkL':_0x153977(0xe0),'EtNxs':'answered','ZlHFn':_0x153977(0x1cd),'YMbaf':function(_0x3e6879){return _0x3e6879();},'PskqQ':function(_0x2a97bd){return _0x2a97bd();},'UiUxp':function(_0x54f67d,_0x4f26b4){return _0x54f67d===_0x4f26b4;},'SiAln':'timed_study','dKlbR':_0x153977(0x129),'jMgRN':function(_0x1353d3){return _0x1353d3();}};if(!questionsData||_0x1ad23f[_0x153977(0x95)](questionsData[_0x153977(0x125)],0x0)){document[_0x153977(0x303)](_0x1ad23f[_0x153977(0x3cf)])[_0x153977(0x1ed)]=_0x1ad23f[_0x153977(0x1c9)];return;};const _0x5a1332=questionsData[currentQuestionIndex];questionStartTime=Date['now'](),selectedOption=questionStates[currentQuestionIndex][_0x153977(0x24f)];const _0x183d07=_0x1ad23f['bJPhH']((currentQuestionIndex+0x1)/questionsData[_0x153977(0x125)],0x64);document['getElementById'](_0x1ad23f[_0x153977(0x151)])[_0x153977(0x1a5)]['width']=_0x183d07+'%',document[_0x153977(0x303)](_0x1ad23f[_0x153977(0x1e9)])[_0x153977(0x3d4)]=_0x1ad23f['gVytN'](currentQuestionIndex,0x1),updateQuestionNav(),document[_0x153977(0x303)](_0x1ad23f['hRrUr'])[_0x153977(0x150)]=currentQuestionIndex===0x0,document[_0x153977(0x303)](_0x1ad23f['utHKM'])[_0x153977(0x1ba)][_0x153977(0x8a)](_0x1ad23f[_0x153977(0x367)]),document[_0x153977(0x303)](_0x1ad23f[_0x153977(0x3cf)])[_0x153977(0x1ed)]=_0x5a1332[_0x153977(0x101)]||_0x1ad23f[_0x153977(0x40f)];let _0x131fd5='';if(_0x5a1332[_0x153977(0x12b)])_0x131fd5+=_0x153977(0x28a)+_0x5a1332[_0x153977(0x12b)]+_0x153977(0x2d8);if(_0x5a1332[_0x153977(0x302)])_0x131fd5+=_0x153977(0x1d4)+_0x5a1332[_0x153977(0x302)]+_0x153977(0x433);_0x5a1332[_0x153977(0x214)]&&(_0x1ad23f[_0x153977(0x328)]!==_0x153977(0x413)?_0x5a1332[_0x153977(0x214)][_0x153977(0x1c1)](_0xc1fc54=>{const _0x4a855c=_0x153977;if(_0x1ad23f[_0x4a855c(0x2c8)](_0x1ad23f['gqiUt'],_0x4a855c(0x10f)))_0x1ad23f[_0x4a855c(0x2bd)](_0x156384);else{if(_0xc1fc54)_0x131fd5+=_0x4a855c(0x2a3)+_0xc1fc54+_0x4a855c(0xf1);}}):_0x1ad23f['SJjCq'](_0x371687));document[_0x153977(0x303)](_0x153977(0xb9))['innerHTML']=_0x131fd5;const _0x4dffcd=document[_0x153977(0x303)](_0x153977(0x40a));_0x4dffcd[_0x153977(0x1ed)]='',_0x4dffcd[_0x153977(0x1ba)]['remove'](_0x1ad23f[_0x153977(0xe5)]),_0x5a1332['choices']&&Array[_0x153977(0x397)](_0x5a1332[_0x153977(0x1ef)])&&(_0x1ad23f['ZlHFn']!==_0x1ad23f[_0x153977(0x389)]?(delete _0x3de303[_0x140e34],_0xf0510[_0x153977(0x2fb)](_0x1ad23f[_0x153977(0x340)],_0x3601b7['stringify'](_0x297efd)),_0x11aa6b['log'](_0x1ad23f['zOOMp'])):(_0x5a1332[_0x153977(0x1ef)]['forEach']((_0xfa5e0c,_0x24faac)=>{const _0x230530=_0x153977,_0x3ff3c3=String[_0x230530(0x369)](0x41+_0x24faac),_0xdd0f9c=_0x1ad23f['bMCsV'](selectedOption,_0x24faac),_0x584b62=document['createElement'](_0x1ad23f[_0x230530(0x3b0)]);_0x584b62[_0x230530(0x1ed)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20'+(_0xdd0f9c?_0x1ad23f[_0x230530(0x132)]:'')+_0x230530(0x182)+_0x24faac+_0x230530(0x2e8)+_0x3ff3c3+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>'+(_0xfa5e0c['text']||_0x1ad23f[_0x230530(0x3b6)](_0x230530(0x9c),_0x24faac+0x1))+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20',_0x4dffcd[_0x230530(0x2e9)](_0x584b62);}),_0x4dffcd[_0x153977(0x10d)](_0x153977(0xc4),function(_0x2e19a7){const _0x28d7d1=_0x153977,_0x14b4c3={'ZPuuT':function(_0x126e15,_0x2ebf5d){const _0x1ff061=_0x772b;return _0x1ad23f[_0x1ff061(0x2e6)](_0x126e15,_0x2ebf5d);},'mxcSm':function(_0x246e97){const _0xd5b687=_0x772b;return _0x1ad23f[_0xd5b687(0x2bd)](_0x246e97);},'aliWc':function(_0x3ed0b1){const _0xf6489c=_0x772b;return _0x1ad23f[_0xf6489c(0x2bd)](_0x3ed0b1);}},_0x527de0=_0x2e19a7[_0x28d7d1(0x1d9)][_0x28d7d1(0x85)]('.option-button');if(_0x527de0){if(_0x1ad23f[_0x28d7d1(0x1b5)](_0x28d7d1(0x226),_0x1ad23f[_0x28d7d1(0x1be)])){const _0x35f21a=_0x1ad23f[_0x28d7d1(0x1d2)](parseInt,_0x527de0[_0x28d7d1(0x38d)](_0x1ad23f[_0x28d7d1(0x11a)]));_0x1ad23f[_0x28d7d1(0x1d2)](selectOption,_0x35f21a);}else _0x9bd5b0>0x0&&(_0x16480f&&(_0x16759e[_0x1ace40][_0x28d7d1(0x24a)]+=_0x14b4c3[_0x28d7d1(0x35d)](_0x5eb080[_0x28d7d1(0x292)](),_0x4d165f)),_0x3cbff4--,_0x14b4c3[_0x28d7d1(0x372)](_0x52c525),_0x14b4c3[_0x28d7d1(0x2f0)](_0x247e62));}}))),_0x1ad23f['YMbaf'](updateBookmarkButton),_0x1ad23f[_0x153977(0x25c)](updateMarkReviewButton),(_0x1ad23f[_0x153977(0x3a0)](currentMode,_0x1ad23f[_0x153977(0x208)])||_0x1ad23f['HbLTY'](currentMode,_0x1ad23f[_0x153977(0xae)]))&&!isQuizCompleted&&_0x1ad23f['jMgRN'](startTimer);}function selectOption(_0x16a711){const _0x26a26a=_0x248e04,_0x21a850={'nWsZG':_0x26a26a(0x186),'OZnIy':_0x26a26a(0x2cf),'EZgMb':'selected','jwSBQ':function(_0x3251f3,_0x1ccd38){return _0x3251f3===_0x1ccd38;},'clARW':_0x26a26a(0x2ca),'Frvvt':'1|3|2|5|4|0','ZxyqE':_0x26a26a(0x348),'DybnA':_0x26a26a(0x9e),'pEXsh':_0x26a26a(0xee),'xqswl':function(_0x2d8666,_0xed4324){return _0x2d8666+_0xed4324;},'LOWtZ':_0x26a26a(0x375),'Ozqdh':function(_0x552ce,_0x340477){return _0x552ce<_0x340477;},'vcLlA':function(_0x317194,_0x82c894){return _0x317194(_0x82c894);},'EsAKd':_0x26a26a(0x40a),'UvqWj':_0x26a26a(0x1b1),'bOenB':function(_0x5ccebc,_0x690f1e){return _0x5ccebc!==_0x690f1e;},'vcCuW':_0x26a26a(0xe2),'TmLEG':function(_0x901783,_0x199154){return _0x901783-_0x199154;},'qtjOb':_0x26a26a(0x2b4),'PvTmS':function(_0x4fd58a){return _0x4fd58a();},'ZUHcW':function(_0x1cec7f,_0x1ad86e){return _0x1cec7f===_0x1ad86e;},'AbMMU':_0x26a26a(0x2b7),'ruAvU':_0x26a26a(0x329),'gmAEh':_0x26a26a(0x10e),'UIRFB':function(_0x1db9ff){return _0x1db9ff();},'pVGUe':function(_0x56aaf0){return _0x56aaf0();}},_0xb54612=document[_0x26a26a(0x303)](_0x21a850['EsAKd']);if(_0xb54612[_0x26a26a(0x1ba)][_0x26a26a(0x13d)](_0x21a850[_0x26a26a(0x35c)]))return;questionStartTime&&(_0x21a850[_0x26a26a(0x2db)](_0x21a850['vcCuW'],_0x21a850[_0x26a26a(0x1b4)])?_0x311b98['getElementById'](_0x21a850['nWsZG'])[_0x26a26a(0x1ba)]['toggle'](_0x21a850[_0x26a26a(0x136)]):(questionStates[currentQuestionIndex][_0x26a26a(0x24a)]+=_0x21a850[_0x26a26a(0x35e)](Date[_0x26a26a(0x292)](),questionStartTime),questionStartTime=Date[_0x26a26a(0x292)]()));selectedOption=_0x16a711,questionStates[currentQuestionIndex][_0x26a26a(0x24f)]=_0x16a711,document[_0x26a26a(0xcb)](_0x21a850['qtjOb'])['forEach']((_0x468576,_0x24fec4)=>{const _0x128330=_0x26a26a;_0x468576['classList'][_0x128330(0x2c6)](_0x21a850[_0x128330(0x3c2)],_0x21a850['jwSBQ'](_0x24fec4,_0x16a711));});if(_0x21a850[_0x26a26a(0x377)](currentMode,_0x26a26a(0x124))||_0x21a850[_0x26a26a(0x377)](currentMode,_0x26a26a(0x28f))){if(_0x26a26a(0xb0)==='yKbDx')_0x21a850[_0x26a26a(0x232)](processAnswer);else{const _0x49eb2d=_0x4a964b[_0x26a26a(0x19c)](_0x20ec51[_0x26a26a(0x22c)](_0x21a850['clARW']));if(_0x49eb2d){const _0x36b621=_0x21a850[_0x26a26a(0xd7)]['split']('|');let _0x2e079a=0x0;while(!![]){switch(_0x36b621[_0x2e079a++]){case'0':_0x742ed3[_0x26a26a(0x303)](_0x21a850[_0x26a26a(0x2dd)])['textContent']=_0x274dab[_0x26a26a(0x327)](_0x21a850[_0x26a26a(0x25d)]);continue;case'1':_0x1c0f01=_0x49eb2d[_0x26a26a(0x2a2)];continue;case'2':_0x4723fe=_0x49eb2d[_0x26a26a(0x3dd)];continue;case'3':_0x1efe9b=_0x49eb2d[_0x26a26a(0x227)];continue;case'4':_0x13aa89[_0x26a26a(0x303)](_0x21a850[_0x26a26a(0x2ba)])[_0x26a26a(0x3d4)]=_0x2db072[_0x26a26a(0x125)];continue;case'5':_0x20aec3[_0x26a26a(0x3f9)]=_0x21a850['xqswl'](_0x49f116,_0x21a850[_0x26a26a(0x2d2)]);continue;}break;}}}}else{if(_0x21a850['ZUHcW'](_0x21a850[_0x26a26a(0x22d)],_0x21a850[_0x26a26a(0x248)])){const _0x2ca329=_0xf49dda(_0x47dd12[_0x26a26a(0xbe)])-0x1,_0x120355=_0x3e2804['querySelectorAll']('.option-button');if(_0x21a850[_0x26a26a(0x276)](_0x2ca329,_0x120355[_0x26a26a(0x125)]))_0x21a850[_0x26a26a(0x314)](_0x42bdda,_0x2ca329);}else questionStates[currentQuestionIndex]['status']===_0x21a850[_0x26a26a(0x181)]&&(questionStates[currentQuestionIndex]['status']=_0x26a26a(0x1b1),stats[_0x26a26a(0x257)]++,stats[_0x26a26a(0x103)]--),_0x21a850[_0x26a26a(0x2b8)](updateQuestionNav);}_0x21a850[_0x26a26a(0x13b)](saveProgress);}function processAnswer(){const _0x3a84df=_0x248e04,_0xc88045={'RjdxX':_0x3a84df(0x1a7),'oTDTK':function(_0x2a090d,_0x2485ac){return _0x2a090d+_0x2485ac;},'DMjYe':_0x3a84df(0x37c),'vSBpT':function(_0x88700d,_0x871f1f){return _0x88700d===_0x871f1f;},'ryqCa':function(_0x500edb,_0x1c7aa6){return _0x500edb===_0x1c7aa6;},'Jahtt':function(_0x5316d1,_0x470c08){return _0x5316d1===_0x470c08;},'HodfV':'EmuML','STfyU':'correct','GLJMa':function(_0x158cc6){return _0x158cc6();},'vXSGy':function(_0x4135eb,_0x2753a9){return _0x4135eb(_0x2753a9);}},_0x55831b=questionsData[currentQuestionIndex],_0x3aa38e=_0x55831b[_0x3a84df(0x42c)];if(_0xc88045[_0x3a84df(0xc3)](selectedOption,null))return;const _0xcb2213=_0x55831b['choices'][selectedOption],_0x44ae2f=_0xcb2213['id']===_0x3aa38e;if(_0xc88045[_0x3a84df(0x319)](questionStates[currentQuestionIndex][_0x3a84df(0x1e8)],'not_attempted')){if(_0xc88045[_0x3a84df(0x334)](_0xc88045[_0x3a84df(0x3c9)],_0xc88045[_0x3a84df(0x3c9)])){stats[_0x3a84df(0x257)]++,stats[_0x3a84df(0x103)]--;if(_0x44ae2f)stats['correctAnswers']++;else stats[_0x3a84df(0x380)]++;}else{const _0x3db6a0=_0x51214a['createElement'](_0xc88045['RjdxX']);_0x3db6a0['textContent']=_0xc88045['oTDTK'](_0x38925d,0x1),_0x3db6a0['className']=_0xc88045[_0x3a84df(0x30c)],_0x3db6a0[_0x3a84df(0x133)]=()=>_0x1aca53(_0x1e3263),_0x3db6a0['id']=_0x3a84df(0x2f8)+_0x1431da,_0x2cf617['appendChild'](_0x3db6a0);}}questionStates[currentQuestionIndex]['status']=_0x44ae2f?_0xc88045['STfyU']:_0x3a84df(0x16c),_0xc88045[_0x3a84df(0x17d)](updateStats),_0xc88045[_0x3a84df(0x92)](showInlineFeedback,_0x44ae2f),_0xc88045[_0x3a84df(0x17d)](updateQuestionNav);}function showInlineFeedback(_0x3b87e8){const _0x4e2e82=_0x248e04,_0x5c4939={'zudgX':_0x4e2e82(0x1eb),'QQrWB':_0x4e2e82(0x190),'bfRfS':_0x4e2e82(0x16c),'PxsQN':function(_0x21c4fa,_0x37feb8){return _0x21c4fa!==_0x37feb8;},'MPDSa':_0x4e2e82(0x124),'jScqU':_0x4e2e82(0x28f),'suyXf':'optionsContainer','MbdYT':'.option-button','dTCbe':'answered','iXpqb':function(_0x1784a8){return _0x1784a8();}};if(_0x5c4939['PxsQN'](currentMode,_0x5c4939[_0x4e2e82(0x32f)])&&currentMode!==_0x5c4939['jScqU'])return;const _0xeea4a9=document[_0x4e2e82(0x303)](_0x5c4939[_0x4e2e82(0x1bb)]),_0x1bf7cf=_0xeea4a9[_0x4e2e82(0xcb)](_0x5c4939[_0x4e2e82(0x39b)]),_0x1e1ae2=questionsData[currentQuestionIndex],_0x45c101=_0x1e1ae2[_0x4e2e82(0x42c)];let _0x12f39a=_0x1e1ae2['choices']['findIndex'](_0x50f224=>_0x50f224['id']===_0x45c101);_0xeea4a9[_0x4e2e82(0x1ba)]['add'](_0x5c4939[_0x4e2e82(0x28d)]),_0x1bf7cf[_0x4e2e82(0x1c1)]((_0x13fd4b,_0x1bfd29)=>{const _0x1e53c3=_0x4e2e82;_0x13fd4b[_0x1e53c3(0x1ba)][_0x1e53c3(0x3a2)](_0x5c4939[_0x1e53c3(0x316)]);if(_0x1bfd29===_0x12f39a)_0x13fd4b[_0x1e53c3(0x1ba)]['add'](_0x5c4939[_0x1e53c3(0x37e)]);else{if(_0x1bfd29===selectedOption&&!_0x3b87e8)_0x13fd4b[_0x1e53c3(0x1ba)][_0x1e53c3(0x8a)](_0x5c4939[_0x1e53c3(0x29b)]);}}),_0x5c4939[_0x4e2e82(0x3b1)](showSolution);}function _0x4c07(){const _0x1a92a6=['Latanoprost','border-red-500','join','LkjkL','ujDWh','Cefoperazone','<ul>\x0a<li><strong>Acarbose</strong>\x20is\x20an\x20<strong>alpha-glucosidase\x20inhibitor</strong>&nbsp;and\x20hence\x20does\x20not\x20cause\x20Hypoglycemia.</li>\x0a<li>Reduces\x20conversion\x20of\x20starch\x20and\x20disaccharides\x20to\x20monosaccharides.</li>\x0a<li>Reduces\x20postprandial\x20hyperglycemia.</li>\x0a<li>Since\x20it<strong>\x20<strong>doesn&rsquo;t\x20enhance\x20the\x20release\x20of\x20insulin,\x20hypoglycemia\x20doesn&rsquo;t\x20occur</strong>.</strong></li>\x0a</ul>\x0a<p>NOTE:\x20Metformin\x20also\x20<strong>does\x20not\x20cause\x20hypoglycemia</strong>.\x20Hypoglycemia\x20during\x20biguanide\x20therapy\x20is\x20essentially\x20unknown.\x20These\x20agents\x20are\x20therefore\x20more\x20appropriately\x20termed\x20&ldquo;euglycemic&rdquo;\x20agents.</p>','jBerU','Which\x20of\x20the\x20following\x20is\x20an\x20atypical\x20antipsychotic?','<p><strong>Cariprazine</strong>\x20is\x20an\x20<strong>atypical\x20antipsychotic</strong>\x20with\x20<strong>partial\x20agonist\x20activity\x20at\x20D2\x20receptors\x20and\x205-HT2A\x20receptors.</strong></p>\x0a<p>Fluphenazine,\x20perphenazine\x20and\x20thioridazine\x20are\x20first-generation\x20typical\x20antipsychotics\x20having\x20D2\x20receptor\x20antagonism\x20activity\x20(options\x20a,b\x20and\x20d).</p>','MPDSa','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','<p>According\x20to\x20<strong>Vaughan\x20Williams\x20and\x20Singh&rsquo;s\x20classification\x20of\x20Antiarrhythmic\x20drugs\x20beta\x20blockers\x20are\x20included\x20in\x20type\x20II.</strong></p>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td>&nbsp;<strong>Class\x20I</strong></td>\x0a<td>\x0a<p><strong>Membrane\x20stabilizing\x20agents\x20(Na+\x20channel\x20blockers)</strong></p>\x0a<ul>\x0a<li>Moderately\x20decrease\x20dv/dt\x20of\x200\x20phase</li>\x0a<li>Little\x20decrease\x20in\x20dv/dt\x20of\x200\x20phase</li>\x0a<li>Marked\x20decrease\x20in\x20dv/dt\x20of\x200\x20phase&nbsp;</li>\x0a</ul>\x0a</td>\x0a<td>&nbsp;\x0a<ul>\x0a<li><strong>Quinidine,\x20Procainamide,\x20Disopyramide</strong></li>\x0a<li><strong>Lidocaine,\x20Mexiletine</strong></li>\x0a<li><strong>Propafenone,\x20Flecainide</strong>&nbsp;</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Class\x20II</strong></td>\x0a<td><strong>Anti-adrenergic\x20agents\x20</strong><strong>(&beta;\x20blockers)</strong></td>\x0a<td>Propranolol,\x20Esmolol,\x20Sotalol\x20(also\x20class\x20III)&nbsp;</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Class\x20III</strong></td>\x0a<td><strong>Agents\x20widening\x20AP&nbsp;</strong>(prolong\x20repolarization\x20and\x20ERP)\x20&nbsp;</td>\x0a<td>Amiodarone,\x20Dronedarone,\x20Dofetilide,\x20Ibutilide</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Class\x20IV</strong></td>\x0a<td><strong>Calcium\x20channel\x20blockers</strong></td>\x0a<td>Verapamil,\x20Diltiazem</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Class\x20V</strong></td>\x0a<td><strong>Miscellaneous</strong></td>\x0a<td>Digoxin,\x20adenosine,\x20magnesium,\x20atropine\x20and\x20potassium.&nbsp;</td>\x0a</tr>\x0a</tbody>\x0a</table>','UgiUE','In\x20diabetics\x20because\x20it\x20can\x20cause\x20hyperglycemia','Jahtt','kTlVR','application/vnd.apple.mpegurl','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','Qthgp','It\x20has\x20a\x20greater\x20duration\x20of\x20action\x20than\x20ACh','kCawV','HRfzK','Diethylcarbamazine\x20(DEC)','Xspqq','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','NiFqa','eRfdP','Fluphenazine','Isoniazid','wMurJ','Potassium','shDpw','EJhGv','push','quizHierarchy','<p>Among\x20fluoroquinolones,\x20<strong>Sparfloxacin\x20has\x20maximum\x20incidence\x20of\x20phototoxicity.</strong></p>','Trastuzumab\x20–\x20Human\x20EGFR\x201\x20monoclonal\x20Ab','BpgZy','wVNqa','Which\x20of\x20the\x20following\x20antiglaucoma\x20medications\x20is\x20unsafe\x20in\x20infants?','Brimonidine','toXSZ','UrDXU','rCmQq','XyFqi','solutionContainer','YHXoQ','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','UGVMb','round','itDhA','Galantamine','Stoss\x20Therapy','For\x20mild-to-moderate\x20pain,\x20morphine\x20is\x20more\x20effective\x20than\x20tramadol','UvqWj','ZPuuT','TmLEG','QJdss','ogAHI','Hypercalcaemia','EUtHS','3GsZXVF','lIiaQ','Spurious\x20drugs','bnFQY','oCkGv','Iloperidone','fromCharCode','strokeDasharray','A:\x20Thiazides\x20B:\x20Loop\x20diuretics','Both\x20a\x20and\x20b','No\x20advice\x20as\x20most\x20of\x20drug\x20are\x20not\x20present\x20in\x20breast\x20milk','It\x20is\x20used\x20as\x20a\x20pre\x20anaesthetic\x20medication','nav-btn-bookmarked','gtWDW','jFzWM','mxcSm','<p><span\x20class=\x22TextRun\x20SCXW81824019\x22\x20lang=\x22EN-US\x22\x20xml:lang=\x22EN-US\x22><span\x20class=\x22NormalTextRun\x20SCXW81824019\x22><strong>Flagellate\x20hyperpigmentation/flagellate\x20erythema</strong>&nbsp;</span></span><span\x20class=\x22TextRun\x20SCXW81824019\x22\x20lang=\x22EN-US\x22\x20xml:lang=\x22EN-US\x22><span\x20class=\x22NormalTextRun\x20SCXW81824019\x22>is</span></span><span\x20class=\x22TextRun\x20SCXW81824019\x22\x20lang=\x22EN-US\x22\x20xml:lang=\x22EN-US\x22><span\x20class=\x22NormalTextRun\x20SCXW81824019\x22>&nbsp;a\x20characteristic\x20cutaneous\x20reaction\x20to\x20treatment\x20with\x20<strong>b</strong></span></span><strong><span\x20class=\x22TextRun\x20Underlined\x20SCXW81824019\x22\x20lang=\x22EN-US\x22\x20xml:lang=\x22EN-US\x22><span\x20class=\x22NormalTextRun\x20SCXW81824019\x22>leomycin</span></span></strong><span\x20class=\x22TextRun\x20SCXW81824019\x22\x20lang=\x22EN-US\x22\x20xml:lang=\x22EN-US\x22><span\x20class=\x22NormalTextRun\x20SCXW81824019\x22>.&nbsp;</span></span></p>\x0a<p><span\x20class=\x22TextRun\x20SCXW81824019\x22\x20lang=\x22EN-US\x22\x20xml:lang=\x22EN-US\x22><span\x20class=\x22NormalTextRun\x20SCXW81824019\x22>Clinical\x20features\x20include\x20<strong>multiple\x20linear\x20streaks</strong>\x20(erythematous\x20or\x20hyperpigmented)\x20<strong>at\x20sites\x20of\x20trauma\x20and\x20generalized\x20pruritus</strong>.</span></span></p>','endsWith','\x20-\x20Brain\x20And\x20Scalpel','ZHbLN','jwSBQ','REwuV','Infliximab','PrOYp','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','Netupitant','QQrWB','Progress\x20loaded.','incorrectAnswers','A\x2040-year-old\x20woman\x20had\x20diabetes\x20mellitus\x20that\x20was\x20not\x20controlled\x20with\x20oral\x20hypoglycemic\x20agents.\x20She\x20was\x20started\x20on\x20short-acting\x20insulin\x20to\x20prevent\x20post-prandial\x20glycemia.\x20Which\x20of\x20the\x20following\x20drug\x20would\x20have\x20been\x20used?','hUeuI','trace','questionReviewSection','Loop\x20diuretics','questionStates','Vitamins','https://dhmbxeygs57ff.cloudfront.net/uploads/55f6f5aafdc94595ab07d959ee58f480x769x673.JPEG','ZlHFn','StDnJ','NEET\x20PG\x20Test\x20Series\x20Subject\x20Wise','MqMEF','getAttribute','0.6-1.0','Which\x20of\x20the\x20following\x20antiepileptic\x20drug\x20does\x20not\x20act\x20via\x20inhibition\x20of\x20sodium\x20channels:','not-attempted','A\x20neurology\x20resident\x20changed\x20the\x20current\x20oral\x20medication\x20of\x20a\x20patient\x20with\x20Alzheimer\x27s\x20disease\x20to\x20a\x20transdermal\x20patch\x20of\x20a\x20cholinesterase\x20inhibitor.\x20What\x20must\x20be\x20the\x20new\x20drug\x20that\x20was\x20prescribed?','KRxVy','<p>The\x20administration\x20of\x20<strong>barbiturates</strong>\x20is\x20<strong>contraindicated</strong>\x20in&nbsp;<strong>acute\x20intermittent\x20porphyria</strong>.</p>\x0a<p><strong>Acute\x20intermittent\x20porphyria\x20</strong>is\x20a\x20disorder\x20of\x20heme\x20synthesis,\x20characterized\x20by\x20a\x20deficiency\x20of\x20hydroxymethylbilane\x20synthase\x20(HMBS).</p>\x0a<p>Barbiturates\x20are\x20<strong>enzyme\x20inducers</strong>\x20and\x20they\x20result\x20in\x20the\x20increased\x20synthesis\x20of\x20porphyrins\x20and\x20subsequent\x20<strong>precipitation</strong>\x20of\x20acute\x20intermittent\x20<strong>porphyria.&nbsp;</strong>The\x20biochemical\x20basis\x20for\x20the<strong>\x20worsening\x20</strong>of\x20porphyria\x20by\x20<strong>barbiturates</strong>\x20is<strong>\x20the\x20de-repression/induction\x20</strong>of\x20<strong>ALA\x20synthase.</strong></p>\x0a<div\x20class=\x22ng-scope\x22>\x0a<p>Barbiturates\x20are\x20metabolized\x20by<strong>\x20microsomal\x20CYP450,\x20</strong>a\x20<strong>heme-protein\x20oxidase</strong>\x20system\x20found\x20in\x20the\x20liver.\x20In\x20patients\x20with\x20porphyria,\x20barbiturates\x20<strong>precipitate</strong>\x20an\x20attack\x20of\x20<strong>porphyria\x20</strong>by\x20the\x20following\x20mechanism:</p>\x0a<table\x20style=\x22height:\x20162px;\x20width:\x20427px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20417px;\x20text-align:\x20center;\x22><strong>&nbsp;</strong>Barbiturates&nbsp;<strong>increase</strong>\x20the\x20synthesis\x20of\x20<strong>CYP450</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20417px;\x20text-align:\x20center;\x22><strong>\x20&nbsp;</strong>&darr;</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20417px;\x20text-align:\x20center;\x22><strong>Enhanced\x20consumption</strong>\x20of\x20heme</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20417px;\x20text-align:\x20center;\x22>&darr;</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20417px;\x20text-align:\x20center;\x22>A\x20<strong>decrease</strong>\x20in\x20<strong>heme\x20concentration</strong>\x20in\x20the\x20liver&nbsp;</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20417px;\x20text-align:\x20center;\x22>&darr;</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20417px;\x20text-align:\x20center;\x22><strong>De-repression/induction\x20of\x20ALAS-1</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20417px;\x20text-align:\x20center;\x22>&darr;</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20417px;\x20text-align:\x20center;\x22><strong>Increased\x20synthesis</strong>\x20of\x20heme\x20precursors</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20417px;\x20text-align:\x20center;\x22>&darr;</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20417px;\x20text-align:\x20center;\x22>Precipitation\x20of\x20porphyria</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><br\x20/>Other\x20options:</p>\x0a<p>Theophylline,\x20chlorpromazine,\x20and\x20benzodiazepine\x20are\x20not\x20contraindicated\x20in&nbsp;acute\x20intermittent\x20porphyria.</p>\x0a</div>','Timolol','Rituximab\x20–\x20Anti\x20CD20\x20monoclonal\x20antiboides','Paromomycin','isArray','Glipizide','Increased\x20risk\x20of\x20bone\x20fractures','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','MbdYT','Orexin\x20receptor\x20antagonist\x20indicated\x20for\x20insomnia\x20is','Incorrect','Misbranded\x20drug','HLA-B\x201502','UiUxp','Beta\x20blockers\x20belong\x20to\x20which\x20class\x20of\x20antiarrhythmic\x20drugs','remove','pFOX\x20inhibition','MxhQc','QIXjK','YSIVD','gpepz','Acarbose','pdwJA','MgNHK','Evolocumab','Tilisolol','Calculate\x20the\x20therapeutic\x20index\x20of\x20a\x20drug\x20whose\x20dose-response\x20curves\x20are\x20plotted\x20as\x20shown\x20below:','rkKkV','stats','sFtgj','iXpqb','solutionImages','<p><strong>Glucuronidation</strong>\x20is\x20the\x20only\x20phase\x20II\x20biotransformation\x20reaction\x20that\x20involves\x20microsomal\x20enzymes.</p>\x0a<p>All\x20the\x20other\x20phase\x20II\x20biotransformation\x20reactions\x20involve\x20non-micorsomal\x20enzymes\x20(options\x20a,\x20b\x20and\x20c).</p>','DuoLM','Low\x20dose\x20aspirin\x20should\x20be\x20used\x20with\x20caution\x20in\x20a\x20few\x20patients\x20with\x20co-morbidities.\x20True\x20statement\x20among\x20the\x20following\x20is','MMvkR','gBCdb','Give\x20longer\x20half-life\x20drugs','ufeTC','Pharmacology\x20Test\x20\x20Ii','rLwah','bEIvP','TJcAa','return\x20(function()\x20','</span></div>','Previous\x20progress\x20cleared.','preventDefault','EZgMb','currentMode','PBxUC','pfZmv','NEOTi','solution','totalTime','HodfV','ifZsx','1077429IZKPmB','Stimulates\x20osteoblasts','XaehL','GpyFY','wilME','src','KMzjy','Vancomycin','Which\x20of\x20the\x20following\x20statements\x20is\x20false\x20about\x20Methacholine?','textContent','HIV\x20protease','Minocycline','<p><strong>Metolazone</strong>\x20is\x20a\x20thiazide-like\x20diuretic.</p>\x0a<p>Points\x20to\x20note\x20about\x20metolazone:</p>\x0a<ul>\x0a<li>Unlike\x20other\x20diuretics,\x20the\x20<strong>antihypertensive\x20and\x20diuretic\x20action</strong>\x20of\x20metolazone\x20is\x20<strong>retained\x20even\x20in\x20severe\x20renal\x20failure\x20(GFR\x20&lt;15\x20ml/min).</strong></li>\x0a<li><strong>Additional\x20proximal\x20tubular\x20action</strong>\x20has\x20been\x20observed.</li>\x0a</ul>','Norfloxacin','userHistory','Plasma\x20half\x20life','eURnK','MmpTL','hierarchy','ntzRp','fphsD','<p>The\x20secretion\x20resumes\x20normally\x20in\x20<strong>3-4\x20days\x20of\x20stopping</strong>\x20the\x20drug\x20when\x20<strong>new\x20proton\x20pumps\x20are\x20synthesized</strong>.</p>\x0a<p>Omeprazole\x20after\x20absorption\x20enters\x20into\x20the\x20systemic\x20circulation,\x20after\x20which\x20it\x20diffuses\x20into\x20the\x20parietal\x20cells\x20and\x20accumulates\x20in\x20the\x20acidic\x20canaliculi.</p>\x0a<p>Inside\x20canaliculi,\x20it\x20is\x20activated\x20by\x20proton\x20catalyzed\x20the\x20formation\x20of\x20a\x20tetracyclic\x20sulfenamide\x20that\x20irreversibly\x20inhibits\x20H+/K+\x20ATPase.</p>\x0a<p>Inhibition\x20of\x20HCl\x20secretion\x20occurs\x20within\x201\x20hour\x20and\x20reaches\x20a\x20maximum\x20at\x202\x20hrs.</p>\x0a<p>The\x20inhibition\x20gradually\x20increases\x20over\x20daily\x20dosing\x20and\x20reaches\x20a\x20plateau\x20after\x204\x20days\x20(80-98%\x20inhibition).</p>\x0a<p>The\x20secretion\x20resumes\x20gradually\x20over\x203-4\x20days\x20of\x20stopping\x20the\x20drug\x20when\x20new\x20proton\x20pumps\x20are\x20synthesized<strong>.</strong></p>','VUjQf','yecvM','canPlayType','Amyloid\x20polypeptide','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','UFPte','hDxeS','Erythromycin','KOIoi','QSVXR','UQBMO','Setcf','Cefadroxil','nCBmm','Which\x20of\x20the\x20following\x20is\x20a\x205th\x20generation\x20cephalosporin?','<p>Chronic\x20consumption\x20of\x20ethyl\x20alcohol\x20results\x20in\x20the\u00a0<strong>induction\x20of\x20CYP2E1\x20enzymes</strong>\x20and\x20results\x20in\x20faster\x20metabolism\x20of\x20drugs\x20that\x20are\x20dependent\x20on\x20CYP2E1.</p>\x0a<p>Acutely,\x20ethyl\x20alcohol\x20can\x20inhibit\x20the\x20action\x20of\x20various\x20metabolizing\x20enzymes\x20including\x20CYP2E1.</p>','dJHyE','qeAOy','PPAR-\x20gamma\x20agonist','nHvTk','Golimumab','wnXBq','correctCount','Inhibits\x20osteoclasts','title','<p>The\x20dosing\x20rate\x20in\x20this\x20patient\x20is\u00a0<strong>60\x20ng/min.</strong></p>\x0a<p>The\x20<strong>oral\x20bioavailability\x20of\x20digoxin\x20is\x2070%\x20(F\x20=\x200.7)</strong>\x20and\x20the\x20required\x20target\x20plasma\x20concentration\x20(Cp)\x20is\x20<strong>0.70\x20ng/mL</strong>.\x20<strong>CL</strong>\x20is\x20the\x20clearance\x20of\x20digoxin\x20which\x20is\u00a060\x20mL/min.</p>\x0a<p>Hence,\x20the\x20appropriate\x20dose\x20rate\x20for\x20this\x20patient\x20can\x20be\x20calculated\x20as:</p>\x0a<p><strong>Dosing\x20rate\x20=\x20Target\x20Cp\x20x\x20CL/F</strong></p>\x0a<p>=\x20[0.70\x20ng/mL\x20×\x2060\x20mL/min]\x20÷\x20[0.7]</p>\x0a<p>=\x20<strong>60\x20ng/min</strong></p>','Iodoquinol','XUzxs','koIvL','correctAnswers','Primaquine','<p><strong>Aspirin\x20at\x20lower\x20doses\x20(&lt;2\x20g/day)\x20causes\x20urate\x20retention\x20</strong>and<strong>\x20block\x20the\x20effect\x20of\x20uricosuric\x20drugs</strong>.</p>\x0a<p>At\x20intermediate\x20doses\x20(2-3\x20g/day),\x20there\x20is&nbsp;no\x20effect\x20on\x20urate\x20levels.</p>\x0a<p>Only\x20at\x20high\x20doses\x20(&gt;5\x20g/day),\x20there\x20is\x20uricosuric\x20effect\x20<strong>but\x20such\x20large\x20doses\x20have\x20poor\x20tolerability.</strong></p>\x0a<p>Aspirin\x20use\x20is\x20associated\x20with\x20Reye&rsquo;s\x20syndrome\x20which\x20is\x20a\x20rare\x20form\x20of\x20hepatic\x20encephalopathy\x20seen\x20in\x20children\x20having\x20a\x20viral\x20disease\x20(Option\x20B).</p>\x0a<p><strong>Low\x20dose\x20aspirin</strong>\x20use\x20is\x20not\x20associated\x20with\x20hyperglycemia\x20but<strong>\x20can\x20cause\x20hypoglycemia</strong>\x20in\x20diabetic\x20patients\x20that\x20warrants\x20caution\x20(Option\x20A).</p>\x0a<p>In\x20pregnancy,\x20the\x20use\x20of\x20aspirin\x20is\x20<strong>associated\x20with\x20low\x20birth\x20weight\x20and\x20perinatal\x20complications</strong>\x20but\x20<strong>not\x20with\x20a\x20high\x20risk\x20of\x20teratogenicity</strong>\x20(Option\x20D).</p>','XrMGB','console','dHuCw','referrer','<p>The\x20drug\x20<strong>efavirenz</strong>\x20<strong>inhibits&nbsp;HIV\x20reverse\x20transcriptase</strong>.\x20It\x20is\x20an\x20NNRTI.</p>\x0a<p>There\x20are\x20five\x20classes\x20of\x20drugs\x20in\x20combination\x20can\x20be\x20termed\x20antiretro\x20viral\x20therapy\x20(ART),\x20combination\x20antiretroviral\x20therapy\x20(cART)\x20or\x20highly\x20active\x20antiretroviral\x20therapy\x20(HAART).</p>\x0a<p>Antiretroviral\x20drugs\x20are\x20classified\x20by\x20the\x20phase\x20of\x20the\x20retrovirus\x20life\x20cycle\x20that\x20the\x20drug\x20inhibits.</p>','currentQuestionIndex','giUml','Rivastigmine','MHofz','optionsContainer','MhnJl','Peak\x20action\x20is\x20seen\x20within\x202-3\x20hours\x20and\x20lasts\x20for\x20about\x206\x20hours','It\x27s\x20analgesic\x20action\x20is\x20equal\x20to\x20morphine\x20in\x20post-operative\x20pain','Benzodiazepine','PWmhI','eJmzR','Which\x20of\x20the\x20following\x20statements\x20is\x20false\x20about\x20tramadol?','KyWaA','gjwhn','Schedule\x20J\x20drugs','timeDisplay','cHESr','KmJeJ','Sildenafil','72jBOVTT','baUDX','Potassium\x20sparing\x20diuretics','kkfDE','modeModal','XKtzE','https://dhmbxeygs57ff.cloudfront.net/uploads/0735275b88fc4d678851ba62673b565ex1280x1621.JPEG','quizFile','MRhnU','incorrectCount','div','none','green','Schedule\x20H\x20drugs','hidden','VSfLX','BXOJI','All\x20of\x20the\x20following\x20statements\x20are\x20true\x20about\x20Ertugliflozin,\x20which\x20has\x20been\x20recently\x20approved\x20by\x20the\x20FDA,\x20except','Chronic\x20consumption\x20results\x20in\x20inhibition','correct_choice_id','MdESu','SxTyC','fHaME','60\x20ng/min','ZpqiQ','block','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','Which\x20of\x20the\x20following\x20drugs\x20doesn’t\x20cause\x20hypoglycemia:','HIV\x20reverse\x20transcriptase','It\x20interacts\x20with\x20opiod\x20receptors','QWJCb','Chlorprocaine','completed','loadSource','resume','<p><strong>Suvorexant</strong>\x20is\x20the\x20<strong>orexin\x20receptor\x20antagonist</strong>\x20that\x20is\x20approved\x20for\x20<strong>use\x20in\x20insomnia</strong>.\x20<strong>Orexins\x20promote\x20wakefulness</strong>\x20and\x20antagonists\x20of\x20orexin\x20receptor\x20induces\x20sleep.</p>\x0a<p>Aprepitant,\x20rolaprepitant\x20and\x20netupitant\x20are\x20NK1\x20receptor\x20antagonist\x20used\x20as\x20antiemetics\x20(options\x20a,\x20b\x20and\x20d).</p>','Sertraline','iONLj','foxzD','closest','DyfnT','2mg\x20IV','<p><strong>Niacin</strong>\x20would\x20be\x20<strong>absolutely\x20contraindicated</strong>\x20for\x20the\x20lady\x20presenting\x20with\x20the\x20above\x20clinical\x20history.\u00a0</p>\x0a<p>Contraindications\x20to\x20niacin\x20are:</p>\x0a<ul>\x0a<li>Pregnancy</li>\x0a<li>Concurrent\x20use\x20with\x20statin\x20-\x20causes\x20myopathy</li>\x0a<li>History\x20of\x20peptic\x20ulcer\x20disease</li>\x0a<li>Gout\x20-\x20is\x20a\x20relative\x20contraindication</li>\x0a</ul>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A-\x20<strong>Ezetimibe</strong>\x20in\x20combination\x20with\x20statin\x20results\x20in\x20further\x20reduction\x20of\x20low\x20density\x20lipoproteins\x20(LDL)\x20cholesterol.\x20However\x20this\x20<strong>combination</strong>\x20should\x20<strong>not\x20be\x20used</strong>\x20in\x20<strong>pregnant</strong>\x20women.\x20Ezetimibe\x20should\x20also\x20not\x20be\x20used\x20along\x20with\x20bile\x20acid\x20sequestrants\x20as\x20they\x20inhibit\x20its\x20absorption.</p>\x0a<p>Option\x20B-\x20<strong>Cholestyramine</strong>\x20is\x20contraindicated\x20is\x20<strong>severe\x20hypertriglyceridemia</strong>\x20(Note:\x20since\x20the\x20dyslipidemia\x20in\x20the\x20question\x20is\x20not\x20specific,\x20this\x20cannot\x20be\x20the\x20answer).</p>\x0a<p>Option\x20C-\x20<strong>Evolocumab</strong>\x20is\x20a\x20fully\x20human\x20monoclonal\x20antibody\x20that\x20inhibits\x20proprotein\x20convertase\x20subtilisin/Kexin\x20type\x209\x20(PCSK9).\x20It\x20is\x20contraindicated\x20in\x20those\x20with\x20hypersensitivity.</p>','https://cdn1.dailyrounds.org/uploads/b5bf7be9e10e41ccada2362472a803c6.PNG','add','ALboI','Correct\x20pairing\x20of\x20drug\x20and\x20its\x20mechanism\x20of\x20action\x20among\x20the\x20following\x20is?','WaeKd','ebiHC','HdFTp','None\x20of\x20the\x20above','Tiagabine','vXSGy','<p><strong>Prilocaine\x20</strong>is\x20a\x20local\x20anesthetic\x20that\x20is\x20classified\x20as\x20an\x20Amide.</p>\x0a<p>All\x20the\x20other\x20drugs\x20are\x20classified\x20as\x20esters.</p>','5HT3\x20receptor\x20antagonism','bMCsV','Oral\x20digoxin\x20is\x20being\x20given\x20to\x20a\x2065-year-old\x20male\x20patient\x20with\x20congestive\x20heart\x20failure\x20as\x20a\x20maintenance\x20dose\x20to\x20gradually\x20digitalize\x20him.\x20A\x20target\x20plasma\x20concentration\x20of\x200.70\x20ng/mL\x20is\x20decided\x20upon.\x20The\x20digoxin\x20clearance\x20for\x20this\x20particular\x20individual\x20is\x20calculated\x20as\x2060\x20mL/min.\x20Knowing\x20that\x20the\x20oral\x20bioavailability\x20of\x20digoxin\x20is\x2070%,\x20what\x20is\x20the\x20dosing\x20rate\x20in\x20this\x20patient?','NjkqF','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','JqUBa','get','Clearance','Option\x20','3|5|0|2|1|4','\x20>\x20','Fuppu','Therapeutic\x20level\x20of\x20lithium\x20(mEq/L)\x20that\x20is\x20indicated\x20for\x20prophylaxis\x20of\x20mania\x20is','FBdWH','Cevimeline','nav-btn-incorrect','dGnzG','Mark\x20for\x20Review','cetpf','No\x20solution\x20provided','Mechanism\x20of\x20action\x20of\x20the\x20antidiarrheal\x20agent\x20racecadotril\x20is','rkcEH','explanationVideoPlayer','3-4\x20days','<p><strong>Sugammadex</strong>\x20is\x20a\x20novel\x20reversal\x20agent\x20for\x20<strong>rocuronium\x20and\x20vecuronium.</strong></p>\x0a<p>Sugammadex\x20is\x20a\x20modified\x20gamma-cyclodextran\x20that\x20binds\x20rocuronium\x20and\x20vecuronium\x20tightly\x20and\x20decreases\x20the\x20concentration\x20of\x20free\x20plasma\x20levels.</p>','<p><strong>Rituximab</strong>\x20is\x20an\x20<strong>anti\x20CD20\x20monoclonal\x20antibody.</strong></p>\x0a<ul>\x0a<li>Rituximab\x20is\x20a\x20chimeric\x20monoclonal\x20antibody\x20that\x20targets\x20the\x20CD20\x20B-cell\x20antigen.\x20CD20\x20is\x20found\x20on\x20cells\x20from\x20the\x20pre&ndash;B\x20cell\x20stage\x20through\x20its\x20terminal\x20differentiation\x20to\x20plasma\x20cells\x20and\x20is\x20expressed\x20on\x20<strong>90%\x20of\x20B-cell\x20neoplasms</strong>.</li>\x0a<li>Monoclonal\x20antibody\x20binding\x20to\x20CD20\x20generates\x20transmembrane\x20signals\x20that\x20produce\x20<strong>autophosphorylation\x20and\x20activation\x20of\x20serine/tyrosine\x20protein\x20kinases</strong>,\x20induction\x20of\x20<em>c-Myc\x20</em>oncogene\x20expression,\x20and\x20expression\x20of\x20major\x20histocompatibility\x20complex\x20class\x20II\x20molecules.</li>\x0a<li>Rituximab\x20is\x20approved\x20as\x20a\x20single\x20agent\x20for\x20<strong>relapsed\x20indolent\x20lymphomas</strong>\x20and\x20significantly\x20enhances\x20response\x20and\x20survival\x20in\x20combination\x20with\x20chemotherapy\x20for\x20the\x20initial\x20treatment\x20of<strong>\x20diffuse\x20large\x20B-cell\x20lymphoma(DLBCL)</strong>.</li>\x0a<li>It\x20remains\x20effective\x20in\x20patients\x20who\x20relapse\x20after\x20initial\x20treatment\x20with\x20rituximab-based\x20combinations.</li>\x0a<li>Rituximab\x20improves\x20response\x20rates\x20when\x20added\x20to\x20combination\x20chemotherapy\x20for\x20other\x20indolent\x20B-cell\x20non-Hodgkin&rsquo;s\x20lymphomas\x20(NHLs),\x20including\x20CLL,\x20mantle\x20cell\x20lymphoma,\x20Waldenström\x20macroglobulinemia,\x20and\x20marginal\x20zone\x20lymphomas.</li>\x0a</ul>\x0a<p\x20class=\x22p1\x22>The\x20<strong>EGFR</strong>\x20belongs\x20to\x20the\x20ErbB\x20family\x20of\x20transmembrane\x20receptor\x20tyrosine\x20kinases\x20also\x20known\x20as\x20ErbB1\x20or\x20HER1\x20(human\x20EGFR\x201).\x20EGFR\x20is\x20essential\x20for\x20the\x20growth\x20and\x20differentiation\x20of\x20epithelial\x20cells.</p>\x0a<p\x20class=\x22p1\x22><strong>Two\x20separate\x20classes\x20of\x20drugs</strong>\x20that\x20target\x20the\x20EGFR\x20pathway\x20are\x20important\x20in\x20the\x20therapy\x20of\x20solid\x20tumors:</p>\x0a<ol>\x0a<li\x20class=\x22p1\x22><strong>Monoclonal\x20antibodies</strong>\x20recognize\x20the\x20extracellular\x20domain\x20of\x20the\x20EGFR,\x20inhibit\x20ligand-induced\x20signaling,\x20and\x20can\x20elicit\x20an\x20immune\x20response.&nbsp;<strong>Cetuximab</strong>&nbsp;is\x20a\x20recombinant,\x20chimeric\x20human/mouse\x20IgG<span\x20class=\x22s1\x22>1\x20</span>antibody\x20that\x20binds\x20to\x20<strong>EGFR</strong>\x20and\x20prevents\x20ligand-dependent\x20signaling\x20and\x20receptor\x20dimerization,\x20thereby\x20blocking\x20cell\x20growth\x20and\x20survival\x20signals.\x20It\x20is\x20used\x20to\x20treat\x20patients\x20with\x20<strong>metastatic\x20colon\x20cancers\x20and\x20Head\x20and\x20neck\x20squamous\x20cell\x20carcinoma(HNSCC)</strong>.</li>\x0a<li\x20class=\x22p1\x22><strong>Protein\x20tyrosine\x20kinase\x20inhibitors</strong>&nbsp;bind\x20to\x20the\x20intracellular\x20kinase\x20domain\x20and\x20inhibit\x20the\x20enzymatic\x20function\x20of\x20an\x20EGFR.\x20Erlotinib\x20is\x20a\x20reversible\x20EGFR\x20tyrosine\x20kinase\x20inhibitor\x20used\x20for\x20advanced\x20<strong>non-small\x20cell\x20lung\x20cancer</strong>(NSCLC)\x20with\x20mutant\x20EGFR\x20and\x20advanced\x20<strong>pancreatic\x20cancer</strong>\x20in\x20combination\x20with\x20gemcitabine.</li>\x0a</ol>\x0a<p\x20class=\x22p1\x22><strong>Trastuzumab</strong>\x20is\x20a\x20humanized\x20IgG1\x20monoclonal\x20antibody\x20of\x20<strong>HER2</strong>-human\x20epidermal\x20growth\x20factor\x20receptor\x202,\x20inhibiting\x20hetero-\x20and\x20homodimerization\x20and\x20signal\x20transduction.\x20It\x20is\x20approved\x20for\x20HER2-overexpressing\x20<strong>breast\x20and\x20gastric\x20cancer.</strong></p>','dKlbR','Doxycycline,\x20azithromycin','yKbDx','iPbnf','oktSP','2|4|3|0|5|1','290dypGZM','vZRBg','Vincristine','Which\x20of\x20the\x20following\x20shows\x20a\x20U-shaped\x20dose-response\x20curve?','The\x20lab\x20report\x20of\x20a\x2035\x20year\x20old\x20lady\x20who\x20underwent\x20a\x20medical\x20checkup\x20suggests\x20dyslipidemia.\x20She\x20has\x20a\x20past\x20medical\x20history\x20of\x20peptic\x20ulcer\x20disease.\x20Also\x202\x20months\x20back,\x20she\x20had\x20severe\x20pain\x20in\x20her\x20great\x20toe\x20which\x20was\x20cured\x20temporarily\x20by\x20taking\x20NSAIDs.\x20She\x20has\x20been\x20taking\x20statins\x20for\x20past\x201\x20month.\x20Which\x20of\x20the\x20below\x20drugs\x20is\x20absolutely\x20contraindicated\x20in\x20this\x20patient?','questionMedia','qKFdo','Ivermectin','<p><strong>Probenecid</strong>\x20is\x20a\x20<strong>uricosuric\x20agent</strong>\x20that\x20acts\x20by\x20inhibiting\x20the\x20<strong>organic\x20anion\x20transporter\x20(OATP)</strong>\x20in\x20renal\x20tubules.</p>\x0a<p><strong>Pilocarpine</strong>\x20is\x20a\x20<strong>muscarinic\x20agonist</strong>\x20(option\x20a).</p>\x0a<p><strong>Acetazolamide</strong>\x20inhibits\x20<strong>carbonic\x20anhydrase</strong>\x20enzyme\x20(option\x20c).</p>\x0a<p><strong>Vigabatrin</strong>\x20is\x20a\x20<strong>GABA\x20transaminase\x20inhibitor</strong>\x20(option\x20d).</p>','Pregabalin','key','A:\x20Loop\x20diuretics\x20B:\x20Carbonic\x20anhydrase\x20inhibitors','ljqdI','stringify','WxCAe','vSBpT','click','Which\x20of\x20the\x20following\x20statements\x20is\x20not\x20true\x20about\x20biotransformation?','https://cdn1.dailyrounds.org/uploads/8fdfb392b7bf40a6a930c7765f899b6e.PNG','It\x20is\x20used\x20for\x20diagnosis\x20of\x20bronchial\x20airway\x20hyperreactivity','SvyGh','Metolazone\x20belongs\x20to\x20the\x20following\x20class\x20of\x20diuretics','DxGfg','querySelectorAll','Jvnci','Chelators','<div\x20class=\x22mt-4\x22><img\x20src=\x22','QQRzG','Anti-cancer\x20drugs','qoill','SafNk','Cefdinir\x20Pivoxil','erGxw','GFBAU','emorq','Frvvt','JFhDv','A\x20patient\x20presents\x20with\x20fever,\x20abdominal\x20pain,\x20and\x20a\x20recent\x20history\x20of\x20diarrhea.\x20He\x20has\x20associated\x20tenderness\x20over\x20the\x20right\x20upper\x20quadrant\x20of\x20the\x20abdomen.\x20Abdominal\x20CT\x20is\x20shown\x20below.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20indicated\x20for\x20the\x20management\x20of\x20the\x20CT\x20finding?','includes','Sugammadex\x20is\x20a\x20reversal\x20agent\x20for','pop','Marked','progressBar','https://dhmbxeygs57ff.cloudfront.net/uploads/e0db32ffbadd42dd9c69b75a9398ff60x1280x1420.JPEG','VicVt','<p>The\x20<strong>volume\x20of\x20distribution</strong>\x20of\x20the\x20drug\x20<strong>determines</strong>\x20the<strong>\x20loading\x20dose</strong>\x20of\x20the\x20drug.</p>\x0a<p>Loading\x20Dose\x20=\x20Vol.\x20of\x20distribution\x20x\x20Desired\x20steady\x20state\x20plasma\x20concentration.</p>\x0a<p>When\x20the\x20time\x20to\x20reach\x20a\x20steady-state\x20is\x20long,\x20as\x20it\x20is\x20for\x20<strong>drugs</strong>\x20with\x20<strong>long\x20half-lives,</strong>\x20it\x20may\x20be\x20desirable\x20to\x20<strong>administer</strong>\x20a\x20<strong>loading\x20dose</strong>\x20that\x20promptly\x20raises\x20the\x20concentration\x20of\x20drug\x20in\x20plasma\x20to\x20the\x20target\x20concentration.</p>\x0a<p>Option\x20A:<strong>&nbsp;</strong>Clearance\x20is\x20used\x20to\x20determine\x20the\x20maintenance\x20dose.&nbsp;</p>\x0a<p>Maintenance\x20dose\x20=\x20Clearance\x20x&nbsp;Desired\x20Steady-state\x20plasma\x20concentration.</p>\x0a<p>Options\x20C\x20and\x20D:\x20Plasma\x20<strong>half-life</strong>\x20primarily\x20<strong>determines</strong>\x20the\x20<strong>frequency</strong>\x20of\x20dosing,\x20while\x20<strong>bioavailability</strong>\x20<strong>determines</strong>\x20the\x20<strong>route</strong>\x20of\x20administration.&nbsp;Though\x20bioavailability\x20may\x20affect\x20the\x20dose\x20necessary,\x20it\x20will\x20not\x20be\x20the\x20primary\x20factor\x20considered\x20during\x20the\x20calculation\x20of\x20the\x20loading\x20dose.</p>','CQLiG','Mechanism\x20of\x20action\x20of\x20nicorandil\x20in\x20angina\x20is/are','YZOCs','EtNxs','pharmacology-test-ii-dfca44bd.html','explanation_audio_eng','Used\x20clinically\x20to\x20increase\x20blood\x20pressure\x20in\x20shock','Correct','UOdKe','LCEYo','<p>A\x20drug\x20stating\x20that\x20500mg\x20of\x20paracetamol\x20is\x20present\x20in\x20each\x20tablet,\x20but\x20contains\x20only\x20200mg\x20is\x20a\x20<strong>misbranded\x20drug</strong>,\x20according\x20to\x20the\x20CDSCO\x20(Central\x20drugs\x20standard\x20control\x20organization).</p>\x0a<p>The\x20drug\x20and\x20cosmetics\x20act\x20initially\x20passed\x20in\x201940\x20and\x20amended\x20in\x202016\x20provides\x20a\x20definition\x20of&nbsp;<strong>misbranded</strong>,\x20<strong>spurious</strong>,\x20and\x20<strong>adulterated</strong>\x20drugs.</p>\x0a<p>A\x20drug\x20is\x20considered&nbsp;<strong>misbranded</strong>\x20if\x20it\x20fulfills\x20any\x20of\x20the\x20following\x20three\x20conditions:</p>\x0a<ul>\x0a<li>If\x20the\x20appearance\x20of\x20the\x20drug\x20has\x20been\x20altered\x20to\x20conceal\x20physical\x20damage\x20or\x20make\x20it\x20appear\x20of\x20greater\x20therapeutic\x20value\x20than\x20it\x20actually\x20is\x20(or)</li>\x0a<li>If\x20it\x20is\x20not\x20labeled\x20in\x20the\x20prescribed\x20manner\x20(or)</li>\x0a<li>If\x20the\x20label\x20or\x20container\x20of\x20the\x20drug\x20makes\x20a\x20false\x20or\x20misleading\x20claim\x20about\x20the\x20drug.\x20In\x20this\x20case,\x20the\x20packet\x20states\x20that\x20there\x20is\x20500\x20mg\x20of\x20paracetamol\x20present\x20as\x20opposed\x20to\x20the\x20200\x20mg\x20that\x20is\x20actually\x20present.</li>\x0a</ul>\x0a<p>A\x20drug\x20is\x20considered&nbsp;<strong>spurious</strong>\x20if\x20it\x20fulfills\x20the\x20following\x20conditions:</p>\x0a<ul>\x0a<li>If\x20the\x20drug\x20is\x20imported\x20under\x20a\x20name\x20that\x20belongs\x20to\x20another\x20drug\x20(or)</li>\x0a<li>If\x20the\x20drug\x20is\x20an\x20imitation\x20of\x20another\x20drug\x20with\x20the\x20intent\x20to\x20deceive\x20(or)</li>\x0a<li>If\x20the\x20label\x20depicts\x20a\x20manufacturer\x20that\x20is\x20either\x20fictitious\x20or\x20a\x20real\x20company\x20with\x20no\x20ties\x20to\x20the\x20product\x20(or)</li>\x0a<li>If\x20it\x20has\x20been\x20substituted\x20wholly\x20or\x20in\x20part\x20by\x20another\x20drug\x20or\x20substance.</li>\x0a</ul>\x0a<p>A\x20drug\x20is\x20considered\x20<strong>adulterated</strong>\x20if\x20it\x20fulfills\x20the\x20following\x20conditions:</p>\x0a<ul>\x0a<li>If\x20it\x20consists\x20wholly\x20or\x20in\x20part\x20of\x20any\x20filthy,\x20putrid,\x20poisonous,\x20or\x20decomposed\x20substance\x20(or)</li>\x0a<li>If\x20it\x20has\x20been\x20manufactured\x20under\x20unsanitary\x20conditions\x20(or)</li>\x0a<li>If\x20it\x20bears\x20a\x20coloring\x20other\x20than\x20the\x20one\x20prescribed\x20(or)</li>\x0a<li>If\x20it\x20has\x20been\x20mixed\x20with\x20any\x20substance\x20that\x20may\x20reduce\x20its\x20quality\x20or\x20strength.</li>\x0a</ul>\x0a<p>*Note:\x20The\x20term\x20counterfeit\x20drugs\x20is\x20a\x20broad\x20term\x20and\x20is\x20used\x20by\x20the\x20WHO.\x20This\x20may\x20also\x20be\x20conceived\x20to\x20include\x20misbranded,\x20spurious,\x20or\x20adulterated\x20drugs.\x20However,\x20the\x20term\x20misbranded\x20drugs\x20would\x20be\x20a\x20more\x20appropriate\x20answer\x20here\x20since\x20it\x20is\x20likely\x20that\x20the\x20reference\x20used\x20is\x20from\x20CDSCO.&nbsp;</p>','Inhibition\x20of\x20peripheral\x20enkephalinase','totalQuestions','RMcsl','AnGxV','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','KTWzX','Steroids','Thioradazine','wpvPw','mWtSo','duRAu','Which\x20of\x20the\x20following\x20is\x20true\x20about\x20ketorolac?','Bookmark','vNLWM','TebVN','Vigabatrin','nav-btn-marked-review','NbGGu','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','studyModeLegend','text','MWWzQ','notAttempted','ynwQO','split','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','TLxpz','ArrowRight','Azithromycin,\x20doxycycline','sXcxE','Procaine','Hlvwl','addEventListener','not_attempted','DAecW','NXgcK','zXymD','btIFi','Foxar','To\x20feed\x20just\x20before\x20the\x20next\x20dose,\x20when\x20the\x20plasma\x20concentration\x20of\x20the\x20drug\x20would\x20be\x20the\x20least','reduce','<p><strong>Class\x201A</strong>\x20antiarrhythmic\x20agents\x20<strong>block\x20sodium\x20channels</strong>\x20with\x20moderate\x20intensity.\x20It\x20also\x20has\x20an\x20<strong>additional\x20action</strong>\x20of\x20<strong>blockade\x20of\x20potassium\x20channels</strong>\x20that\x20is\x20responsible\x20for\x20<strong>prolonging\x20the\x20action\x20potential\x20duration</strong>.</p>','scoreCircle','explanation_video','lkJsM','tmXzY','YIDhC','<p>The\x20drug\x20of\x20choice\x20for\x20a\x20case\x20of&nbsp;<strong>scrub\x20typhus</strong>\x20during\x20<strong>pregnancy</strong>&nbsp;is\x20<strong>azithromycin.&nbsp;</strong>For\x20other\x20patients\x20the\x20drug\x20of\x20choice\x20is&nbsp;<strong>doxycycline</strong>.</p>\x0a<p>An\x20alternative\x20treatment\x20option\x20in\x20pregnant\x20women\x20and\x20patients\x20allergic\x20to\x20doxycycline\x20is\x20chloramphenicol.</p>','mVgLL','Epinephrine\x20injection','SYvKd','awETz','ofTXy','Xiusn','search','study','length','Which\x20of\x20the\x20following\x20drugs\x20causes\x20flagellate\x20pigmentation?','map','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','timed_exam','oZNcM','question_audio','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','markedForReview','Vatxt','A\x20patient\x20diagnosed\x20with\x20peptic\x20ulcer\x20disease\x20is\x20being\x20treated\x20with\x20sucralfate.\x20Which\x20of\x20the\x20following\x20adverse\x20effects\x20can\x20be\x20seen\x20in\x20the\x20patient?','EObVx','GfZEe','nYLWn','onclick','AXzqh','oePcV','OZnIy','Maximum\x20incidence\x20of\x20phototoxicity\x20is\x20associated\x20with:','UsdJM','dvPSO','bOBNa','pVGUe','<0.6','contains','vITto','ubcCx','mPdsR','<p>Among\x20atypical\x20antipsychotics,<strong>&nbsp;risperidone,</strong><strong>&nbsp;paliperidone\x20</strong>and<strong>&nbsp;amisulpride&nbsp;</strong>have&nbsp;a&nbsp;<strong>higher</strong>&nbsp;<strong>risk\x20of\x20galactorrhoea</strong>.</p>\x0a<p><strong>Tuberoinfundibular\x20neurons</strong>\x20project\x20<strong>from</strong>\x20the\x20<strong>arcuate</strong>\x20<strong>nucleus</strong>\x20of\x20the\x20hypothalamus\x20<strong>to\x20the\x20anterior\x20pituitary</strong>.\x20<strong>Dopamine</strong>\x20is\x20<strong>delivered</strong>\x20in\x20this\x20region\x20via\x20the\x20hypophyseal\x20vessels.\x20Dopamine\x20<strong>binds\x20to</strong>\x20the\x20<strong>D<sub>2</sub></strong>\x20<strong>receptors</strong>\x20present\x20<strong>on</strong>\x20the\x20<strong>lactotropes</strong>\x20in\x20the\x20<strong>anterior\x20pituitary</strong>,\x20and\x20tonically\x20<strong>inhibits\x20the\x20prolactin\x20secretion</strong>\x20from\x20these\x20cells.&nbsp;</p>\x0a<p>The\x20<strong>more\x20potent</strong>\x20a\x20D<sub>2</sub>\x20blocking\x20drug\x20is,\x20the\x20<strong>more\x20likely</strong>\x20it\x20is\x20<strong>to\x20cause\x20hyperprolactinemia</strong>.\x20All\x20first-generation\x20antipsychotic\x20drugs\x20cause\x20hyperprolactinemia\x20due\x20to\x20their\x20D<sub>2</sub>\x20blocking&nbsp;properties.\x20Among\x20the\x20<strong>atypical\x20antipsychotics</strong>,\x20<strong>risperidone</strong>,\x20<strong>paliperidone,</strong>\x20and\x20<strong>amisulpride</strong>\x20are\x20associated\x20with\x20<strong>hyperprolactinemia</strong>.\x20Hyperprolactinemia\x20can\x20induce\x20<strong>breast\x20engorgement</strong>,\x20<strong>galactorrhea,</strong>\x20and\x20<strong>infertility</strong>\x20in\x20women,\x20and\x20sexual\x20dysfunction\x20in\x20men.</p>','Bioavailability','border-green-500','Which\x20of\x20the\x20following\x20is\x20not\x20a\x20TNF\x20alpha\x20inhibitor?','<p>Tolerance\x20develops\x20to\x20most\x20of\x20the\x20effects\x20of\x20morphine\x20<strong>except\x20miosis,\x20constipation\x20and\x20convulsions</strong>.</p>','DOMContentLoaded','Aripiprazole','mcMAp','testModeReviewLegend','Bookmarked','Ibrutinib\x20is\x20a\x20_______','QPorn','1mg\x20IV','prototype','solutionText','disabled','aplOM','Flavin\x20containing\x20monooxygenases\x20are\x20a\x20part\x20of\x20phase\x202\x20enzymes','Ethambutol','UYdjL','PWyVe','4nRqDvq','xSDiG','__proto__','<p><strong>Hypokalemia</strong>\x20is\x20the\x20<strong>most\x20common\x20complication</strong>\x20of\x20loop\x20diuretics.</p>\x0a<ul>\x0a<li><strong>Degree\x20of\x20Hypokalemia</strong>\x20depends\x20on\x20the\x20<strong>duration\x20of\x20action\x20of\x20the\x20drug</strong>\x20&ndash;\x20longer\x20acting\x20drugs\x20have\x20higher\x20risk.</li>\x0a<li>Presents\x20with\x20-\x20weakness,\x20fatigue,\x20muscle\x20cramps;\x20<strong>cardiac\x20arrhythmias</strong>\x20are\x20the\x20<strong>serious\x20complications.</strong></li>\x0a<li>Hypokalaemia\x20can\x20be\x20<strong>prevented\x20and\x20treated\x20by:</strong>\x0a<ul>\x0a<li>High\x20dietary\x20K+\x20intake</li>\x0a<li>Supplements\x20of\x20KCl\x20(24&ndash;72\x20mEq/day)</li>\x0a<li>Concurrent\x20use\x20of\x20K+\x20sparing\x20diuretics</li>\x0a</ul>\x0a</li>\x0a</ul>','markReviewBtn','<p><strong>HLA\x20allele\x20B-1502\x20</strong>is\x20implicated\x20as\x20a\x20<strong>marker\x20for\x20carbamazepine-induced\x20Stevens-Johnson\x20syndrome\x20and\x20toxic\x20epidermal\x20necrolysis</strong>\x20in\x20Han\x20Chinese,\x20the\x20USFDA\x20recommends\x20genotyping\x20all\x20Asians\x20for\x20the\x20allele.</p>','<p><span\x20style=\x22font-family:\x20-apple-system,\x20BlinkMacSystemFont,\x20\x27Segoe\x20UI\x27,\x20Roboto,\x20Oxygen,\x20Ubuntu,\x20Cantarell,\x20\x27Open\x20Sans\x27,\x20\x27Helvetica\x20Neue\x27,\x20sans-serif;\x22><strong>Mycophenolate</strong>\x20<strong>mofetil</strong>\x20is\x20the\x20immunosuppressive\x20agent\x20that\x20would\x20be\x20an\x20alternate\x20drug\x20in\x20this\x20scenario\x20indicated\x20as\x20a\x20prophylaxis\x20for\x20transplant\x20rejection</span><strong>.\u00a0</strong></p>\x0a<p>Mycophenolate\x20mofetil\x20is\x20a\x20prodrug\x20that\x20is\x20rapidly\x20converted\x20to\x20mycophenolic\x20acid.\x20It\x20is\x20a\x20selective,\x20non-competitive,\x20<strong>reversible\x20inhibitor\x20of\x20inosine\x20monophosphate\x20dehydrogenase\x20(IMPDH),</strong>\x20an\x20important\x20enzyme\x20in\x20the\x20de\x20novo\x20pathway\x20of\x20guanine\x20nucleotide\x20synthesis\x20and\x20a\x20suitable\x20alternative\x20for\x20managing\x20transplant\x20rejection\x20in\x20cases\x20where\x20cyclosporine\x20or\x20tacrolimus\x20is\x20not\x20tolerated.\u00a0</p>\x0a<p><strong>Cyclosporine</strong>\x20is\x20commonly\x20used\x20for\x20<strong>immunosuppression</strong>\x20following\x20<strong>transplantation</strong>\x20to\x20<strong>prevent\x20organ\x20rejection</strong>.\x20However,\x20it\x20can\x20cause\x20side\x20effects\x20such\x20as\x20<strong>nausea,\x20diarrhoea</strong>,\x20and\x20<strong>elevated\x20liver\x20enzymes</strong>.\x20These\x20symptoms\x20are\x20<strong>adverse\x20effects</strong>\x20of\x20cyclosporine\x20rather\x20than\x20indicative\x20of\x20treatment\x20failure.</p>\x0a<p><strong>Azathioprine</strong>\x20may\x20be\x20used\x20as\x20another\x20alternative,\x20although\x20it\x20is\x20<strong>less\x20commonly\x20preferred</strong>\x20due\x20to\x20its\x20potential\x20for\x20<strong>myelosuppression.</strong></p>\x0a<p>When\x20a\x20patient\x20experiences\x20i<strong>ntolerable\x20side\x20effects</strong>\x20with\x20<strong>cyclosporine,\x20tacrolimus</strong>\x20is\x20often\x20used\x20as\x20an\x20<strong>alternative</strong>.\x20Tacrolimus,\x20another\x20effective\x20immunosuppressant,\x20can\x20also\x20cause\x20nausea,\x20<strong>dizziness</strong>,\x20and\x20<strong>dyspnea</strong>\x20in\x20some\x20patients.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:<strong>\x20Etanercept</strong>\x20is\x20a\x20<strong>TNF-α\x20antagonist</strong>\x20used\x20in\x20rheumatoid\x20arthiritis\x20and\x20Crohn’s\x20disease.</p>\x0a<p>Option\x20C:\x20<strong>Tocilizumab</strong>\x20is\x20an\x20<strong>anti-IL-6\x20antibody</strong>\x20that\x20would\x20be\x20of\x20little\x20benefit\x20following\x20an\x20organ\x20transplant.</p>\x0a<p>Option\x20D:\x20<strong>Basiliximab</strong>\x20is\x20an\x20interleukin-2\x20receptor\x20antagonist\x20for\x20activated\x20T\x20lymphocytes\x20that\x20may\x20cause\x20shortness\x20of\x20breath.\x20As\x20the\x20patient\x20has\x20dyspnoea,\x20the\x20administration\x20of\x20basiliximab\x20will\x20further\x20worsen\x20his\x20condition.</p>','PiqfK','The\x20drug\x20not\x20acting\x20on\x20tubulin\x20is:','All\x20phase\x20II\x20biotransformation\x20reactions\x20involve\x20non-micorsomal\x20enzymes\x20except','attachMedia','4|5|0|3|1|2','Ciprofloxacin','Probenecid','5HT4\x20receptor\x20agonism','DVeRz','<p><strong>Ethambutol</strong>\x20is\x20the\x20<strong>only\x20bacteriostatic\x20drug</strong>\x20among\x20the\x20first\x20line\x20antitubercular\x20drugs.</p>','Alcohol','error','<p>Analgesic\x20action\x20of\x20ketorolac\x20is\x20equal\x20to\x20morphine\x20in\x20post-operative\x20pain</p>\x0a<p>Ketorolac,\x20an\x20NSAID\x20is\x20an\x20aryl\x20acetic\x20acid\x20derivative\x20with\x20the\x20following\x20properties</p>\x0a<ul>\x0a<li>It\x20has\x20<strong>mild\x20anti-inflammatory</strong>\x20action\x20but\x20is\x20a\x20<strong>potent\x20analgesic</strong>\x20(Option\x20A).\x20In<strong>\x20postoperative\x20pain\x20reduction,\x20</strong>the\x20efficacy\x20of\x20<strong>ketorolac\x20is\x20comparable\x20to\x20morphine</strong>.\x20Many\x20studies\x20have\x20concluded\x20that\x20the\x20analgesic\x20action\x20of\x20ketorolac\x20is\x20equivalent\x20to\x20morphine.&nbsp;</li>\x0a<li>It\x20does\x20not\x20interact\x20with\x20the\x20opioid\x20receptors\x20and\x20is\x20therefore\x20free\x20of\x20the\x20opioid\x20side\x20effects\x20(<strong>Option\x20D</strong>)</li>\x0a<li>It\x20is\x20mainly\x20used\x20in\x20postoperative\x20pain\x20relief\x20(<strong>Option\x20C</strong>)</li>\x0a</ul>','Cholestyramine','solutionVideo','incorrect','rNRLa','Paracetamol','BCR-ABL\x20Kinase\x20inhibitor','kILlo','aRqmC','toLowerCase','<p>The\x20<strong>therapeutic\x20index</strong>\x20is\x20<strong>4</strong>.</p>\x0a<p>In\x20the\x20above\x20graph,</p>\x0a<p>Median\x20lethal\x20dose\x20(LD50)\x20=\x20400</p>\x0a<p>Median\x20effective\x20dose\x20(ED50)\x20=\x20100</p>\x0a<p><strong>Therapeutic\x20index\x20(TI)</strong>\x20=<strong>\u00a0LD50/ED50.</strong></p>\x0a<p>Hence,</p>\x0a<p>Therapeutic\x20index\x20(TI\x20)\x20=\x20400/100\x20=\x204</p>\x0a<p>Clinically,\x20the\x20therapeutic\x20range\x20bound\x20by\x20the\x20dose\x20that\x20produces\x20the\x20minimal\x20therapeutic\x20effect\x20and\x20the\x20dose\x20that\x20produces\x20the\x20maximal\x20acceptable\x20adverse\x20effect\x20is\x20more\x20relevant.</p>\x0a<p>\u00a0</p>','Ceftaroline','Quinine','location','Vitamin\x20B12\x20deficiency','Pyrantel\x20pamoate','GABA\x20transporter\x20inhibitor\x20among\x20the\x20following\x20is','nav-btn-correct','In\x20pregnancy,\x20because\x20of\x20high\x20risk\x20of\x20teratogenicity','Acetylation','GLJMa','Risperidone','XsnoX','<p><strong>Anakinra</strong>\x20is\x20a\x20recombinant,\x20non-glycosylated\x20form\x20of\x20<strong>human\x20interleukin\x201A</strong>.\x20It\x20is\x20approved\x20for\x20use\x20in\x20<strong>rheumatoid\x20arthritis</strong>\x20and\x20for\x20cryopyrin-associated\x20periodic\x20syndromes\x20(CAPS).</p>\x0a<p><strong>Infliximab,\x20etanercept,\x20and\x20golimumab</strong>\x20are\x20<strong>TNF\x20alpha\x20inhibitors</strong>\x20(options\x20a,\x20b\x20and\x20d).\x20Adalimumab\x20&amp;\x20Certolizumab\x20are\x20other\x20TNF\x20alpha\x20inhibitors</p>','gmAEh','\x22\x20data-option-index=\x22','gwWXZ','bookmarkText','Paclitaxel','quizSidebar','nav-btn-current','AAyrN','jfJwL','PuhJC','<p>Generalized\x20urticaria,\x20swelling\x20of\x20lips,\x20hypotension,\x20and\x20bronchospasm\x20suggests\x20that\x20the\x20patient\x20is\x20developing\x20<strong>anaphylactic\x20shock.&nbsp;</strong><strong>Epinephrine\x20</strong>injection\x20administered<strong>\x20intramuscularly\x20</strong>is\x20the\x20preferred\x20choice\x20in\x20anaphylactic\x20shock.\x20Epinephrine\x20is\x20a&nbsp;<strong>powerful\x20bronchodilator</strong>&nbsp;and\x20it\x20is\x20a\x20<strong>potent\x20vasopressor</strong>.</p>\x0a<p>Antihistamines\x20have\x20only\x20an\x20adjuvant\x20role\x20in\x20anaphylactic\x20shock\x20and\x20are\x20not\x20routinely\x20used\x20in\x20emergency\x20cases.&nbsp;</p>','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','HLA-B\x201507','QgVyK','rokuF','correct','HIV\x20entry\x20into\x20cell','toISOString','bind','5317710WsTXJp','tZVot','Carvedilol','EgXWN','tGFMY','PFtpD','KUdtm','MBBYj','parse','FVMkj','Chloramphenicol,\x20doxycycline','RZdDK','ylNRw','accuracy','vZPYH','IUfaK','It\x20is\x20indicated\x20for\x20the\x20treatment\x20of\x20type\x20I\x20diabetes\x20mellitus','style','OICXc','button','Treatment\x20for\x20the\x20nutritional\x20form\x20of\x20this\x20disease\x20includes:','oPUAg','Cariprazine','Metronidazole','ioHuj','<p><strong>Rivastigmine</strong>&nbsp;is\x20a\x20cholinesterase\x20inhibitor\x20that\x20is\x20available\x20as\x20a\x20<strong>transdermal\x20patch</strong>\x20for\x20use\x20in\x20Alzheimer\x27s\x20disease.\x20It\x20can&nbsp;be\x20applied\x20for\x20over\x2024\x20hours.\x20Transdermal\x20delivery\x20<strong>reduces\x20the\x20fluctuation</strong>\x20and\x20avoids\x20direct\x20gastric\x20irritation\x20effects\x20associated\x20with\x20oral\x20formulations.&nbsp;</p>\x0a<p>Option\x20A:\x20Tacrine\x20is\x20an\x20anticholinesterase\x20that\x20is\x20obsolete\x20because\x20of\x20its\x20association\x20with\x20hepatotoxicity.&nbsp;</p>\x0a<p>Options\x20B\x20and\x20D:\x20Donepezil\x20and\x20galantamine\x20transdermal\x20formulations\x20are\x20under\x20development\x20and\x20<strong>yet\x20to\x20be\x20available</strong>\x20in\x20the\x20market.</p>','yYoxj','createElement','KVdTj','answered','pathname','nav-btn-answered','vcCuW','HbLTY','Hypergastrinemia','WuBSU','apply','Vernaciline','classList','suyXf','TPMzP','display','JKAFT','What\x20instruction\x20do\x20you\x20give\x20to\x20a\x20mother\x20who\x20is\x20lactating\x20for\x20drug\x20use?','DMVuy','forEach','table','fmYXr','jbWOK','<ul>\x0a<li><strong>Ertugliflozin</strong>\u00a0is\x20a\x20sodium-glucose\x20co-transporter\x202\x20(SGLT2)\x20inhibitor\x20indicated\x20as\x20an\x20adjunct\x20to\x20diet\x20and\x20exercise\x20<strong>to\x20improve\x20glycemic\x20control\x20in\x20adults\x20with\x20type\x202\x20diabetes\x20mellitus.</strong></li>\x0a<li>It\x20is\x20<strong>not\x20used\x20for\x20the\x20treatment\x20of\x20type\x201\x20diabetes\x20mellitus</strong>\x20or\x20<strong>diabetic\x20ketoacidosis</strong>.</li>\x0a</ul>\x0a<p><strong>Dosage\x20and\x20administration:</strong></p>\x0a<ul>\x0a<li>The\x20recommended\x20starting\x20dose\x20is\x20<strong>5\x20mg\x20once\x20daily</strong>,\x20taken\x20in\x20the\x20morning,\x20with\x20or\x20without\x20food.</li>\x0a<li>The\x20dosage<strong>\x20can\x20be\x20increased\x20to\x2015\x20mg\x20once\x20daily</strong>\x20in\x20those\x20tolerating\x20Ertugliflozin\x20and\x20needing\x20additional\x20glycemic\x20control.</li>\x0a<li>Do\x20not\x20use\x20in\x20patients\x20with\x20an\x20estimated\x20glomerular\x20filtration\x20rate\x20(eGFR)\x20below\x2030\x20mL/minute/1.73\x20m<sup>2</sup>.</li>\x0a<li>Initiation\x20and\x20continued\x20use\x20are\x20not\x20recommended\x20in\x20patients\x20with\x20an\x20eGFR\x20persistently\x20between\x2030\x20and\x20less\x20than\x2060\x20mL/min/1.73\x20m<sup>2</sup>.</li>\x0a</ul>\x0a<p><strong>Mechanism\x20of\x20action:</strong></p>\x0a<ul>\x0a<li><strong>SGLT2</strong>\x20is\x20the\x20predominant\x20transporter\x20responsible\x20for\x20<strong>reabsorption\x20of\x20glucose\x20from\x20the\x20glomerular\x20filtrate</strong>\x20back\x20into\x20the\x20circulation.</li>\x0a<li><strong>Ertugliflozin</strong>\x20is\x20an\x20<strong>inhibitor\x20of\x20SGLT2</strong>.</li>\x0a<li>By\x20inhibiting\x20SGLT2,\x20Ertugliflozin\x20<strong>reduces\x20renal\x20reabsorption\x20of\x20filtered\x20glucose</strong>\x20and\x20lowers\x20the\x20renal\x20threshold\x20for\x20glucose,\x20and\x20thereby\x20increases\x20urinary<strong>\u00a0glucose\x20excretion.</strong></li>\x0a</ul>\x0a<p><strong>Contraindication:</strong></p>\x0a<ul>\x0a<li>Severe\x20renal\x20impairment,\x20end-stage\x20renal\x20disease,\x20or\x20dialysis.\u00a0</li>\x0a<li>History\x20of\x20serious\x20hypersensitivity\x20reaction\x20to\x20Ertugliflozin.</li>\x0a</ul>\x0a<p><strong>Adverse\x20reactions:</strong></p>\x0a<ul>\x0a<li>The\x20<strong>most\x20common\x20adverse\x20reactions</strong>\x20associated\x20with\x20Ertugliflozin\x20(incidence\x20≥\x205%)\x20were\x20<strong>female\x20genital\x20mycotic\x20infections.</strong></li>\x0a</ul>','It\x20is\x20not\x20recommended\x20in\x20patients\x20with\x20an\x20estimated\x20GFR\x20below\x2030\x20mL/minute/1.73\x20m2','submitSection','floor','tDyIJ','Incorrect\x20statement\x20about\x20angiotensin\x20II\x20is','https://cdn1.dailyrounds.org/uploads/622c455438be4ab480ed5ee698509c1f.JPEG','<p>The\x20name\x20\x22motilide\x22\x20refers\x20to\x20a\x20<strong>motilin-like\x20macrolide</strong>.\x20The\x20effects\x20of\x20motilin\x20can\x20be\x20mimicked\x20by\x20<strong>erythromycin</strong>.</p>\x0a<p>Erythromycin\x20<strong>induces\x20phase\x20III\x20migrating\x20motor\x20complex.</strong></p>\x0a<p>It\x20has\x20multiple\x20effects\x20on\x20upper\x20GI\x20motility,\x20increasing\x20lower\x20esophageal\x20pressure\x20and\x20stimulating\x20gastric\x20and\x20small-bowel\x20contractility.\x20However,\x20it\x20has\x20<strong>little\x20or\x20no\x20effect\x20on\x20colonic\x20motility</strong>.</p>\x0a<p\x20class=\x22p1\x22>Erythromycin\x20is\x20used\x20as\x20a\x20<strong>prokinetic</strong>\x20agent\x20in\x20patients\x20with\x20<strong>diabetic\x20gastroparesis</strong>,\x20where\x20it\x20can\x20improve\x20gastric\x20emptying\x20in\x20the\x20short\x20term.</p>\x0a<p\x20class=\x22p1\x22>Rapid\x20development\x20of\x20tolerance\x20(~28\x20days)\x20to\x20erythromycin,\x20possibly\x20by\x20downregulation\x20of\x20the\x20motilin\x20receptor,\x20and\x20antibiotic\x20effects\x20(undesirable\x20in\x20this\x20context)\x20limit\x20the\x20use\x20of\x20this\x20drug\x20as\x20a\x20prokinetic\x20agent.</p>\x0a<p\x20class=\x22p1\x22>A\x20standard\x20dose\x20of\x20erythromycin\x20for\x20gastric\x20stimulation\x20is\x20<strong>1.5&ndash;3\x20mg/kg\x20intravenous\x20infusion</strong>\x20every\x206\x20h\x20in\x20a\x20hospital\x20setting\x20or\x20<strong>125\x20mg\x20orally</strong>\x20every\x2012\x20h.</p>\x0a<p>At\x20doses\x20higher\x20than\x203\x20mg/kg,\x20it\x20can\x20produce\x20a\x20spastic\x20type\x20of\x20contraction\x20in\x20the\x20small\x20bowel,\x20resulting\x20in\x20cramps,\x20impairment\x20of\x20transit,\x20and\x20vomiting.</p>','fujsk','CWfrm','constructor','Lamotrigine','Carteolol','IUqWP','kAEEm','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','FLCdF','18858492CnxASE','className','GLP-\x201\x20receptor\x20agonist','target','igvGn','lnEKV','Tazobactam','Insulin\x20detemir','hDeYR','It\x20is\x20more\x20resistant\x20to\x20hydrolysis\x20compared\x20to\x20cholinesterase','performanceModal','prevBtn','Donepezil','notAttemptedResult','Amwpx','vMHax','https://dhmbxeygs57ff.cloudfront.net/uploads/cbb79628483a49e5bce96265d68a0673x1280x1154.JPEG','reload','status','poDct','Morphine','selected','<p><strong>Fluoxetine</strong>\x20is\x20the\x20<strong>longest\x20acting\x20SSRI.</strong></p>\x0a<p>Fluoxetine\x20has\x20<strong>plasma\x20t<sub>1/2</sub>\x20of\x2048-72\x20hours.</strong></p>\x0a<p>It\x20is\x20<strong>metabolized\x20to\x20an\x20active\x20product,\x20norfluoxetine</strong>,\x20which\x20may\x20have\x20<strong>plasma\x20concentrations\x20greater\x20than\x20those\x20of\x20fluoxetine.\x20</strong></p>\x0a<p>The\x20<strong>elimination\x20half-life\x20of\x20norfluoxetine\x20is\x20about\x20three\x20times\x20longer\x20than\x20fluoxetine\x20(180\x20hours)</strong>\x20and\x20contributes\x20to\x20the\x20<strong>longest\x20half-life\x20of\x20all\x20the\x20SSRIs.\x20</strong></p>\x0a<p>As\x20a\x20result,\x20fluoxetine\x20has\x20to\x20be\x20<strong>discontinued\x204\x20weeks\x20or\x20longer\x20before\x20an\x20MAOI\x20can\x20be\x20administered\x20to\x20mitigate\x20the\x20risk\x20of\x20serotonin\x20syndrome.</strong></p>','innerHTML','yYvBi','choices','10mg\x20IV','Phase\x20I\x20reactions\x20unmask\x20a\x20functional\x20group','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','Ceftriaxone','UrYbE','test','Sufew','YeojZ','Cotrimoxazole','dysdD','1.5-2.0','Following\x20a\x20kidney\x20transplant,\x20a\x2024-year-old\x20male\x20patient\x20is\x20placed\x20on\x20cyclosporine\x20but\x20after\x2048\x20hours\x20complains\x20of\x20serious\x20nausea\x20and\x20diarrhea\x20and\x20has\x20a\x20sudden\x20increase\x20in\x20transaminases.\x20You\x20switch\x20him\x20to\x20tacrolimus\x20but\x20nausea\x20persists\x20and\x20he\x20complains\x20of\x20getting\x20dizzy\x20and\x20has\x20dyspnea.\x20Which\x20of\x20the\x20following\x20immunosuppressive\x20agents\x20would\x20be\x20an\x20alternate\x20drug\x20in\x20this\x20scenario?','xoUCm','TimkZ','Chlorpheniramine\x20injection','explanation_images','dataset','<p><strong>Bleomycin</strong>\x20is\x20a\x20<strong>glycopeptide\x20antibiotic</strong>\x20acting\x20by\x20<strong>formation\x20of\x20free\x20radicals\x20and\x20causing\x20DNA\x20strand\x20breakage</strong>.</p>\x0a<p><strong>Microtubule\x20damaging\x20agents</strong>\x20are:</p>\x0a<ul>\x0a<li>Vincristine\x20(Oncovin)</li>\x0a<li>Vinblastine</li>\x0a<li>Vinorelbine</li>\x0a<li>Paclitaxel</li>\x0a<li>Docetaxel</li>\x0a<li>Estramustine</li>\x0a</ul>','nYkeq','qblMo','kWEri','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','dqqNv','Sulfation','SiAln','Sparfloxacin','None','mwRlR','Which\x20of\x20the\x20following\x20is\x20gametocidal\x20to\x20all\x20the\x20species\x20causing\x20malaria?','Ydxsj','.m3u8','Marrow','1.0-1.5','XVPCM','Linezolid','Nebivolol','question_images','nxSrT','Mycophenolate\x20mofetil','removeItem','ENgwR','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','The\x20risk\x20of\x20carbamazepine\x20induced\x20Steven\x20Johnson\x20syndrome\x20is\x20increased\x20in\x20the\x20presence\x20of\x20which\x20of\x20the\x20following\x20genes?','Class\x201A\x20antiarrhythmic\x20agents\x20block\x20the\x20following\x20ion\x20channels','bookmarkedQuestions','Carbonic\x20anhydrase\x20inhibitor\x20approved\x20for\x20familial\x20periodic\x20paralysis','Stimulates\x20release\x20of\x20aldosterone','vigsC','iefbC','Bleomycin','Drug\x20of\x20choice\x20for\x20actinomycosis\x20is:','<p><strong>Penicillin\x20G</strong>\x20is\x20the\x20<strong>agent\x20of\x20choice</strong>\x20for\x20the\x20treatment\x20of\x20all\x20forms\x20of\x20<strong>actinomycosis.</strong></p>\x0a<p>The\x20dose\x20should\x20be\x20<strong>18-24\x20million&nbsp;units\x20of\x20penicillin\x20G\x20intravenously</strong>\x20per\x20day\x20<strong>for\x206\x20weeks</strong>.\x20Some\x20physicians\x20continue\x20therapy\x20for\x202-3\x20months\x20with\x20oral\x20penicillin\x20V\x20(500\x20mg\x20four\x20times\x20daily).\x20Surgical\x20drainage\x20or\x20excision\x20of\x20the\x20lesion\x20may\x20be\x20necessary\x20before\x20a\x20cure\x20is\x20accomplished.</p>\x0a<p>Alternatively,\x20treatment\x20can\x20also\x20be\x20done\x20with<strong>\x20tetracyclines</strong>.</p>','HIV\x20integrase','Benzocaine','KJosK','name','Mqbgv','Colchicine','flex','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','getItem','AbMMU','VVJeu','xLedL','IFHfB','dkdwq','PvTmS','isSupported','661842fmGFZb','ucbMM','zLyPv','High\x20dose\x20corticosterone\x20tablet','tqXbJ','eOZAk','duQLl','</span><span>','review-question\x20','vUltU','No\x20effect\x20on\x20both\x20acute\x20and\x20chronic\x20consumption','oTtqO','Tocilizumab','currentQuestion','PHNaq','Has\x20potent\x20anti\x20inflammatory\x20activity','pHyOh','Inhibits\x20osteoblasts','Doxorubicin','1.5mg\x20IV','ruAvU','WaoKK','timeSpent','bookmarked','xVQSk','Joule’s\x20Solution','startAt','selectedAnswer','Opioid\x20delta\x20receptor\x20antagonism','Sulbactam','Suvorexant','A\x2048-year-old\x20male\x20patient\x20presented\x20with\x20severe\x20restlessness,\x20palpitations,\x20facial\x20flushing,\x20and\x20sweating.\x20The\x20patient\x20had\x20an\x20episode\x20of\x20dysentery\x202\x20days\x20prior\x20and\x20had\x20been\x20prescribed\x20medication\x20for\x20that.\x20The\x20patient\x20reports\x20taking\x20alcohol\x202\x20hours\x20after\x20his\x20medications.\x20Which\x20of\x20the\x20following\x20drug\x20does\x20not\x20cause\x20similar\x20effects?','wnPmw','MxbrJ','90563AQPuJH','totalAttempted','Glucuronidation','Nebulized\x20salbutamol','Beta-lactamase\x20inhibitor\x20that\x20does\x20not\x20cause\x20suicidal\x20inhibition\x20of\x20beta-lactamase\x20is','data-option-index','PskqQ','DybnA','Chloroquine','COpQB','Sjeoq','rZgBS','uulhw','<p>The\x20above\x20clinical\x20scenario\x20of\x20a\x20patient\x20presenting\x20with\x20<strong>fever</strong>,\x20<strong>abdominal\x20pain</strong>,\x20a\x20<strong>recent\x20history\x20of\x20diarrhea,</strong>\x20and\x20an\x20<strong>abdominal\x20CT</strong>\x20showing\x20a\x20moderate-sized\x20<strong>abscess\x20in\x20the\x20right\x20liver\x20lobe</strong>\x20is\x20suggestive\x20of\x20an\x20<strong>amebic\x20liver\x20abscess</strong>.\x20It\x20is\x20an\x20<strong>extra-intestinal\x20infection</strong>\x20caused\x20by\x20<strong><em>Entamoeba\x20histolytica</em></strong>\x20and\u00a0<strong>metronidazole</strong>\x20is\x20the\x20<strong>drug\x20of\x20choice</strong>\x20for\x20treating\x20this\x20condition.\u00a0</p>\x0a<p>Amebic\x20liver\x20abscess\x20<strong>follows\x20intestinal\x20amebiasis</strong>.\x20However,\x20a\x20history\x20of\x20diarrhea\x20may\x20not\x20always\x20be\x20present\x20as\x20most\x20patients\x20remain\x20asymptomatic\x20carriers.\x20In\x20patients\x20presenting\x20with\x20the\x20above\x20symptoms,\x20<strong>stool\x20examination</strong>,\x20<strong>serological\x20tests</strong>,\x20and\x20<strong>radiological\x20imaging</strong>\x20help\x20to\x20confirm\x20the\x20diagnosis.\u00a0</p>\x0a<p>Metronidazole\x20is\u00a0the\x20<strong>drug\x20of\x20choice</strong>\x20for\x20treating\x20<strong>invasive\x20amebiasis</strong>\x20like\x20an\x20amebic\x20liver\x20abscess.\x20It\x20is\x20a\x20<strong>nitroimidazole</strong>\x20compound\x20and\x20is\x20a\x20highly\x20<strong>active\x20tissue\x20amebicide.\x20</strong><strong>Tinidazole</strong>,\x20which\x20is\x20another\x20longer-acting\x20imidazole,\x20is\x20also\x20highly\x20effective\x20for\x20the\x20management\x20of\x20this\x20condition.\x20Other\x20tissue\x20amebicides\x20include\x20secnidazole,\x20satranidazole\x20and\x20ornidazole.</p>\x0a<p>Metronidazole\x20is\x20also\x20effective\x20against\x20<strong>other\x20anaerobic</strong>\x20and\x20<strong>microaerophilic</strong>\x20organisms.\x20It\x20is\x20used\x20in\x20the\x20management\x20of\x20<strong>giardiasis</strong>,\x20<strong>trichomoniasis</strong>,\x20anaerobic\x20bacterial\x20infections\x20(e.g.,\x20pelvic\x20or\x20abdominal\x20abscesses\x20following\x20surgery),\x20<strong>pseudomembranous\x20enterocolitis,\x20</strong>and\x20<strong><em>Helicobacter\x20pylori</em>\x20gastritis</strong>.</p>\x0a<p>Adverse\x20effects\x20include\x20<strong>gastrointestinal\x20manifestations</strong>\x20like\x20anorexia,\x20nausea,\x20and\x20a\x20metallic\x20taste.\x20It\x20is\x20known\x20for\x20its\x20ability\x20to\x20produce\x20a\x20<strong>disulfiram-like\x20reaction</strong>\x20when\x20taken\x20with\x20alcohol.\x20Metronidazole\x20can\x20<strong>decrease\x20the\x20renal\x20elimination\x20of\x20lithium</strong>\x20and\x20potentiate\x20its\x20toxicity.\x20It\x20may\x20also\x20cause\x20significant\x20bleeding\x20in\x20patients\x20on\x20<strong>warfarin\x20therapy</strong>.</p>\x0a<p>Other\x20options:<br\x20/><br\x20/><strong>Iodoquinol\x20</strong>(Option\x20B),\x20<strong>paromomycin\x20</strong>(Option\x20C),\x20and\x20<strong>diloxanide\x20furoate\u00a0</strong>(Option\x20D)\x20are<strong>\x20luminal\x20amebicides</strong>.\x20They\x20are\x20poorly\x20absorbed\x20and\x20thus\x20reach\x20high\x20concentrations\x20in\x20the\x20bowel\x20and\x20are\x20used\x20in\x20the\x20management\x20of\x20<strong>intestinal\x20amebiasis</strong>.\x20They\x20are\x20also\x20indicated\x20for\x20invasive\x20amebiasis.\x20However,\x20<strong>their\x20role\x20is\x20to\x20eradicate\x20cysts</strong>\x20and\x20<strong>prevent\x20further\x20transmission.</strong>\x20They\x20<strong>would\x20not\x20have\x20any\x20direct\x20effect</strong>\x20on\x20the\x20<strong>extraintestinal\x20liver\x20abscess</strong>\x20as\x20seen\x20in\x20this\x20case.</p>','The\x20package\x20description\x20of\x20a\x20drug\x20states\x20that\x20500mg\x20of\x20paracetamol\x20is\x20present\x20in\x20each\x20unit\x20of\x20the\x20tablet\x20formulation,\x20but\x20in\x20reality,\x20each\x20unit\x20contains\x20only\x20200mg.\x20What\x20is\x20the\x20terminology\x20used\x20to\x20refer\x20to\x20these\x20kinds\x20of\x20drugs?','<p><strong>Cevimeline</strong>,\x20a\x20quinuclidine\x20derivative\x20of\x20acetylcholine,\x20is\x20a\x20newer\x20<strong>direct-acting\x20muscarinic\x20agonist</strong>\x20used\x20for\x20the<strong>\x20treatment\x20of\x20dry\x20mouth</strong>\x20associated\x20with\x20Sjogren’s\x20syndrome\x20or\x20caused\x20by\x20radiation\x20damage\x20of\x20the\x20salivary\x20glands.</p>\x0a<p>It\x20is\x20a\x20synthetic\x20<strong>M<sub>3\x20</sub></strong>selective\x20cholinomimetic\x20drug.</p>','PXplF','Biotransformation\x20of\x20drugs\x20occurs\x20primarily\x20in\x20the\x20liver','Dantrolene','<p>Therapeutic\x20level\x20of\x20lithium\x20that\x20is\x20indicated\x20for\x20<strong>prophylaxis\x20of\x20mania</strong>\x20is\u00a0<strong>0.6-1.0mEq/L</strong></p>\x0a<p>Target\x20therapeutic\x20levels\x20for\x20lithium\x20in\x20various\x20conditions</p>\x0a<p><strong>1.0-1.5mEq/L</strong>:\x20Acute\x20mania</p>\x0a<p><strong>0.6-1.0mEq/L</strong>:\x20Prophylaxis\x20of\x20acute\x20mania</p>\x0a<p><strong>0.6-1.0mEq/L</strong>:\x20Bipolar\x20disorder</p>','incorrectResult','Both\x20A\x20and\x20B','Decreases\x20thirst','A\x2070-year-old\x20man\x20was\x20administered\x20penicillin\x20intravenously\x20for\x20Anthrax\x20disease.\x20Within\x205\x20minutes,\x20he\x20developed\x20generalized\x20urticaria,\x20swelling\x20of\x20lips,\x20hypotension,\x20and\x20bronchospasm.\x20The\x201st\x20choice\x20drug\x20to\x20administer\x20is','apsEG','Ondwd','YxPXI','80\x20ng/min','It\x20is\x20a\x20sodium\x20glucose\x20co-transporter\x202\x20(SGLT2)\x20inhibitor','kLlAq','Rocuronium','xiKvN','Ozqdh','Bethanechol','<p><strong>Lenalidomide\x20and\x20thalidomide</strong>\x20increase\x20the\x20risk\x20for\x20thromboembolic\x20events,\x20including\x20deep\x20vein\x20thrombosis,\x20stroke,\x20and\x20myocardial\x20infarction,\x20which\x20occur\x20with\x20increased\x20frequency\x20in\x20combination\x20with\x20<strong>glucocorticoids\x20and\x20with\x20anthracyclines.</strong></p>','totalTimeResult','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','https://dhmbxeygs57ff.cloudfront.net/uploads/23699bc3b29d46ed9c13c1f6a2abef2cx1280x1282.JPEG','Phase\x20II\x20reactions\x20may\x20precede\x20phase\x20I\x20reactions','true','questionIndex','log','Agonist\x20at\x20ATP-sensitive\x20potassium\x20channels','lbztH','toString','BoocE','qJJNE','quizPerformanceData','Which\x20of\x20the\x20following\x20drugs\x20causes\x20capillary\x20leak\x20syndrome?','totalQuestionsResult','Which\x20of\x20the\x20following\x20is\x20available\x20for\x20intravenous\x20administration\x20for\x20influenza\x20B\x20infections?','zqbCG','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','VNZmY','Pilocarpine','dTCbe','lqDll','timed_study','OGZBm','It\x20has\x20major\x20nicotinic\x20action','now','HLA-B\x205701','Rolaprepitant','HqdsH','eYMvB','GdAyU','Shohl’s\x20Solution','ndOsb','custom_quiz.html','bfRfS','Succinylcholine','padStart','BeSPC','Gastric\x20bezoars','Acute\x20consumption\x20results\x20in\x20induction','explanation_audio_hin','questions','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','EBXFR','<p>Granulocyte-macrophage\x20colony-stimulating\x20factor(<strong>GM\x20CSF)</strong>\x20is\x20known\x20to\x20cause\x20<strong>capillary\x20leak\x20syndrome</strong>.</p>\x0a<p>With\x20prolonged\x20administration,\x20a\x20few\x20patients\x20may\x20develop\x20a\x20capillary\x20leak\x20syndrome,\x20with\x20peripheral\x20edema\x20and\x20pleural\x20and\x20pericardial\x20effusions.</p>\x0a<p>Other\x20drugs\x20causing\x20capillary\x20leak\x20syndrome:</p>\x0a<ul>\x0a<li>IL\x202</li>\x0a<li>IL\x204</li>\x0a<li>Clofarabine</li>\x0a<li>Denileukin\x20diftitox</li>\x0a<li>Gemcitabine</li>\x0a</ul>\x0a<p>Other\x20options:\x20All\x20of\x20them\x20are\x20Granulocyte-colony\x20stimulating\x20factor\x20analogues\x20and\x20do\x20not\x20cause\x20capillary\x20leak\x20syndrome.</p>','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','border-gray-600','iEdqg','Has\x20a\x20nitrate-like\x20action','<p><strong>Dichlorphenamide,</strong>\x20a\x20carbonic\x20anhydrase\x20inhbitor\x20is\x20approved<strong>\x20for\x20familial\x20periodic\x20paralysis.</strong>\x20The\x20mechanism\x20for\x20benefit\x20is\x20still\x20unknown\x20but\x20most\x20probable\x20due\x20to\x20induction\x20of\x20metabolic\x20acidosis.&nbsp;</p>\x0a<p>Chlorpheiramine\x20is\x20a\x20first\x20generation\x20anti-histaminergic\x20agent\x20(<strong>Option\x20A</strong>).</p>\x0a<p>Diethylcarbamazine\x20is\x20an\x20antifilarial\x20agent\x20(<strong>Option\x20C</strong>).</p>\x0a<p>Chloroprocaine\x20is\x20a\x20local\x20anesthetic\x20(<strong>Option\x20D</strong>).</p>','1054719MJhtna','All\x20of\x20the\x20above','pdYSh','Year\x202019\x20-\x2020','<24\x20hours','MrDoy','Theophylline','7dhhTMx','Antibiotics','.option-button','ezMOh','70\x20ng/min','QvEAF','UIRFB','CIqrA','pEXsh','eHuCf','Miotic','SJjCq','exception','Beta-blocker\x20having\x20potassium\x20channel\x20opening\x20action','ZYoEu','statsBar','mNSTo','<p>Nicorandil\x20has\x20both\x20<strong>nitrate-like</strong>\x20<strong>(c-GMP\x20dependent)\x20properties</strong>\x20and\x20acts\x20as\x20an\x20<strong>agonist\x20of\x20ATP-sensitive\x20potassium\x20channels</strong>.</p>\x0a<p>Vasodilating\x20action\x20of\x20nicorandil\x20is\x20potentiated\x20by\x20PDE5\x20inhibitors\x20and\x20only\x20partially\x20blocked\x20by\x20inhibitors\x20of\x20potassium\x20sensitive\x20ATP\x20channels\x20suggesting\x20that\x20both\x20mechanisms\x20is\x20relevant\x20for\x20its\x20action.</p>','EIHMG','Cyclin\x20Dependent\x20Kinase(CDK)\x20inhibitor','toggle','zHPtb','AVcKK','Chlorpromazine','customQuizData','jFuuC','bookmarkBtn','FwLqU','markReviewText','open','filter','Schedule\x20M\x20drugs','LOWtZ','<p><strong>Vigabatrin</strong>\x20is\x20a\x20<strong>GABA\x20transaminase\x20inhibitor</strong>\x20and\x20has\x20<strong>no\x20effect\x20on\x20sodium\x20channels</strong>.</p>','Rimonabant','testModeLegend','questionNav','ORxsm','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','Citalopram','Fluoxamine','bOenB','What\x20is\x20the\x20drug\x20of\x20choice\x20for\x20scrub\x20typhus\x20during\x20pregnancy\x20and\x20otherwise\x20respectively?','ZxyqE','Adulterated\x20drugs','bFBHW','WHvgY','<p><strong>DEC</strong>\x20-\x20Diethylcarbamazine\x20is\x20the<strong>&nbsp;drug\x20of\x20choice\x20for\x20the\x20treatment\x20of\x20loiasis</strong>,\x20but\x20it\x20is\x20advisable\x20to\x20start\x20with\x20a\x20small\x20initial\x20dose\x20to\x20diminish\x20host\x20reactions\x20that\x20result\x20from\x20the\x20destruction\x20of\x20microfilariae.</p>\x0a<p\x20class=\x22p1\x22>Treatment\x20is\x20initiated\x20with\x20test\x20doses\x20of\x20<strong>50\x20mg</strong>\x20(1\x20mg/kg\x20in\x20children)\x20daily\x20for\x202&ndash;3\x20days,\x20escalating\x20to\x20maximally\x20tolerated\x20daily\x20doses\x20of\x20<strong>9\x20mg/kg</strong>\x20in\x20three\x20doses\x20for\x20<strong>2&ndash;3\x20weeks</strong>.</p>\x0a<p>Glucocorticoids\x20pretreatment\x20may\x20be\x20administered\x20to\x20ameliorate\x20acute\x20reactions.\x20In\x20rare\x20instances,\x20life-threatening\x20encephalopathy\x20follows\x20the\x20treatment\x20of\x20loiasis,\x20probably\x20due\x20to\x20the\x20inflammatory\x20reaction\x20to\x20dead\x20or\x20dying\x20microfilariae\x20lodged\x20in\x20the\x20cerebral\x20microvasculature.</p>','VPhqz','Topiramate','<p><strong>Flavin\x20containing\x20monooxygenases\x20(FMO)\x20</strong>are\x20a\x20part\x20of\x20Phase\x201\x20oxidation\x20reactions.\x20Others\x20are\x20carried\x20out\x20by\x20<strong>Cytochrome\x20P450s</strong>,\x20,\x20aand\x20<strong>Epoxide\x20hydrolases(EH)</strong>.</p>\x0a<p><strong>&nbsp;</strong>Phase\x20I\x20reactions\x20usually\x20convert\x20the\x20parent\x20drug\x20to\x20a\x20more\x20polar\x20metabolite\x20by\x20introducing\x20or\x20<strong>unmasking/\x20adding\x20a\x20functional\x20group</strong>\x20such\x20as\x20&ndash;OH,\x20&ndash;COOH,\x20&ndash;SH,\x20&ndash;O&ndash;,\x20or\x20NH2.\x20Reactions\x20carried\x20out\x20by\x20phase\x201\x20enzymes\x20usually\x20lead\x20to\x20the\x20<strong>inactivation\x20of\x20a\x20drug</strong>/activation\x20of\x20the\x20drug.</p>\x0a<p>Majority\x20of\x20the\x20drugs\x20undergo\x20these\x20biotransformation\x20reactions\x20in\x20a<strong>\x20sequential\x20manner.\x20</strong>However,\x20rarely<strong>\x20Phase\x20II\x20reactions\x20may\x20precede\x20phase\x20I\x20</strong>reaction.</p>\x0a<p>The\x20biotransformation\x20of\x20drugs\x20occurs\x20primarily\x20in\x20the\x20<strong>liver</strong>.\x20Other\x20organs\x20with\x20significant\x20drug-metabolizing\x20capacity\x20include\x20the\x20<strong>GI\x20tract,\x20kidneys,\x20and\x20lungs</strong>.</p>','red','CjsjC','replace','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','appendChild','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','Hypocalcaemia','Filgrastim','UqEbt','<p><strong>Ceftaroline</strong>\x20is\x20a\x20<strong>fifth-generation\x20cephalosporin</strong>,\x20which\x20exhibits\x20broad-spectrum\x20activity\x20against\x20Gram-positive\x20bacteria,\x20including\x20MRSA\x20and\x20extensively-resistant\x20strains,\x20such\x20as\x20vancomycin-intermediate&nbsp;<em>S.\x20aureus</em>&nbsp;(VISA),\x20heteroresistant\x20VISA\x20(hVISA),\x20and\x20vancomycin-resistant&nbsp;<em>S.\x20aureus</em>&nbsp;(VRSA).</p>\x0a<p><strong>Ceftobiprole</strong>\x20is\x20another\x205th\x20generation\x20Cephalosporin.</p>','FeFFS','aliWc','JnpAj','PeRNN','Insulin\x20degludec','Which\x20of\x20the\x20following\x20local\x20anaesthetics\x20is\x20an\x20amide?','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','EvjVw','dvcrK','navBtn_','accuracyScore','Penicillin\x20G','setItem','In\x20gout\x20because\x20it\x20can\x20increase\x20serum\x20uric\x20acid','2898258rJaEmp','Granulocyte-colony\x20stimulating\x20factor','bdtzV','Female\x20genital\x20mycotic\x20infections\x20are\x20the\x20most\x20common\x20among\x20all\x20adverse\x20reactions','The\x20most\x20common\x20complication\x20of\x20loop\x20diuretic','question_video','getElementById','questionText','DPP-\x20IV\x20inhibitor','UWMkm','Barbiturates','In\x20children\x20with\x20viral\x20disease\x20because\x20of\x20the\x20risk\x20of\x20acute\x20renal\x20failure','oDdhC','Tyrosine\x20Kinase\x20inhibitor','VszMZ','DMjYe','DztQd','Cetuximab\x20-\x20Angiogenesis\x20inhibitor','<p>Among\x20the\x20given\x20options,\x20<strong>insulin\x20aspart</strong>\x20is\x20a\x20<strong>short-acting\x20insulin</strong>\x20that\x20has\x20better\x20control\x20of\x20meal\x20time\x20hyperglycemia\x20and\x20lower\x20rates\x20of\x20postprandial\x20hypoglycemic\x20events.&nbsp;</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20877\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>The\x20short-acting\x20insulin\x20analogs\x20are\x20absorbed\x20more\x20rapidly\x20from\x20subcutaneous\x20sites\x20and\x20should\x20be\x20<strong>injected\x2015\x20min\x20or\x20less</strong>\x20before\x20a\x20meal.\x20When\x20used\x20to\x20treat\x20glycemia\x20after\x20meals,\x20the\x20short-acting\x20analogs\x20have\x20lower\x20rates\x20of\x20hypoglycemia\x20and\x20improved\x20A1c\x20levels.&nbsp;It\x20has\x20rapid\x20absorption\x20and\x20a\x20shorter\x20duration\x20of\x20action\x20due\x20to\x20instantaneous\x20dissociation\x20into\x20monomers.\x20Short-acting\x20insulin\x20analogs\x20are:</p>\x0a<ul>\x0a<li><strong>Insulin\x20lispro</strong>\x20is\x20identical\x20to\x20human\x20insulin\x20except\x20at\x20positions\x20B28\x20and\x20B29.</li>\x0a<li><strong>Insulin\x20aspart</strong>\x20is\x20formed\x20by\x20the\x20replacement\x20of\x20proline\x20at\x20B28\x20with\x20aspartic\x20acid,\x20reducing\x20self-association.</li>\x0a<li><strong>Insulin\x20glulisine</strong>\x20is\x20formed\x20when\x20glutamic\x20acid\x20replaces\x20lysine\x20at\x20B29\x20and\x20lysine\x20replaces\x20asparagine\x20at\x20B3.</li>\x0a</ul>\x0a<p><strong>Regular\x20insulin</strong>\x20has\x20slow\x20absorption\x20following\x20subcutaneous\x20injection\x20and\x20should\x20be\x20injected\x2030&ndash;45\x20min\x20before\x20a\x20meal.&nbsp;</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p>Short-acting\x20insulins\x20are\x20used\x20in\x20the\x20management\x20of\x20diabetes\x20mellitus,\x20diabetic\x20ketoacidosis\x20(regular\x20insulin)\x20and\x20in\x20non-ketotic\x20hyperosmolar\x20hyperglycemic\x20coma.</p>','TPZgu','ySKjA','qErLh','krVUk','vcLlA','lxbZI','zudgX','Nateglinide','Mechanism\x20of\x20action\x20of\x20alendronate\x20is\x20_____','ryqCa','Diloxanide\x20furoate','EifkE','<p><strong>Vitamins</strong>\u00a0and\x20<strong>essential\x20metals</strong>\x20show\x20a\x20<strong>U-shaped\x20dose-response\x20curve</strong>.</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x2074\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>At\x20a\u00a0<strong>low\x20dose,</strong>\x20adverse\x20effects\x20are\x20observed\x20because\x20there\x20is\x20a\x20<strong>deficiency</strong>\x20of\x20these\x20nutrients\x20to\x20maintain\x20homeostasis.\x20As\x20<strong>dose\x20increases,\x20homeostasis</strong>\x20is\x20achieved,\x20and\x20the\x20bottom\x20of\x20the\x20U-shaped\x20dose-response\x20curve\x20is\x20reached.\x20As\x20the\x20<strong>dose\x20increases</strong>\x20to\x20surpass\x20the\x20amount\x20required\x20to\x20maintain\x20homeostasis,\x20<strong>toxicity</strong>\x20can\x20ensue.</p>\x0a<p>Thus,\x20<strong>adverse\x20effects</strong>\x20are\x20seen\x20at\x20both\x20<strong>low</strong>\x20and<strong>\x20high\x20doses.\u00a0</strong></p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>','Basiliximab','XKcru','Etanercept','Clavulanic\x20acid','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','Volume\x20of\x20distribution','Methylation','Stimulates\x20release\x20of\x20ADH'];_0x4c07=function(){return _0x1a92a6;};return _0x4c07();}function showSolution(){const _0x23fbb6=_0x248e04,_0x233396={'xoUCm':function(_0x479855,_0x53d7e6){return _0x479855===_0x53d7e6;},'PrOYp':_0x23fbb6(0x2a7),'NEOTi':function(_0x2e1b2f,_0x2d9082){return _0x2e1b2f+_0x2d9082;},'kWEri':function(_0x252ecd){return _0x252ecd();},'rkcEH':function(_0x57201c,_0x1d2cb0){return _0x57201c<=_0x1d2cb0;},'WuBSU':function(_0x5d220b,_0x2ce097){return _0x5d220b(_0x2ce097);},'bEIvP':_0x23fbb6(0x129),'yYvBi':function(_0x442950){return _0x442950();},'qblMo':_0x23fbb6(0x20e),'rkKkV':function(_0x5e4e6d,_0x4a25ec,_0x2616dc){return _0x5e4e6d(_0x4a25ec,_0x2616dc);},'Vatxt':'video[data-src]','UFPte':function(_0x5ecbe7,_0x1fed70){return _0x5ecbe7!==_0x1fed70;},'PPABq':_0x23fbb6(0x124),'CVjzK':'timed_study','ylNRw':_0x23fbb6(0x14f),'rokuF':_0x23fbb6(0xaa),'vZRBg':function(_0xc4e437,_0x32fda5,_0x45a5de){return _0xc4e437(_0x32fda5,_0x45a5de);},'TPZgu':function(_0x143513,_0x51dc1c){return _0x143513===_0x51dc1c;},'DMVuy':_0x23fbb6(0xa6),'qJJNE':'FPuwz','MdESu':'hidden','fKliA':'solutionAudio','XWuIF':function(_0x473288,_0x3609fc){return _0x473288!==_0x3609fc;},'nxSrT':'vKNiU','Ydxsj':_0x23fbb6(0x38c),'KbSdX':_0x23fbb6(0x3b2)};if(_0x233396[_0x23fbb6(0x3e6)](currentMode,_0x233396['PPABq'])&&currentMode!==_0x233396['CVjzK'])return;const _0x439d11=questionsData[currentQuestionIndex];document[_0x23fbb6(0x303)](_0x233396[_0x23fbb6(0x1a0)])[_0x23fbb6(0x1ed)]=_0x439d11[_0x23fbb6(0x3c7)]||_0x23fbb6(0xa7);const _0x273f2d=document['getElementById'](_0x23fbb6(0x16b)),_0x3627cf=document[_0x23fbb6(0x303)](_0x233396[_0x23fbb6(0x18f)]),_0x460685=_0x439d11[_0x23fbb6(0x118)];if(_0x460685){_0x273f2d['classList'][_0x23fbb6(0x3a2)](_0x23fbb6(0x427));if(_0x460685['includes'](_0x233396[_0x23fbb6(0x203)]))_0x233396[_0x23fbb6(0xb5)](setupVideo,_0x3627cf,_0x460685);else _0x3627cf[_0x23fbb6(0x3d0)]=_0x460685;}else{if(_0x233396[_0x23fbb6(0x310)](_0x233396[_0x23fbb6(0x1c0)],_0x233396[_0x23fbb6(0x284)])){const _0x5eafe0=_0x2a123d[_0x23fbb6(0x24f)]===_0x28046e,_0x1ddb8d=_0x233396[_0x23fbb6(0x1fc)](_0x4851cc['id'],_0x58a0ce);let _0x17f918=_0x233396[_0x23fbb6(0x37a)];if(_0x1ddb8d)_0x17f918=_0x23fbb6(0x143);else{if(_0x5eafe0)_0x17f918=_0x23fbb6(0x326);}return _0x23fbb6(0x219)+_0x17f918+_0x23fbb6(0x337)+_0x3e8417[_0x23fbb6(0x369)](_0x233396[_0x23fbb6(0x3c6)](0x41,_0x12cd16))+'</span><span>'+_0x49e03c[_0x23fbb6(0x101)]+'</span></div>';}else _0x273f2d['classList'][_0x23fbb6(0x8a)](_0x233396[_0x23fbb6(0x42d)]);}const _0x41eeb2=document[_0x23fbb6(0x303)](_0x233396['fKliA']);_0x41eeb2['innerHTML']='';_0x439d11['explanation_audio_eng']&&(_0x233396['XWuIF'](_0x233396[_0x23fbb6(0x215)],'vKNiU')?(_0x40ef8c--,_0x233396[_0x23fbb6(0x204)](_0x2e5f58),_0x233396[_0x23fbb6(0xa9)](_0x99daf4,0x0)&&(_0x233396[_0x23fbb6(0x1b7)](_0x48274c,_0x54fb70),_0x233396[_0x23fbb6(0x1fc)](_0x41d4c7,_0x233396[_0x23fbb6(0x3bc)])?_0x233396[_0x23fbb6(0x1ee)](_0x47bdc3):_0x44afc0())):_0x41eeb2[_0x23fbb6(0x1ed)]+=_0x23fbb6(0x39a)+_0x439d11[_0x23fbb6(0xe7)]+_0x23fbb6(0x2d8));if(_0x439d11['explanation_audio_hin']){if(_0x233396['XWuIF'](_0x233396['Ydxsj'],_0x233396[_0x23fbb6(0x20d)])){const _0x382916={'QDAIO':_0x233396[_0x23fbb6(0x203)],'DFWzb':function(_0x1b6fe1,_0x5f358a,_0x1c0559){const _0x381ada=_0x23fbb6;return _0x233396[_0x381ada(0x3ae)](_0x1b6fe1,_0x5f358a,_0x1c0559);}};_0x4c35a8[_0x23fbb6(0xcb)](_0x233396[_0x23fbb6(0x12e)])[_0x23fbb6(0x1c1)](_0x33b3ef=>{const _0xad0c0e=_0x23fbb6,_0x1c438e=_0x33b3ef['dataset'][_0xad0c0e(0x3d0)];if(_0x1c438e&&_0x1c438e[_0xad0c0e(0xda)](_0x382916['QDAIO']))_0x382916['DFWzb'](_0x47d169,_0x33b3ef,_0x1c438e);else _0x1c438e&&(_0x33b3ef[_0xad0c0e(0x3d0)]=_0x1c438e);});}else _0x41eeb2[_0x23fbb6(0x1ed)]+=_0x23fbb6(0x27a)+_0x439d11[_0x23fbb6(0x2a1)]+_0x23fbb6(0x2d8);}const _0x378550=document[_0x23fbb6(0x303)](_0x233396['KbSdX']);_0x378550[_0x23fbb6(0x1ed)]='',_0x439d11[_0x23fbb6(0x1ff)]&&_0x439d11[_0x23fbb6(0x1ff)][_0x23fbb6(0x1c1)](_0x5807e3=>{const _0x24078a=_0x23fbb6;if(_0x5807e3)_0x378550[_0x24078a(0x1ed)]+='<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x5807e3+_0x24078a(0x12c);}),document['getElementById'](_0x23fbb6(0x353))[_0x23fbb6(0x1ba)][_0x23fbb6(0x3a2)](_0x233396[_0x23fbb6(0x42d)]);}function _0x772b(_0x5d2e2c,_0x2a5928){const _0x15010c=_0x4c07();return _0x772b=function(_0x59db03,_0x5796a6){_0x59db03=_0x59db03-0x82;let _0xa667e0=_0x15010c[_0x59db03];return _0xa667e0;},_0x772b(_0x5d2e2c,_0x2a5928);}function submitQuiz(){const _0x5f1c67=_0x248e04,_0x480eb0={'FLCdF':function(_0x189c69,_0xa9f27b){return _0x189c69===_0xa9f27b;},'REwuV':_0x5f1c67(0x190),'KOIoi':'incorrect','pdwJA':function(_0x54d1f7,_0x5d57f4){return _0x54d1f7(_0x5d57f4);},'ENgwR':function(_0x4d5954,_0x6fdbbf){return _0x4d5954-_0x6fdbbf;},'ALboI':_0x5f1c67(0x285),'NbGGu':function(_0x4c8fce){return _0x4c8fce();}};if(timer)_0x480eb0['pdwJA'](clearInterval,timer);if(!_0x480eb0[_0x5f1c67(0x3a9)](confirm,_0x5f1c67(0x98)))return;isQuizCompleted=!![];let _0x469a83=0x0,_0x56cd61=0x0;const _0x504f77=_0x480eb0[_0x5f1c67(0x218)](Date[_0x5f1c67(0x292)](),quizStartTime);questionsData['forEach']((_0x1a6cd8,_0x5b5969)=>{const _0x48567c=_0x5f1c67,_0x44ef1c=questionStates[_0x5b5969];_0x44ef1c[_0x48567c(0x24f)]!==null&&(_0x480eb0[_0x48567c(0x1d5)](_0x1a6cd8['choices'][_0x44ef1c[_0x48567c(0x24f)]]['id'],_0x1a6cd8[_0x48567c(0x42c)])?(_0x469a83++,_0x44ef1c[_0x48567c(0x1e8)]=_0x480eb0[_0x48567c(0x378)]):(_0x56cd61++,_0x44ef1c['status']=_0x480eb0[_0x48567c(0x3e9)]));});const _0x5d0b51=JSON['parse'](localStorage[_0x5f1c67(0x22c)](_0x480eb0[_0x5f1c67(0x8b)]))||[];_0x5d0b51[_0x5f1c67(0x347)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x5f1c67(0x292)](),'totalTime':_0x504f77,'stats':{'correct':_0x469a83,'incorrect':_0x56cd61,'notAttempted':_0x480eb0[_0x5f1c67(0x218)](questionsData['length'],_0x469a83+_0x56cd61)}}),localStorage[_0x5f1c67(0x2fb)](_0x480eb0[_0x5f1c67(0x8b)],JSON[_0x5f1c67(0xc1)](_0x5d0b51)),stats[_0x5f1c67(0x3fe)]=_0x469a83,stats['incorrectAnswers']=_0x56cd61,_0x480eb0[_0x5f1c67(0xfe)](markQuizAsCompleted),showPerformanceAnalysis(_0x469a83,_0x56cd61,_0x480eb0[_0x5f1c67(0x218)](questionsData[_0x5f1c67(0x125)],_0x469a83+_0x56cd61),_0x504f77);}function showPerformanceAnalysis(_0x5225fd,_0x3eacc1,_0x14a87b,_0x3adca5){const _0x1bf743=_0x248e04,_0x1038c9={'uPiVL':_0x1bf743(0x1e0),'zGlyH':function(_0x38e364,_0x2080eb){return _0x38e364>_0x2080eb;},'ioHuj':function(_0x89cf41,_0x59e444){return _0x89cf41*_0x59e444;},'dqqNv':function(_0x53e27f,_0x1cd02e){return _0x53e27f/_0x1cd02e;},'SYvKd':function(_0x18ad84,_0x3ce936){return _0x18ad84+_0x3ce936;},'ogAHI':function(_0xfdf092,_0x4427cb){return _0xfdf092-_0x4427cb;},'NXgcK':_0x1bf743(0x2f9),'UOdKe':_0x1bf743(0x287),'jmCpi':_0x1bf743(0x26a),'IFHfB':_0x1bf743(0x1e3),'TfOhs':function(_0x161db3,_0x41368b){return _0x161db3/_0x41368b;},'VPhqz':function(_0x39f9bc,_0x38a9be){return _0x39f9bc%_0x38a9be;},'UGVMb':_0x1bf743(0x279),'UAUSR':function(_0x35c5c5,_0x2bd40f){return _0x35c5c5/_0x2bd40f;},'kLlAq':function(_0x286394,_0x327891){return _0x286394/_0x327891;},'itDhA':'avgTimeResult','UsdJM':'hidden'},_0x52b9b1=document['getElementById'](_0x1038c9['uPiVL']),_0x37575f=_0x1038c9['zGlyH'](_0x5225fd+_0x3eacc1,0x0)?Math[_0x1bf743(0x357)](_0x1038c9[_0x1bf743(0x1ac)](_0x1038c9['dqqNv'](_0x5225fd,_0x1038c9[_0x1bf743(0x11f)](_0x5225fd,_0x3eacc1)),0x64)):0x0,_0x92393a=_0x1038c9['ioHuj'](_0x1038c9['ioHuj'](0x2,Math['PI']),0x41),_0x44a4a5=document[_0x1bf743(0x303)](_0x1bf743(0x117));_0x44a4a5[_0x1bf743(0x1a5)][_0x1bf743(0x36a)]=_0x92393a+'\x20'+_0x92393a,_0x44a4a5[_0x1bf743(0x1a5)]['strokeDashoffset']=_0x1038c9[_0x1bf743(0x360)](_0x92393a,_0x1038c9[_0x1bf743(0x1ac)](_0x1038c9[_0x1bf743(0x206)](_0x37575f,0x64),_0x92393a)),document['getElementById'](_0x1038c9[_0x1bf743(0x110)])[_0x1bf743(0x3d4)]=_0x37575f+'%',document[_0x1bf743(0x303)](_0x1038c9[_0x1bf743(0xea)])['textContent']=questionsData[_0x1bf743(0x125)],document[_0x1bf743(0x303)]('correctResult')[_0x1bf743(0x3d4)]=_0x5225fd,document['getElementById'](_0x1038c9['jmCpi'])['textContent']=_0x3eacc1,document[_0x1bf743(0x303)](_0x1038c9[_0x1bf743(0x230)])[_0x1bf743(0x3d4)]=_0x14a87b;const _0x3e90cc=Math[_0x1bf743(0x1c8)](_0x1038c9[_0x1bf743(0x206)](_0x3adca5,0xea60)),_0x5541a4=Math[_0x1bf743(0x1c8)](_0x1038c9['TfOhs'](_0x1038c9['VPhqz'](_0x3adca5,0xea60),0x3e8));document[_0x1bf743(0x303)](_0x1038c9[_0x1bf743(0x356)])[_0x1bf743(0x3d4)]=_0x3e90cc+':'+_0x5541a4[_0x1bf743(0x282)]()['padStart'](0x2,'0');const _0x578c81=_0x1038c9['UAUSR'](_0x3adca5,questionsData['length']),_0x386085=Math['floor'](_0x1038c9[_0x1bf743(0x273)](_0x578c81,0xea60)),_0xba3b0c=Math[_0x1bf743(0x1c8)](_0x1038c9['dqqNv'](_0x1038c9[_0x1bf743(0x2e2)](_0x578c81,0xea60),0x3e8));document[_0x1bf743(0x303)](_0x1038c9[_0x1bf743(0x358)])['textContent']=_0x386085+':'+_0xba3b0c[_0x1bf743(0x282)]()[_0x1bf743(0x29d)](0x2,'0'),_0x52b9b1[_0x1bf743(0x1ba)][_0x1bf743(0x3a2)](_0x1038c9[_0x1bf743(0x138)]);}function closePerformanceModal(){const _0x512ccf=_0x248e04,_0x22ddba={'PWyVe':_0x512ccf(0x1e0)};document[_0x512ccf(0x303)](_0x22ddba[_0x512ccf(0x155)])['classList']['add']('hidden');}function reviewQuestions(){const _0x2b2327=_0x248e04,_0x1002e9={'MrGmw':'correctCount','ntzRp':_0x2b2327(0x422),'QgVyK':_0x2b2327(0x257),'duQLl':function(_0x688513,_0x29060a){return _0x688513>_0x29060a;},'MBBYj':function(_0x5beb9f,_0x4335cf){return _0x5beb9f*_0x4335cf;},'GFBAU':function(_0x296124,_0xd12050){return _0x296124/_0xd12050;},'jBerU':function(_0x4432fc,_0x5b77d3){return _0x4432fc+_0x5b77d3;},'nHvTk':function(_0x4fb4a8,_0x29b226){return _0x4fb4a8!==_0x29b226;},'EJhGv':_0x2b2327(0x148),'emorq':function(_0x164e94,_0x475773){return _0x164e94===_0x475773;},'kCawV':_0x2b2327(0x143),'HdFTp':'Not\x20Attempted','xVQSk':_0x2b2327(0x249),'idxvG':_0x2b2327(0x3d1),'XUzxs':_0x2b2327(0x190),'RHgZU':_0x2b2327(0xe9),'wpvPw':_0x2b2327(0x39d),'BbbYS':'div','COpQB':_0x2b2327(0x425),'TebVN':function(_0x403a3e,_0x376e0d){return _0x403a3e===_0x376e0d;},'zHPtb':_0x2b2327(0x16c),'MhsWk':_0x2b2327(0x2e5),'QQRzG':'gray','uMsUs':'No\x20solution\x20available.','bFBHW':_0x2b2327(0x427),'rLwah':'reviewQuestionsContainer','ndOsb':function(_0x5e0608){return _0x5e0608();}};document[_0x2b2327(0x303)](_0x2b2327(0x384))['classList']['remove'](_0x1002e9[_0x2b2327(0x2df)]);const _0x320572=document['getElementById'](_0x1002e9[_0x2b2327(0x3bb)]);_0x320572['innerHTML']='',questionsData[_0x2b2327(0x1c1)]((_0xece18b,_0x1d090b)=>{const _0x35346f=_0x2b2327,_0x598dbc={'nYkeq':_0x1002e9['MrGmw'],'QSVXR':_0x1002e9[_0x35346f(0x3de)],'WHvgY':_0x1002e9[_0x35346f(0x18e)],'SxTyC':function(_0x380fc6,_0x4fc096){const _0x533e93=_0x35346f;return _0x1002e9[_0x533e93(0x23a)](_0x380fc6,_0x4fc096);},'miLGz':function(_0x10286f,_0x4afca0){const _0x46777c=_0x35346f;return _0x1002e9[_0x46777c(0x19b)](_0x10286f,_0x4afca0);},'Setcf':function(_0x4e7e09,_0x2ebd9e){const _0x1cc130=_0x35346f;return _0x1002e9[_0x1cc130(0xd5)](_0x4e7e09,_0x2ebd9e);},'oTvkh':'accuracy','baUDX':function(_0x3d6d44,_0x28d09e){const _0x3cd4a7=_0x35346f;return _0x1002e9[_0x3cd4a7(0x32c)](_0x3d6d44,_0x28d09e);},'EIHMG':function(_0xf20f92,_0xb85cc1){return _0xf20f92%_0xb85cc1;},'oPUAg':function(_0xbc465e,_0x2e536a){return _0x1002e9['nHvTk'](_0xbc465e,_0x2e536a);},'tGFMY':_0x1002e9[_0x35346f(0x346)],'zABkU':function(_0x37a37d,_0x5939c7){const _0x4eeee0=_0x35346f;return _0x1002e9[_0x4eeee0(0xd6)](_0x37a37d,_0x5939c7);},'SvyGh':_0x1002e9[_0x35346f(0x33a)],'WsYfA':function(_0x387a37,_0x1854af){const _0x4855a9=_0x35346f;return _0x1002e9[_0x4855a9(0x32c)](_0x387a37,_0x1854af);}},_0x5db22d=questionStates[_0x1d090b],_0x271c45=_0xece18b[_0x35346f(0x42c)];let _0x2d541b=_0x35346f(0x390),_0x23dbfc=_0x1002e9[_0x35346f(0x8f)];if(_0x1002e9[_0x35346f(0x3f4)](_0x5db22d[_0x35346f(0x24f)],null)){if(_0x1002e9[_0x35346f(0x24c)]!==_0x1002e9[_0x35346f(0x24c)]){_0x5d4e12[_0x35346f(0x303)](_0x598dbc[_0x35346f(0x202)])[_0x35346f(0x3d4)]=_0x1da37c[_0x35346f(0x3fe)],_0x5496aa['getElementById'](_0x598dbc[_0x35346f(0x3ea)])[_0x35346f(0x3d4)]=_0x559dc8[_0x35346f(0x380)],_0x5290e1[_0x35346f(0x303)](_0x598dbc[_0x35346f(0x2e0)])['textContent']=_0x55da6b[_0x35346f(0x257)];const _0x179344=_0x598dbc[_0x35346f(0x42e)](_0xcc6290[_0x35346f(0x257)],0x0)?_0x10aeaf[_0x35346f(0x357)](_0x598dbc['miLGz'](_0x598dbc[_0x35346f(0x3ec)](_0x5d1ae6[_0x35346f(0x3fe)],_0x21883c[_0x35346f(0x257)]),0x64)):0x0;_0x14e171[_0x35346f(0x303)](_0x598dbc['oTvkh'])[_0x35346f(0x3d4)]=_0x598dbc[_0x35346f(0x41a)](_0x179344,'%'),_0x1822bb[_0x35346f(0x3c8)]=_0x559596[_0x35346f(0x115)]((_0x28b3df,_0x59e508)=>_0x28b3df+_0x59e508[_0x35346f(0x24a)],0x0);const _0x569e46=_0x3d2e4[_0x35346f(0x1c8)](_0x598dbc[_0x35346f(0x3ec)](_0x1e5966[_0x35346f(0x3c8)],0x3e8)),_0x4d5c65=_0x369e35['floor'](_0x598dbc['Setcf'](_0x569e46,0x3c)),_0x111000=_0x598dbc[_0x35346f(0x2c4)](_0x569e46,0x3c);_0x30f771[_0x35346f(0x303)]('timeSpent')[_0x35346f(0x3d4)]=_0x598dbc['baUDX'](_0x598dbc['baUDX'](_0x4d5c65,':'),_0x111000[_0x35346f(0x282)]()[_0x35346f(0x29d)](0x2,'0'));}else{const _0x229a84=_0xece18b[_0x35346f(0x1ef)][_0x5db22d['selectedAnswer']];_0x1002e9[_0x35346f(0xd6)](_0x229a84['id'],_0x271c45)?_0x1002e9[_0x35346f(0xd6)](_0x1002e9['idxvG'],_0x1002e9['idxvG'])?(_0x2d541b=_0x1002e9[_0x35346f(0x3fc)],_0x23dbfc=_0x1002e9['RHgZU']):(_0x149225[_0x19193e][_0x35346f(0x12d)]=!_0x5bc46b[_0x29b921][_0x35346f(0x12d)],_0xba78c9(),_0x573d47()):(_0x2d541b=_0x35346f(0x16c),_0x23dbfc=_0x1002e9[_0x35346f(0xf5)]);}}const _0x594e2a=document[_0x35346f(0x1af)](_0x1002e9['BbbYS']);_0x594e2a[_0x35346f(0x1d7)]=_0x35346f(0x23c)+_0x2d541b;let _0x19ef82=(_0xece18b['choices']||[])[_0x35346f(0x127)]((_0x39a373,_0xccd17a)=>{const _0x4c72f0=_0x35346f;if(_0x598dbc[_0x4c72f0(0x1a9)](_0x4c72f0(0x23f),_0x598dbc[_0x4c72f0(0x198)])){const _0x3d381c=_0x598dbc['zABkU'](_0x5db22d['selectedAnswer'],_0xccd17a),_0x50c07a=_0x39a373['id']===_0x271c45;let _0x44d42c=_0x4c72f0(0x2a7);if(_0x50c07a)_0x44d42c=_0x598dbc[_0x4c72f0(0xc8)];else{if(_0x3d381c)_0x44d42c='border-red-500';}return _0x4c72f0(0x219)+_0x44d42c+'\x22><span\x20class=\x22font-bold\x20mr-3\x22>'+String[_0x4c72f0(0x369)](_0x598dbc['WsYfA'](0x41,_0xccd17a))+_0x4c72f0(0x23b)+_0x39a373['text']+_0x4c72f0(0x3bf);}else{const _0x167647=_0x4c72f0(0xb3)[_0x4c72f0(0x105)]('|');let _0x31d04c=0x0;while(!![]){switch(_0x167647[_0x31d04c++]){case'0':_0x1ccae9=_0x191acf['currentMode'];continue;case'1':return!![];case'2':_0x1a30c4=_0x582ab7[_0x4c72f0(0x386)];continue;case'3':_0xadc51a=_0x1b3070[_0x4c72f0(0x406)];continue;case'4':_0x3100e3=_0x50bb4d[_0x4c72f0(0x3af)];continue;case'5':_0x40abee[_0x4c72f0(0x27f)](_0x4c72f0(0x37f));continue;}break;}}})[_0x35346f(0x327)]('');const _0x44cd1a=_0xece18b['explanation_video']?'<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-'+_0x1d090b+'\x22\x20data-src=\x22'+_0xece18b[_0x35346f(0x118)]+'\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>':'';let _0x15d475='';if(_0xece18b['explanation_audio_eng'])_0x15d475+=_0x35346f(0x2a6)+_0xece18b[_0x35346f(0xe7)]+_0x35346f(0x2d8);if(_0xece18b[_0x35346f(0x2a1)])_0x15d475+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22'+_0xece18b[_0x35346f(0x2a1)]+_0x35346f(0x2d8);let _0x1c7976=(_0xece18b[_0x35346f(0x1ff)]||[])[_0x35346f(0x127)](_0xc0479b=>_0xc0479b?_0x35346f(0xce)+_0xc0479b+_0x35346f(0x12c):'')[_0x35346f(0x327)]('');_0x594e2a[_0x35346f(0x1ed)]=_0x35346f(0x205)+_0x1002e9['jBerU'](_0x1d090b,0x1)+_0x35346f(0x2ea)+(_0x1002e9[_0x35346f(0xd6)](_0x2d541b,_0x1002e9[_0x35346f(0x3fc)])?_0x1002e9[_0x35346f(0x25f)]:_0x1002e9[_0x35346f(0xfb)](_0x2d541b,_0x1002e9[_0x35346f(0x2c7)])?_0x1002e9['MhsWk']:_0x1002e9[_0x35346f(0xcf)])+'-600\x20text-white\x22>'+_0x23dbfc+_0x35346f(0x1f2)+_0xece18b[_0x35346f(0x101)]+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>'+_0x19ef82+_0x35346f(0x355)+(_0xece18b['solution']||_0x1002e9['uMsUs'])+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x44cd1a+_0x35346f(0x321)+_0x15d475+_0x35346f(0x321)+_0x1c7976+_0x35346f(0x330),_0x320572['appendChild'](_0x594e2a);}),_0x1002e9[_0x2b2327(0x299)](initializeReviewVideos);}function initializeReviewVideos(){const _0x5b0d11=_0x248e04,_0x2506a4={'wURWe':function(_0x4d472c,_0xf857cb){return _0x4d472c!==_0xf857cb;},'foxzD':_0x5b0d11(0x392),'EifkE':_0x5b0d11(0x20e),'jFuuC':'video[data-src]'};document[_0x5b0d11(0xcb)](_0x2506a4[_0x5b0d11(0x2cb)])[_0x5b0d11(0x1c1)](_0xf5dac9=>{const _0x4d4fc2=_0x5b0d11;if(_0x2506a4['wURWe'](_0x2506a4[_0x4d4fc2(0x84)],_0x2506a4[_0x4d4fc2(0x84)]))_0xb9185a++,_0x146106[_0x4d4fc2(0x1e8)]=_0x4d4fc2(0x16c);else{const _0x58203d=_0xf5dac9[_0x4d4fc2(0x200)][_0x4d4fc2(0x3d0)];if(_0x58203d&&_0x58203d[_0x4d4fc2(0xda)](_0x2506a4[_0x4d4fc2(0x31b)]))setupVideo(_0xf5dac9,_0x58203d);else _0x58203d&&(_0xf5dac9[_0x4d4fc2(0x3d0)]=_0x58203d);}});}function retakeQuiz(){const _0x4f5df0=_0x248e04,_0x4c087e={'UrzVc':_0x4f5df0(0x187),'GfZEe':function(_0xc1eea5,_0x3fb14a){return _0xc1eea5(_0x3fb14a);},'DztQd':_0x4f5df0(0xff),'xiKvN':_0x4f5df0(0x29a),'RMcsl':function(_0x5bed0b,_0x320203){return _0x5bed0b!==_0x320203;},'pHyOh':_0x4f5df0(0x2ad),'HRfzK':_0x4f5df0(0x2ca),'kILlo':function(_0xa7a789){return _0xa7a789();}};_0x4c087e[_0x4f5df0(0x131)](confirm,_0x4c087e[_0x4f5df0(0x30d)])&&(window[_0x4f5df0(0x176)][_0x4f5df0(0x1b2)]['endsWith'](_0x4c087e[_0x4f5df0(0x275)])&&(_0x4c087e[_0x4f5df0(0xef)](_0x4f5df0(0x2ad),_0x4c087e[_0x4f5df0(0x244)])?_0x11edfe=_0x4c087e['UrzVc']:localStorage[_0x4f5df0(0x217)](_0x4c087e[_0x4f5df0(0x33b)])),_0x4c087e[_0x4f5df0(0x170)](clearProgress),location[_0x4f5df0(0x1e7)]());}function loadBookmarkedQuestions(){const _0x581b82=_0x248e04,_0xd4e82d={'KUdtm':function(_0xcff03d,_0x59f42f){return _0xcff03d-_0x59f42f;},'fmYXr':_0x581b82(0x17a),'iNIxm':function(_0x24be39,_0xd9a591){return _0x24be39===_0xd9a591;},'jWhWv':_0x581b82(0xa3),'Sjeoq':'nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','mPdsR':function(_0x102233,_0x152a59){return _0x102233<_0x152a59;},'bdtzV':function(_0x3b2a42,_0x254c0b){return _0x3b2a42!==_0x254c0b;},'hUeuI':_0x581b82(0x104),'PeRNN':_0x581b82(0x376),'UYdjL':_0x581b82(0x28e),'OGZBm':_0x581b82(0x21c)},_0x11f85f=JSON['parse'](localStorage[_0x581b82(0x22c)](_0xd4e82d[_0x581b82(0x290)]))||[];_0x11f85f[_0x581b82(0x1c1)](_0x5b7745=>{const _0x25adb4=_0x581b82,_0x3ca013={'lxbZI':function(_0x453687,_0xc64750){const _0x21176b=_0x772b;return _0xd4e82d[_0x21176b(0x19a)](_0x453687,_0xc64750);},'XKcru':_0xd4e82d[_0x25adb4(0x1c3)],'wzRgl':function(_0x3597eb,_0x1d6916){return _0xd4e82d['iNIxm'](_0x3597eb,_0x1d6916);},'mVgLL':_0x25adb4(0x16c),'eYMvB':_0xd4e82d['jWhWv'],'YSIVD':_0xd4e82d[_0x25adb4(0x260)],'lYAFU':function(_0x4123de,_0x5c8f29){const _0x321251=_0x25adb4;return _0xd4e82d[_0x321251(0x140)](_0x4123de,_0x5c8f29);}};if(_0xd4e82d[_0x25adb4(0x2ff)](_0x25adb4(0x104),_0xd4e82d[_0x25adb4(0x382)]))_0xa96a3a[_0x142549][_0x25adb4(0x24a)]+=_0x3ca013[_0x25adb4(0x315)](_0x53f747[_0x25adb4(0x292)](),_0x4ac903);else{if(_0x5b7745['quizFile'][_0x25adb4(0xda)](quizName[_0x25adb4(0x172)]()['replace'](/ /g,'-'))){if(_0xd4e82d[_0x25adb4(0x2f2)]!=='fOUIh'){if(_0x5b7745[_0x25adb4(0x27e)]<questionsData[_0x25adb4(0x125)]){if(_0xd4e82d[_0x25adb4(0x154)]===_0xd4e82d['UYdjL'])questionStates[_0x5b7745[_0x25adb4(0x27e)]]['bookmarked']=!![];else{if(_0xeea3d6[_0x25adb4(0x1e8)]===_0x25adb4(0x190))_0x45f253=_0x3ca013[_0x25adb4(0x31e)];else{if(_0x3ca013['wzRgl'](_0x58e225[_0x25adb4(0x1e8)],_0x3ca013[_0x25adb4(0x11d)]))_0x410c63=_0x3ca013[_0x25adb4(0x296)];else _0xfff4d=_0x3ca013[_0x25adb4(0x3a6)];}}}}else _0x520a66[_0x25adb4(0x420)][_0x25adb4(0xda)](_0x14e7f4['toLowerCase']()[_0x25adb4(0x2e7)](/ /g,'-'))&&(_0x3ca013['lYAFU'](_0x3552af['questionIndex'],_0x501a63[_0x25adb4(0x125)])&&(_0x40ff61[_0x4e71c9['questionIndex']]['bookmarked']=!![]));}}});}function toggleBookmark(){const _0x3f6102=_0x248e04,_0x59715b={'koIvL':_0x3f6102(0x21c),'BeSPC':function(_0xdda2a7){return _0xdda2a7();}},_0x1c14dc=!questionStates[currentQuestionIndex][_0x3f6102(0x24b)];questionStates[currentQuestionIndex][_0x3f6102(0x24b)]=_0x1c14dc;let _0x359cb0=JSON[_0x3f6102(0x19c)](localStorage['getItem'](_0x59715b[_0x3f6102(0x3fd)]))||[];if(_0x1c14dc){const _0x25b7e4={'quizName':quizName,'quizFile':window['location'][_0x3f6102(0x1b2)][_0x3f6102(0x105)]('/')[_0x3f6102(0xdc)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x3f6102(0x292)]()};_0x359cb0['push'](_0x25b7e4);}else _0x359cb0=_0x359cb0[_0x3f6102(0x2d0)](_0x1f8fb8=>!(_0x1f8fb8['quizFile']['includes'](quizName[_0x3f6102(0x172)]()[_0x3f6102(0x2e7)](/ /g,'-'))&&_0x1f8fb8['questionIndex']===currentQuestionIndex));localStorage['setItem'](_0x59715b[_0x3f6102(0x3fd)],JSON[_0x3f6102(0xc1)](_0x359cb0)),_0x59715b[_0x3f6102(0x29e)](updateBookmarkButton),updateQuestionNav();}function updateBookmarkButton(){const _0x1d77a4=_0x248e04,_0x606ba1={'DVeRz':_0x1d77a4(0x184),'yecvM':_0x1d77a4(0x2f5),'eURnK':_0x1d77a4(0x14a),'FBdWH':_0x1d77a4(0xf9)},_0x1a98a5=document[_0x1d77a4(0x303)](_0x1d77a4(0x2cc)),_0x285dcf=document['getElementById'](_0x606ba1[_0x1d77a4(0x165)]),_0x4561f1=questionStates[currentQuestionIndex][_0x1d77a4(0x24b)];_0x1a98a5[_0x1d77a4(0x1d7)]=_0x4561f1?_0x606ba1[_0x1d77a4(0x3e2)]:_0x1d77a4(0x106),_0x285dcf[_0x1d77a4(0x3d4)]=_0x4561f1?_0x606ba1[_0x1d77a4(0x3db)]:_0x606ba1[_0x1d77a4(0xa1)];}function toggleMarkForReview(){const _0xffac9d=_0x248e04,_0x4f6118={'qeAOy':function(_0x4516b0){return _0x4516b0();}};questionStates[currentQuestionIndex]['markedForReview']=!questionStates[currentQuestionIndex][_0xffac9d(0x12d)],_0x4f6118[_0xffac9d(0x3f2)](updateMarkReviewButton),_0x4f6118[_0xffac9d(0x3f2)](updateQuestionNav);}function updateMarkReviewButton(){const _0xd72220=_0x248e04,_0x1b8b3f={'tZVot':_0xd72220(0x15a),'BXOJI':_0xd72220(0x2ce),'kAEEm':_0xd72220(0x37b),'hDxeS':_0xd72220(0xdd),'ljqdI':_0xd72220(0xa5)},_0x45b7c5=document[_0xd72220(0x303)](_0x1b8b3f[_0xd72220(0x195)]),_0x31514a=document[_0xd72220(0x303)](_0x1b8b3f[_0xd72220(0x429)]),_0x318ded=questionStates[currentQuestionIndex]['markedForReview'];_0x45b7c5[_0xd72220(0x1d7)]=_0x318ded?_0xd72220(0x3e5):_0x1b8b3f[_0xd72220(0x1d3)],_0x31514a[_0xd72220(0x3d4)]=_0x318ded?_0x1b8b3f[_0xd72220(0x3e7)]:_0x1b8b3f[_0xd72220(0xc0)];}function previousQuestion(){const _0x14ffb3=_0x248e04,_0x45a6a0={'MRhnU':'markReviewBtn','WdAQw':_0x14ffb3(0x149),'PHNaq':function(_0x55c06e,_0x2e456b){return _0x55c06e===_0x2e456b;},'TJcAa':_0x14ffb3(0x1f5),'WGpuf':_0x14ffb3(0x129),'ezMOh':_0x14ffb3(0x2c1),'PXplF':_0x14ffb3(0x424),'sXcxE':_0x14ffb3(0x432),'dysdD':_0x14ffb3(0x100),'PBxUC':_0x14ffb3(0x1c7),'wVNqa':_0x14ffb3(0x22a),'JnpAj':_0x14ffb3(0x28f),'vZPYH':'timerContainer','dHuCw':function(_0x360ce4,_0x2b068d){return _0x360ce4(_0x2b068d);},'MgNHK':function(_0x3baec5,_0x5e97b0){return _0x3baec5>=_0x5e97b0;},'eJmzR':function(_0x3c6329){return _0x3c6329();},'EvjVw':_0x14ffb3(0x22b),'WFbHb':_0x14ffb3(0xf6),'VNZmY':'fejBk','eHuCf':'Ondwd','TPMzP':function(_0x46f05d,_0x3fa884){return _0x46f05d-_0x3fa884;}};if(currentQuestionIndex>0x0){if(_0x45a6a0['WFbHb']!==_0x45a6a0[_0x14ffb3(0x28b)]){if(questionStartTime){if(_0x14ffb3(0x26f)!==_0x45a6a0[_0x14ffb3(0x2bb)]){_0x438455=_0x1e0054[_0x14ffb3(0x292)]();const _0x32ebc0=_0x3046b0['getElementById'](_0x14ffb3(0x2cc)),_0x123959=_0x564393[_0x14ffb3(0x303)](_0x45a6a0[_0x14ffb3(0x421)]),_0x2c278d=_0x190f6f[_0x14ffb3(0x303)](_0x45a6a0['WdAQw']),_0x1ec5ec=_0x45a6a0[_0x14ffb3(0x242)](_0x47bd6b,_0x45a6a0[_0x14ffb3(0x3bd)])||_0x45a6a0[_0x14ffb3(0x242)](_0x76bbf5,_0x45a6a0['WGpuf']);_0x331275[_0x14ffb3(0x303)](_0x45a6a0[_0x14ffb3(0x2b5)])[_0x14ffb3(0x1a5)][_0x14ffb3(0x1bd)]=_0x1ec5ec?_0x45a6a0[_0x14ffb3(0x266)]:_0x45a6a0[_0x14ffb3(0x10a)],_0xbca0c[_0x14ffb3(0x303)](_0x45a6a0[_0x14ffb3(0x1f9)])[_0x14ffb3(0x1a5)][_0x14ffb3(0x1bd)]=_0x1ec5ec?'none':_0x45a6a0[_0x14ffb3(0x10a)],_0x2026dc[_0x14ffb3(0x303)](_0x14ffb3(0x2d5))[_0x14ffb3(0x1a5)][_0x14ffb3(0x1bd)]=_0x1ec5ec?_0x45a6a0['sXcxE']:_0x45a6a0['PXplF'],_0x110056['getElementById'](_0x45a6a0[_0x14ffb3(0x3c4)])['style'][_0x14ffb3(0x1bd)]=_0x1ec5ec?_0x45a6a0[_0x14ffb3(0x10a)]:_0x45a6a0[_0x14ffb3(0x266)],_0x32ebc0[_0x14ffb3(0x1a5)][_0x14ffb3(0x1bd)]=_0x1ec5ec?_0x45a6a0[_0x14ffb3(0x266)]:_0x45a6a0['wVNqa'],_0x123959[_0x14ffb3(0x1a5)]['display']=_0x1ec5ec?_0x14ffb3(0x22a):_0x45a6a0[_0x14ffb3(0x266)],_0x2c278d[_0x14ffb3(0x1a5)]['display']=_0x1ec5ec?_0x45a6a0[_0x14ffb3(0x34c)]:_0x14ffb3(0x424),(_0x56492f===_0x45a6a0[_0x14ffb3(0x2f1)]||_0x2cdb79===_0x14ffb3(0x129))&&_0x5c6148[_0x14ffb3(0x303)](_0x45a6a0[_0x14ffb3(0x1a2)])[_0x14ffb3(0x1ba)][_0x14ffb3(0x3a2)](_0x14ffb3(0x427)),!_0x45a6a0[_0x14ffb3(0x403)](_0x48ae12,_0x3fa149)&&_0x45a6a0[_0x14ffb3(0x3aa)](_0xc2ed91,0x0)&&_0x1dc715<_0x57b3ef['length']&&(_0x415c52=_0x2ed69c),_0x41df00(),_0x4e9863(),_0x45a6a0[_0x14ffb3(0x410)](_0x261eec),_0x45a6a0[_0x14ffb3(0x410)](_0x1e2a68);}else questionStates[currentQuestionIndex][_0x14ffb3(0x24a)]+=_0x45a6a0[_0x14ffb3(0x1bc)](Date['now'](),questionStartTime);}currentQuestionIndex--,_0x45a6a0[_0x14ffb3(0x410)](displayQuestion),saveProgress();}else _0x45a6a0[_0x14ffb3(0x403)](_0x45d185,_0x45a6a0[_0x14ffb3(0x2f6)])&&(_0x377def=0x0,_0x45a6a0[_0x14ffb3(0x410)](_0x56d615),_0x45a6a0[_0x14ffb3(0x410)](_0x2615c2));}}function nextQuestion(){const _0x57e242=_0x248e04,_0x217f34={'YHXoQ':function(_0x4584ec){return _0x4584ec();},'DBpdI':_0x57e242(0x22a),'tqXbJ':function(_0x7450ba,_0x3ae148){return _0x7450ba-_0x3ae148;},'wwcgC':_0x57e242(0x33e),'YeojZ':function(_0x582e58,_0x1807e7){return _0x582e58!==_0x1807e7;},'NKsdv':_0x57e242(0x239),'ubcCx':_0x57e242(0x437),'Hlvwl':function(_0x66ee14,_0x104c8e){return _0x66ee14<_0x104c8e;},'WLseR':function(_0x1424ec,_0x58f511){return _0x1424ec===_0x58f511;},'hDtcq':_0x57e242(0x3b7),'DyfnT':'test','toXSZ':_0x57e242(0x129),'iefbC':_0x57e242(0x3b4),'Foxar':_0x57e242(0x2c0),'EgXWN':function(_0x2e8d07,_0x2f9374){return _0x2e8d07!==_0x2f9374;},'LCEYo':_0x57e242(0x1ce),'dJHyE':function(_0x1d94bb,_0x5898b3){return _0x1d94bb(_0x5898b3);},'XaehL':_0x57e242(0x22b),'ZpqiQ':_0x57e242(0xe4),'EBXFR':function(_0x29dbbc){return _0x29dbbc();},'zLyPv':function(_0x126661){return _0x126661();}};questionStartTime&&(_0x217f34[_0x57e242(0x1f7)](_0x217f34['NKsdv'],_0x217f34[_0x57e242(0x13f)])?questionStates[currentQuestionIndex][_0x57e242(0x24a)]+=_0x217f34[_0x57e242(0x238)](Date[_0x57e242(0x292)](),questionStartTime):(_0x217f34[_0x57e242(0x354)](_0x1da45c),_0x585892['getElementById'](_0x57e242(0x41d))[_0x57e242(0x1a5)][_0x57e242(0x1bd)]=_0x217f34['DBpdI'])),_0x217f34[_0x57e242(0x10c)](currentQuestionIndex,_0x217f34[_0x57e242(0x238)](questionsData[_0x57e242(0x125)],0x1))?(currentQuestionIndex++,_0x217f34[_0x57e242(0x354)](displayQuestion),saveProgress()):_0x217f34['WLseR'](_0x217f34['hDtcq'],_0x217f34['hDtcq'])?currentMode===_0x217f34[_0x57e242(0x86)]||currentMode===_0x217f34[_0x57e242(0x34f)]?_0x217f34['WLseR'](_0x217f34[_0x57e242(0x220)],_0x217f34[_0x57e242(0x113)])?_0x1f7f8b[_0x32e255][_0x57e242(0x24a)]+=_0x217f34['tqXbJ'](_0x144138[_0x57e242(0x292)](),_0x110ccc):confirm(_0x57e242(0x33e))&&(_0x217f34[_0x57e242(0x197)](_0x217f34['LCEYo'],_0x217f34[_0x57e242(0xeb)])?_0x246bd8(_0x217f34['wwcgC'])&&_0x217f34[_0x57e242(0x354)](_0x433c75):_0x217f34[_0x57e242(0x354)](submitQuiz)):_0x217f34[_0x57e242(0x3f1)](confirm,_0x217f34[_0x57e242(0x3cd)])&&(_0x217f34[_0x57e242(0x431)]!==_0x217f34[_0x57e242(0x431)]?_0x391a7d=_0x97b58a[_0x57e242(0x2d0)](_0x1fc0ff=>!(_0x1fc0ff[_0x57e242(0x420)][_0x57e242(0xda)](_0x365cc6['toLowerCase']()['replace'](/ /g,'-'))&&_0x1fc0ff[_0x57e242(0x27e)]===_0x3f82e6)):(currentQuestionIndex=0x0,_0x217f34[_0x57e242(0x2a4)](displayQuestion),_0x217f34[_0x57e242(0x236)](saveProgress))):_0x5a55a8['innerHTML']+=_0x57e242(0x27a)+_0x4bbe1e['explanation_audio_hin']+_0x57e242(0x2d8);}function startTimer(){const _0x5270c8=_0x248e04,_0x32fc72={'FeFFS':function(_0x38d993){return _0x38d993();},'TQZLp':function(_0x29a54d,_0x5c6584){return _0x29a54d!==_0x5c6584;},'RZdDK':_0x5270c8(0xfa),'gpepz':_0x5270c8(0x42f),'kTlVR':function(_0x58c48a){return _0x58c48a();},'StDnJ':function(_0x2a99f9,_0x1a1b5a){return _0x2a99f9<=_0x1a1b5a;},'qErLh':function(_0x558261,_0xa9abb1){return _0x558261!==_0xa9abb1;},'jfJwL':_0x5270c8(0x171),'fphsD':function(_0x38e4fb,_0x58603c){return _0x38e4fb===_0x58603c;},'btIFi':'timed_exam','KyWaA':function(_0x5dfbdf){return _0x5dfbdf();},'rbWGH':function(_0x2aa8e8){return _0x2aa8e8();}};if(timer)clearInterval(timer);timeRemaining=0x78,_0x32fc72['rbWGH'](updateTimerDisplay),timer=setInterval(()=>{const _0x2cda63=_0x5270c8;_0x32fc72['TQZLp'](_0x32fc72[_0x2cda63(0x19f)],_0x32fc72[_0x2cda63(0x3a7)])?(timeRemaining--,_0x32fc72[_0x2cda63(0x335)](updateTimerDisplay),_0x32fc72[_0x2cda63(0x38a)](timeRemaining,0x0)&&(_0x32fc72[_0x2cda63(0x312)](_0x2cda63(0x171),_0x32fc72[_0x2cda63(0x189)])?(_0x5838c0++,_0x22a2f9(),_0x32fc72[_0x2cda63(0x2ef)](_0x2d2eae)):(clearInterval(timer),_0x32fc72[_0x2cda63(0x3df)](currentMode,_0x32fc72[_0x2cda63(0x112)])?_0x32fc72[_0x2cda63(0x412)](submitQuiz):_0x32fc72['KyWaA'](nextQuestion)))):_0x238baa();},0x3e8);}function updateTimerDisplay(){const _0xd31f96=_0x248e04,_0x51626f={'HqdsH':function(_0x126020,_0x2a3d24){return _0x126020/_0x2a3d24;},'zXymD':_0xd31f96(0x415),'rNRLa':function(_0x3ca663,_0x5ae1a5){return _0x3ca663+_0x5ae1a5;},'EObVx':function(_0x469755,_0x2718a9){return _0x469755+_0x2718a9;}},_0x5953bb=Math[_0xd31f96(0x1c8)](_0x51626f[_0xd31f96(0x295)](timeRemaining,0x3c)),_0x20a569=timeRemaining%0x3c;document[_0xd31f96(0x303)](_0x51626f[_0xd31f96(0x111)])['textContent']=_0x51626f[_0xd31f96(0x16d)](_0x51626f[_0xd31f96(0x130)](_0x5953bb,':'),_0x20a569[_0xd31f96(0x282)]()[_0xd31f96(0x29d)](0x2,'0'));}function toggleSidebar(){const _0x413d95=_0x248e04,_0x314881={'wnXBq':_0x413d95(0x186),'kqvCy':_0x413d95(0x2cf)};document['getElementById'](_0x314881[_0x413d95(0x3f6)])[_0x413d95(0x1ba)][_0x413d95(0x2c6)](_0x314881['kqvCy']);}document[_0x248e04(0x10d)](_0x248e04(0x146),()=>{const _0x578ac1=_0x248e04,_0xb05959={'vITto':function(_0x35cf56){return _0x35cf56();},'igvGn':_0x578ac1(0x41d),'sTfYb':_0x578ac1(0x424),'grXpG':function(_0x987d88){return _0x987d88();},'lnEKV':'PrWRW','QIXjK':_0x578ac1(0x22a),'ucbMM':function(_0x44454f,_0x5f04dc){return _0x44454f!==_0x5f04dc;},'lkJsM':_0x578ac1(0x107),'GpyFY':function(_0x5139a5){return _0x5139a5();}};if(resume)_0xb05959['vITto'](loadProgress)?(document[_0x578ac1(0x303)](_0xb05959['igvGn'])[_0x578ac1(0x1a5)][_0x578ac1(0x1bd)]=_0xb05959['sTfYb'],_0xb05959['grXpG'](initializeQuiz)):_0xb05959[_0x578ac1(0x1db)]!==_0xb05959[_0x578ac1(0x1db)]?_0x65617f[_0x578ac1(0x27e)]<_0x4bbfd6[_0x578ac1(0x125)]&&(_0x1bc19a[_0x57966b['questionIndex']][_0x578ac1(0x24b)]=!![]):(clearProgress(),document[_0x578ac1(0x303)](_0xb05959[_0x578ac1(0x1da)])['style'][_0x578ac1(0x1bd)]=_0x578ac1(0x22a));else!window[_0x578ac1(0x176)][_0x578ac1(0x1b2)][_0x578ac1(0x374)](_0x578ac1(0x29a))?(_0xb05959[_0x578ac1(0x13e)](clearProgress),document['getElementById'](_0x578ac1(0x41d))[_0x578ac1(0x1a5)][_0x578ac1(0x1bd)]=_0xb05959[_0x578ac1(0x3a5)]):_0xb05959[_0x578ac1(0x235)](_0xb05959[_0x578ac1(0x119)],_0x578ac1(0x107))?_0xc96f98[_0x578ac1(0x3d0)]=_0x442f86:_0xb05959[_0x578ac1(0x3ce)](initializeQuiz);}),document[_0x248e04(0x10d)]('keydown',function(_0x323a5c){const _0x29d34e=_0x248e04,_0x3d0ecd={'fMscW':_0x29d34e(0x3d9),'Mqbgv':_0x29d34e(0x9d),'rCmQq':'study','TimkZ':function(_0x4972b7,_0x93a281){return _0x4972b7===_0x93a281;},'MWWzQ':_0x29d34e(0x28f),'krVUk':'incorrectCount','AAyrN':_0x29d34e(0x257),'Fuppu':function(_0x4864c9,_0x3e7c6e){return _0x4864c9>_0x3e7c6e;},'zqbCG':function(_0x160a6f,_0x23838d){return _0x160a6f*_0x23838d;},'OBOpF':function(_0x5e93da,_0x23d928){return _0x5e93da+_0x23d928;},'XsnoX':function(_0x4cbc5a,_0x541894){return _0x4cbc5a/_0x541894;},'nCBmm':function(_0x151d4b,_0x2b314e){return _0x151d4b%_0x2b314e;},'BpgZy':_0x29d34e(0x24a),'GzeXz':function(_0x2cf57e,_0x32fe87){return _0x2cf57e+_0x32fe87;},'lbztH':function(_0x25cc1c,_0x22b990){return _0x25cc1c+_0x22b990;},'rZgBS':_0x29d34e(0x41d),'iONLj':_0x29d34e(0x424),'kkfDE':function(_0x3c82bd,_0x4b93f3){return _0x3c82bd===_0x4b93f3;},'HtqCQ':_0x29d34e(0x1e0),'pYDFi':_0x29d34e(0x427),'XKtzE':function(_0x95d11,_0x51184c){return _0x95d11>=_0x51184c;},'awETz':function(_0x1d4a6b,_0x362923){return _0x1d4a6b<=_0x362923;},'mqfcf':_0x29d34e(0x35f),'loJSP':_0x29d34e(0x283),'dGnzG':function(_0x5462e6,_0x3861d9){return _0x5462e6-_0x3861d9;},'VszMZ':function(_0x1ca430,_0x579b26){return _0x1ca430(_0x579b26);},'hDeYR':'ArrowLeft','lIiaQ':_0x29d34e(0x3b9),'ujPjZ':_0x29d34e(0x108),'Xiusn':function(_0x2b13ea){return _0x2b13ea();},'ebiHC':function(_0x535949,_0x3277ea){return _0x535949===_0x3277ea;},'oDdhC':function(_0x3521b6,_0x5c9068){return _0x3521b6!==_0x5c9068;},'ifZsx':function(_0x41a6cc,_0x551386){return _0x41a6cc===_0x551386;},'ySKjA':'test','apsEG':'timed_exam','rwUNW':function(_0x209bf4,_0x205420){return _0x209bf4===_0x205420;},'XVPCM':function(_0x320799,_0x44c8b9){return _0x320799===_0x44c8b9;}};if(document[_0x29d34e(0x303)](_0x3d0ecd[_0x29d34e(0x261)])['style'][_0x29d34e(0x1bd)]!==_0x3d0ecd[_0x29d34e(0x83)])return;if(_0x3d0ecd[_0x29d34e(0x41c)](document[_0x29d34e(0x303)](_0x3d0ecd['HtqCQ'])[_0x29d34e(0x1ba)]['contains'](_0x3d0ecd['pYDFi']),![]))return;if(_0x3d0ecd[_0x29d34e(0x41e)](_0x323a5c[_0x29d34e(0xbe)],'1')&&_0x3d0ecd[_0x29d34e(0x120)](_0x323a5c[_0x29d34e(0xbe)],'4')){if(_0x3d0ecd[_0x29d34e(0x1fd)](_0x3d0ecd['mqfcf'],_0x3d0ecd['loJSP']))_0x119702[_0x29d34e(0x214)]['forEach'](_0x1a520f=>{const _0x443564=_0x29d34e;if(_0x1a520f)_0x5d1795+=_0x443564(0x2a3)+_0x1a520f+_0x443564(0xf1);});else{const _0x3e87cc=_0x3d0ecd[_0x29d34e(0xa4)](_0x3d0ecd[_0x29d34e(0x30b)](parseInt,_0x323a5c[_0x29d34e(0xbe)]),0x1),_0x412c2b=document[_0x29d34e(0xcb)](_0x29d34e(0x2b4));if(_0x3e87cc<_0x412c2b[_0x29d34e(0x125)])_0x3d0ecd[_0x29d34e(0x30b)](selectOption,_0x3e87cc);}}else{if(_0x3d0ecd[_0x29d34e(0x41c)](_0x323a5c['key'],_0x3d0ecd[_0x29d34e(0x1de)])){if(_0x3d0ecd[_0x29d34e(0x364)]===_0x3d0ecd['lIiaQ'])previousQuestion();else{const _0x458ef5=_0x5c5ec7[_0x29d34e(0x19c)](_0x17ee3e[_0x29d34e(0x22c)](_0x3d0ecd['fMscW']))||{},_0x5287b9=_0x458ef5[_0x5cab77];if(_0x5287b9){const _0x3ccb79=_0x3d0ecd[_0x29d34e(0x228)]['split']('|');let _0x1b7599=0x0;while(!![]){switch(_0x3ccb79[_0x1b7599++]){case'0':_0x444fbd=_0x5287b9['currentQuestionIndex'];continue;case'1':_0x208e8d[_0x29d34e(0x27f)]('Progress\x20loaded.');continue;case'2':_0x2e34da=_0x5287b9['currentMode'];continue;case'3':_0x544baa=_0x5287b9[_0x29d34e(0x386)];continue;case'4':return!![];case'5':_0x992547=_0x5287b9[_0x29d34e(0x3af)];continue;}break;}}return![];}}else{if(_0x3d0ecd[_0x29d34e(0x41c)](_0x323a5c[_0x29d34e(0xbe)],_0x3d0ecd['ujPjZ'])||_0x3d0ecd[_0x29d34e(0x41c)](_0x323a5c[_0x29d34e(0xbe)],'\x20'))_0x323a5c[_0x29d34e(0x3c1)](),_0x3d0ecd[_0x29d34e(0x122)](nextQuestion);else{if(_0x3d0ecd[_0x29d34e(0x8e)](_0x323a5c['key'][_0x29d34e(0x172)](),'b')&&(_0x3d0ecd['kkfDE'](currentMode,_0x3d0ecd[_0x29d34e(0x351)])||currentMode===_0x3d0ecd[_0x29d34e(0x102)])){if(_0x3d0ecd[_0x29d34e(0x309)](_0x29d34e(0x1e5),'OyvUO'))toggleBookmark();else{if(_0x242cfb===_0x3d0ecd[_0x29d34e(0x351)]||_0x3d0ecd['TimkZ'](_0x4befec,_0x3d0ecd[_0x29d34e(0x102)])){_0x3faa32[_0x29d34e(0x303)]('correctCount')['textContent']=_0x1ed125[_0x29d34e(0x3fe)],_0x218870['getElementById'](_0x3d0ecd[_0x29d34e(0x313)])['textContent']=_0x30505c[_0x29d34e(0x380)],_0x100e1b['getElementById'](_0x3d0ecd[_0x29d34e(0x188)])[_0x29d34e(0x3d4)]=_0x1a8b96[_0x29d34e(0x257)];const _0x38ba47=_0x3d0ecd[_0x29d34e(0x9f)](_0x26e030[_0x29d34e(0x257)],0x0)?_0x46f682[_0x29d34e(0x357)](_0x3d0ecd[_0x29d34e(0x289)](_0x1c1f48[_0x29d34e(0x3fe)]/_0x7ef681[_0x29d34e(0x257)],0x64)):0x0;_0x45fef8['getElementById'](_0x29d34e(0x1a1))[_0x29d34e(0x3d4)]=_0x3d0ecd['OBOpF'](_0x38ba47,'%'),_0x2703e7['totalTime']=_0x34c1af[_0x29d34e(0x115)]((_0x143abe,_0x48d411)=>_0x143abe+_0x48d411[_0x29d34e(0x24a)],0x0);const _0x8126c5=_0x39697a[_0x29d34e(0x1c8)](_0x3d0ecd['XsnoX'](_0x1541f4[_0x29d34e(0x3c8)],0x3e8)),_0x46495c=_0x1bf3e3[_0x29d34e(0x1c8)](_0x3d0ecd[_0x29d34e(0x17f)](_0x8126c5,0x3c)),_0x4a597f=_0x3d0ecd[_0x29d34e(0x3ee)](_0x8126c5,0x3c);_0x569cf8['getElementById'](_0x3d0ecd[_0x29d34e(0x34b)])[_0x29d34e(0x3d4)]=_0x3d0ecd['GzeXz'](_0x3d0ecd[_0x29d34e(0x281)](_0x46495c,':'),_0x4a597f[_0x29d34e(0x282)]()[_0x29d34e(0x29d)](0x2,'0'));}}}else{if(_0x3d0ecd[_0x29d34e(0x3ca)](_0x323a5c[_0x29d34e(0xbe)][_0x29d34e(0x172)](),'m')&&(currentMode===_0x3d0ecd[_0x29d34e(0x311)]||_0x3d0ecd[_0x29d34e(0x1fd)](currentMode,_0x3d0ecd[_0x29d34e(0x26e)])))_0x3d0ecd[_0x29d34e(0x122)](toggleMarkForReview);else _0x323a5c['key'][_0x29d34e(0x172)]()==='s'&&(_0x3d0ecd['rwUNW'](currentMode,_0x3d0ecd[_0x29d34e(0x311)])||_0x3d0ecd[_0x29d34e(0x211)](currentMode,'timed_exam'))&&submitQuiz();}}}}});</script>

</body></html>